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 ABSTRACT 
 Students’ use of substances with the intent to enhance cognitive and/or academic 
functioning (referred to as “neuroenhancement”) has received increased academic 
attention in recent years.  However, additional research regarding individual differences 
that increase risk of engagement in neuroenhancement is needed.  Across three studies 
(total N = 410), the current dissertation sought to broaden the extant work in this area by 
investigating one candidate mechanism for university students’ engagement in 
neuroenhancement: self-control.   
 In Study 1, associations of lifetime engagement in various modes of 
neuroenhancement (e.g., “legal neuroenhancement” using legal substances such as 
caffeine, over-the-counter substances, and nicotine; neuroenhancement using illicit drugs; 
and neuroenhancement via non-medical use of prescription stimulants [NMUPS] and 
other prescription drugs) with trait self-control (as measured via a multi-method 
approach) were investigated.  Results demonstrated an association of self-control with 
neuroenhancement broadly, but demonstrated a differential pattern of associations of 
multivariate self-control across the various modes of neuroenhancement.  Thus, this study 
highlighted poor self-control as an important characteristic of students who engage in 
neuroenhancement broadly and emphasized the importance of differentiating substance-
specific classes of neuroenhancement. 
 Study 2 sought to investigate the impacts of state self-control depletion on 
neuroenhancement outcomes (i.e., willingness to engage in neuroenhancement, self-
reported likelihood of future engagement in neuroenhancement behaviour).  Participants 
were randomly-assigned to complete either a purportedly “self-control-depleting” or non-
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depleting condition of a well-established experimental paradigm (Baumeister et al., 
1998).  Although trait self-control was inversely related to intent to engage in 
neuroenhancement, the study failed to demonstrate an effect of state self-control 
depletion on neuroenhancement (operationalized as attitudes and future 
neuroenhancement intent). 
 Finally, Study 3 investigated self-control as a potential contributing factor to the 
previously-demonstrated association of poor academic functioning with engagement in 
NMUPS. As a secondary aim, this study also compared this association across NMUPS 
history variables derived across two time-frames (i.e., dichotomous coding of lifetime 
and past 30-day history of NMUPS) and two measurement methods (i.e., 30-day NMUPS 
history, as measured via a single question vs. through an adapted timeline follow-back 
approach).  Although the pattern of associations varied across models, self-control and 
GPA both contributed to the statistical prediction of neuroenhancement history.  In the 
case of past 30-day history (measured dichotomously), associations of GPA with 
neuroenhancement were fully accounted for by self-control. Interestingly, timeline 
follow-back measurement of NMUPS was associated with neither GPA nor the self-
control variables. 
Across these three studies, variations in self-control were demonstrated to be 
associated with students’ engagement in substance use for cognitive enhancement 
purposes.  Findings are discussed in the context of the Drug Instrumentalization Theory 
(Mueller & Schumann, 2011) and existing models of neuroenhancement as a behaviour 
aimed at self-medication of undiagnosed or subclinical cognitive symptoms (e.g., 
inattention).  Implications for assessment of neuroenhancement are also discussed. 
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I. LITERATURE REVIEW 
Humans have a profound capacity to plan, organize, and monitor their thoughts, 
emotions, and behaviour in order to bring themselves closer to desired long-term goals.  
This capacity is particularly critical in the university setting, where students are faced 
with the need to manage both academic and social demands on their time.  In such a 
setting, self-control is crucial for success; however, self-control is subject to variation 
between individuals, such that some individuals possess less capacity to exert self-control 
across situations (Tangney, Baumeister, & Boone, 2004).  Moreover, it has been 
suggested that self-control is subject to depletion, and therefore may not be available 
when needed (Baumeister, Bratslavsky, Muraven, & Tice, 1998; Baumeister, Vohs, & 
Tice, 2007; Baumeister, Gailliot, DeWall, & Oaten, 2006; Inzlicht, Berkman, Elkins-
Brown, & Inzlicht, 2015; Inzlicht & Schmeichel, 2012; Maples-Keller, Berke, Miller, & 
vanDellen, 2016).  Given the importance of self-control for success in the university 
setting (Duckworth & Seligman, 2005), it is unsurprising that emerging evidence 
suggests students have increasingly sought alternative methods for supplementing one’s 
self-control when it has been exhausted (Englert & Wolff, 2015), often incurring 
considerable personal risk in the process (Clauson, Shields, McQueen, & Persad, 2008; 
Greenhill et al., 2002; Volkow & Swanson, 2003). 
This dissertation comprises a set of studies that collectively seeks to examine 
associations of self-control with one such specific constellation of risky behaviours 
known as “neuroenhancement”, defined as the use of one or more substances with the 
intent to bolster one’s cognitive functioning or otherwise maximize academic 
performance (Eickenhorst, Vitzthum, Klapp, Groneberg, & Mache, 2012).  As such, this 
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT 
 
2 
chapter reviews extant literature related to self-control—including its manifestations as 
both a source of inter-individual and intra-individual variation and its theoretical, 
neurophysiological, and developmental foundations—and provides a framework for 
investigating the relations of this important dimension to the neuroenhancement 
construct. 
Self-Control 
Defining Self-Control 
Although self-control clearly represents an important human function, there is 
considerable disagreement regarding the specific parameters of the self-control construct 
(de Ridder, Lensvelt-Mulders, Finkenauer, Stok, & Baumeister, 2012).  Condensing 
across disparate definitions, however, the literature generally suggests that self-control 
represents an individual’s ability to inhibit or modulate his or her current cognition, 
emotions, or behavioural impulses in favor of bringing himself or herself closer to a 
desired future state (Baumeister, 2013; Duckworth & Kern, 2011; Tangney, Baumeister, 
& Boone, 2004).  This valued end state is informed by the individuals’ internalization of 
societal norms, legal and ethical standards, and his or her own values and goals 
(Baumeister, 2013).   
Dispositional vs. state self-control.  Self-control research has consistently 
demonstrated that self-control varies between individuals.  It has also been proposed that 
self-control varies within individuals (e.g., following self-control “exertion”).  Thus, 
prominent views allow for conceptualization of self-control as both a dispositional and 
state-specific construct.  It therefore follows that low levels of either trait or state self-
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT 
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control may lead to self-regulatory failure (Baumeister, Bratslavsky, Muraven, & Tice, 
1998). 
Dispositional self-control (or “trait self-control”) refers to an individual’s general 
capacity to exert self-control.  Several studies have demonstrated that dispositional self-
control varies across individuals, with some people generally displaying better self-
control than others (Tangney et al., 2004); however, within the individual, dispositional 
self-control remains relatively invariant over time/across development (Hay & Forrest, 
2006; Mischel, Shoda, & Peake, 1988) and predicts outcomes across a range of functional 
domains (de Ridder et al., 2012; Tangney et al., 2004). 
Though self-control varies between persons, it has also been suggested that an 
individual’s level of self-control is subject to influence by environmental, motivational, 
and situational factors (de Ridder et al., 2012); for example, a wealth of studies 
conducted across multiple independent labs has supported the notion that an individuals’ 
ability to enact self-control may dwindle following exertion of self-control (e.g. 
Baumeister, Gailliot, DeWall, & Oaten, 2006; DeWall, Baumeister, Gailliot, & Maner, 
2008; DeWall, Baumeister, Stillman, & Gailliot, 2007; Hagger & Chatzisarantis, 2013; 
Muraven, Tice, & Baumeister, 1998; Post, Boyer, & Brett, 2006; Tuk, Zhang, & 
Sweldens, 2015; Tyler & Burns, 2009); conversely, in this model, one may be less 
susceptible to self-control depletion after systematic “practice” of willpower exertion 
(Baumeister, Gailliot, DeWall, & Oaten, 2006; Oaten & Cheng, 2006) or following 
glucose intake (Gailliot et al., 2007; Gailliot & Baumeister, 2007; Hagger & 
Chatzisarantis, 2013).   
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Although significant debate remains regarding the replicability of this “self-
control depletion effect” (e.g. Baumeister & Vohs, 2016; Hagger & Chatzisarantis, 2016; 
discussed in greater detail below), there does exist a large body of evidence supporting 
the supposed “depletability” of self-control resources.  Thus, although overall levels of 
self-control tend to be relatively stable within the individual over time, one prominent 
view suggests that the availability of self-control resources to the individual at any given 
time may be subject to external and internal influences.  As a result, state levels of self-
control may vary situationally within the parameters dictated by the individuals’ trait self-
control level.   
Self-control vs. impulsivity. In defining self-control, this construct may be 
differentiated from several other intimately-related, yet distinct constructs.  For example, 
it has been argued that self-control and the construct of impulsivity constitute overlapping 
yet discrete aspects of human behavioural functioning (Duckworth & Kern, 2011; 
Kalenscher, Ohmann, & Güntürkün, 2006; Tangney et al., 2004).  Impulsivity is a 
multifactorial construct comprising both cognitive/behavioural (e.g., failure to plan 
ahead, difficulties regulating attention, acting without forethought) and emotional 
features (affective dysregulation, sensation-seeking, and pursuit of risky behaviours; 
Knezevic, 2013).  Generally, impulsivity is thought to result from lower-level or 
“bottom-up” cognitive processes.  It has been suggested, therefore, that  impulsivity is 
conceptually distinct from self-control, which reflects the tendency to employ top-down 
cognitive processes to inhibit these impulses (Duckworth & Kern, 2011).   
Consistent with this view of impulsivity and self-control as separable yet 
interrelated constructs, impulsivity appears to be distinct from self-control on a 
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neurophysiological level; while impulses appear to originate from the activation of 
primarily subcortical regions such as the basal ganglia, amygdala, and lateral temporal 
lobe cortex (Lieberman, 2007), tasks requiring exertion of self-control have been shown 
to activate primarily frontocortical regions of the brain, such as the lateral orbitofrontal 
cortex (Horn, Dolan, Elliott, Deakin, & Woodruff, 2003).  Thus, although they represent 
distinct constructs, self-control and impulsivity may be viewed as opposing processes 
which interact to produce expression or inhibition of a cognitive, emotional, or 
behavioural impulse.  However, it should be noted that, though it is not precisely accurate 
to consider impulsivity and self-control as opposite ends of a single dimension, these 
constructs are at times treated as such (e.g., measures of trait impulsivity are frequently 
employed as measures of self-control; Duckworth & Kern, 2011). 
Self-control vs. self-regulation.  There has also been some disagreement between 
authors regarding whether self-control and self-regulation are synonymous.  At times, 
some have discussed self-control as a component of the broader process of self-
regulation.  Self-regulation has been argued to represent a much broader construct which 
includes both self-control and the capacity to regulate other states (e.g., homeostasis) 
outside of conscious awareness (Hagger, Wood, Stiff, & Chatzisarantis, 2010).  In a 
slightly different interpretation of the construct, de Ridder and colleagues (2012) state 
that “self-control focuses on the efforts people exert to stimulate desirable responses and 
inhibit undesirable responses, and that self-control thereby constitutes an important 
prerequisite for self-regulation” (p. 77; emphasis added).  Although both of these 
accounts suggest that these constructs are apparently separate, these terms are often in 
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practice used interchangeably (Baumeister et al., 2007; Duckworth & Kern, 2011; Kotabe 
& Hofmann, 2015; Tangney et al., 2004). 
Neurodevelopmental Contributions to Self-Control 
 In order for an individual’s level of state and trait self-control to be fully 
understood, it must be situated in its appropriate neurodevelopmental context.  This 
section aims to briefly review the existing research investigating the development of self-
control. 
Initial indicators of development of neural mechanisms for self-control are 
apparent in early childhood (Fox & Calkins, 2003; Posner & Rothbart, 2000; Rueda, 
Posner, & Rothbart, 2005).  For example, as early as approximately 30 months post-
partum, children demonstrate the ability to exert inhibitory control on a developmentally-
modified version of the Stroop task (Posner & Rothbart, 2000).  Additionally, although 
infants can engage in some simple forms of inhibition of behaviour (Garon, Bryson, & 
Smith, 2008), children gain an increased ability to modulate and inhibit their behavioural 
impulses in toddlerhood and throughout the preschool years (Fox & Calkins, 2003). 
Effortful control of one’s attention to relevant internal and external stimuli has been 
found to increase throughout the preschool years and beyond, with continued 
development seen into adulthood (Fox & Calkins, 2003); thus, what may appear to be 
impaired self-control relative to adult-general norms may in fact be normative in the 
context of childhood, adolescence, and even emerging adulthood. 
The developmental progression of self-control has been demonstrated to coincide 
with observed maturation of the frontolimbic regions of the brain (Casey, Jones, & Hare, 
2008).  However, it must be noted that portrayal of an overall pattern of development and 
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greater functionality of these areas ignores discrepant developmental trajectories for the 
involved regions.  For example, development of the corresponding subcortical regions of 
the limbic system responsible for affectivity and reward responsiveness does not 
necessarily proceed in concert with development of the frontal regions that are 
responsible for inhibiting these affective, behavioural, and cognitive impulses (Casey et 
al., 2008).  The discordant developmental trajectories of these two regions can result in 
the emotionality and greater propensity for sensation-seeking and risk-taking often noted 
in adolescence. 
Although this evidence points to a typical pattern of neurobiological progression 
for the development of self-control, such a model (if universally-applied) fails to account 
for the variation between individuals, particularly same-age peers (Casey et al., 2008; 
Fox & Calkins, 2003; Romer, Duckworth, Sznitman, & Park, 2010).  It has been 
suggested that self-control develops as a result of transactional relations between a child’s 
neurobiological development (which may, at baseline, vary from that of peers) and 
factors such as a child’s temperament, parental warmth and control, and the parental 
scaffolding and modeling of behavioural, cognitive, and affective regulation (Casey et al., 
2008; Fox & Calkins, 2003). 
 Thus, self-control appears to develop as part of a complex interchange between 
neurobiological and environmental processes, with different self-control-related skills 
coming “on line” at different points in development.  As such, there are points in 
development (e.g., adolescence and young adulthood) during which a somewhat lower 
level of self-control and a somewhat higher level of impulsivity is relatively normative.  
However, recall that there is considerable inter-individual variation in self-control 
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capacity, even within university-age young adults.  As such, some students may possess 
the requisite self-control abilities to balance competing requirements of academic, 
familial, extracurricular, and social obligations.  By contrast, others may be unable to 
keep up with such diverse demands.   
Theories of Self-Control 
 In light of the complexities of the self-control construct, multiple attempts have 
been made to construct a theoretical framework explaining self-control, its mechanisms 
of operation, sources of inter- and intra-individual variation, and the sequelae of both 
high and low levels of the construct.  According to de Ridder and colleagues (2012), 
theories of dispositional self-control can broadly be classified into three categories: (1) 
those positing a “discounting model of impulsiveness”, (2) “hot-cool system 
approaches”, and (3) the “self-regulatory strength model of self-control” (p. 78).  Briefly 
reviewed here are major perspectives espoused within each of these accounts on self-
control. 
 Discounting models.  The first class of theories of self-control proposed by de 
Ridder and colleagues (2012) encompasses some of the most well-known and most 
thoroughly-researched notions of self-control in the social sciences.  These models (e.g. 
Ainslie, 1975; Gottfredson & Hirschi, 1990; Mischel, Shoda, & Peake, 1988) define self-
control as the capacity to delay immediate gratification in favor of more important 
longer-term gains.  Thus, self-control failure occurs when individuals de-value (or 
“discount”) more valuable future outcomes in favor of less valuable yet more immediate 
outcomes.   
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 Gottfredson and Hirschi’s (1990) Self-Control Theory.  A chief model that 
includes a discounting component was put forth in the late twentieth century by 
criminologists Gottfredson and Hirschi (1990).  In their theory, these authors propose that 
criminal deviance can be wholly accounted for by low self-control, and that self-control 
is expressed in six “elements”.  These elements include: (1) “a concrete here and now 
orientation”, or a tendency to favor immediate gratification over rewarding stimuli 
obtained after a delay; (2) “lack [of] diligence, tenacity, or persistence in a course of 
action”, again reflecting a preference for immediate gratification over rewards which 
require effort in their attainment; (3) tendency to be “adventuresome, active, and 
physical” and (4) “indifferent, or insensitive to the suffering or needs of others”; (5) the 
tendency to “have minimal tolerance for frustration” and (6)  “little ability to respond to 
conflict through verbal rather than physical means” (pp. 89-90).  While the focus of these 
authors’ work was primarily on the mechanisms for criminal behaviour, they additionally 
assert that low self-control is also related to a range of suboptimal yet non-criminal 
outcomes (e.g., alcohol and tobacco use, gambling, risky sex). 
 Gottfredson and Hirschi (1990) suggest that these elements tend to co-occur in 
individuals—an assertion echoed by more recent work; indeed, subsequent theorists have 
suggested that the tendency of these six traits to converge indicates that self-control is a 
single, unidimensional construct reflecting discounting of delayed rewards in a 
preference for smaller, more immediate rewards (Grasmick, Tittle, Bursik, & Arneklev, 
1993).  Of note, however, other authors have alternately suggested that the six elements 
of Gottfredson and Hirschi’s (1990) model constitute individual constructs, reflecting a 
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multidimensional structure of the self-control trait (e.g.,  Arneklev, Grasmick, & Bursik, 
1999; Vazsonyi, Pickering, Junger, & Hessing, 2001). 
 Hot/cool cognition.  A second class of self-control-related theories is that 
comprising “hot/cool cognition” approaches (de Ridder et al., 2012).  These models (e.g. 
Loewenstein, 1996; Mischel, Shoda, & Rodriguez, 1989) consider self-control to be a 
component of a rational, higher-order cognitive network that works to regulate behaviour 
in line with the organism’s long-term goals.  This system is thought to be capable of 
overriding lower-level impulses and emotions but requires the individual’s conscious 
effort to do so.   
 The strength model of self-control.  While the temporal discounting and 
hot/cool cognition approaches to self-control have seen broad use and continue to inform 
current work in this area, the preponderance of recent research in the field has focused on 
the strength model of self-control, a more recent (and controversial) model of human self-
control.  In one study considered foundational to this theory, Baumeister and colleagues 
(1994) posited that, much like a muscle, the employment of self-control to override an 
established behaviour or response routine draws upon a finite internal reserve; it is the 
availability (or lack thereof) of these “willpower” stores which confers self-control 
“strength”, i.e. the likelihood of self-control success.  Critically, all acts requiring self-
control (e.g., self-control of emotion, cognition, or diverse domains of behaviour) are 
hypothesized to draw upon a single reserve under this model. When these limited 
resources become exhausted through exertion of self-control, one is said to be in a state 
of “ego depletion” or self-control depletion, in which the individual is at increased risk of 
self-control failure for any task requiring self-control (Baumeister, 2013; Baumeister et 
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al., 1998; Baumeister & Heatherton, 1996; Inzlicht & Schmeichel, 2012; Vohs et al., 
2008; Vohs, Baumeister, & Ciarocco, 2005).  The central tenets of the strength model of 
self-control have been borne out across numerous empirical studies employing diverse 
paradigms to experimentally manipulate and measure self-control (e.g. Baumeister, 
Gailliot, DeWall, & Oaten, 2006; Chan et al., 2015; DeWall, Baumeister, Gailliot, & 
Maner, 2008; DeWall, Baumeister, Stillman, & Gailliot, 2007; Hagger & Chatzisarantis, 
2013; Muraven, Tice, & Baumeister, 1998; Post, Boyer, & Brett, 2006; Robinson, 
Schmeichel, & Inzlicht, 2010; Tuk, Zhang, & Sweldens, 2015; Tyler & Burns, 2009; 
Wolff, Baumgarten, & Brand, 2013), although some authors have reported null findings 
in their attempts to produce “self-control depletion” effects (e.g., Lurquin et al., 2016; Xu 
et al., 2014). 
 However, despite the large body of single studies that have supported the 
existence of the so-called ego depletion effect, recent efforts to test and refine the 
strength model have resulted in tempered enthusiasm regarding the theory.  For example, 
although some meta-analytic efforts have emerged in support of the viability of the ego-
depletion effect (Blázquez, Botella, & Suero, 2017; Hagger et al., 2010), others have 
suggested that this effect is small or non-existent (Carter, Kofler, Forster, & McCullough, 
2015; Carter & McCullough, 2014).  Similarly, large-scale pre-registered replication 
attempts have produced conflicting results (Garrison, Finley, & Schmeichel, 2018; 
Hagger et al., 2016).  In the context of larger concerns regarding the replicability of social 
science phenomena in general (Heino, Fried, & LeBel, 2017; Świątkowski & Dompnier, 
2017), there also exist concerns that the sizeable literature supporting the existence of an 
“ego depletion effect” is subject to publication bias and questionable research practices 
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(e.g., p-hacking) that lead to bias in the published scientific literature (Friese, Loschelder, 
Gieseler, Frankenbach, & Inzlicht, 2018).  A need for theoretical refinement of the 
mechanisms of the “ego depletion” effect also remains; for example, it has been 
suggested that the “ego depletion” effect is not distinct from other variables already 
specified in literature describing factors producing performance decrements (e.g., 
effort/motivation, fatigue, task difficulty; Hagger et al., 2010). 
 As there are significant limitations to the bodies of evidence both supporting and 
refuting the existence of an “ego depletion” effect, research regarding the demonstrability 
and replicability of the effects hypothesized under the strength model of self-control is 
currently inconclusive (Friese et al., 2018).  As such, although the strength model of self-
control has been instrumental in shaping research on the topic over the past few decades, 
it also remains unclear whether this represents a truly unique and valid effect (as the 
strength model suggests) or a largely erroneous finding reflecting a greater problem in 
psychological science more broadly.  Moreover, there remains need for greater 
specification of the mechanisms of “ego depletion”, and whether they are distinct from 
other, more commonplace phenomena (e.g., fatigue).  Therefore, although it remains a 
prominent theory for the explanation of state variance in self-control, the strength model 
continues to evolve as the body of research supporting, refuting, and refining the model 
expands. 
Correlates of Self-Control 
 Compared to the self-control capacities of neurotypical adults, somewhat lower 
self-control is a normative part of development at some earlier stages of life, such as 
childhood, adolescence, and even young adulthood.  However, while appropriate self-
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control may confer protective effects on the individual, lower self-control compared to 
same-age peers has been linked to a range of suboptimal outcomes at all stages of the 
lifespan.  This section will briefly review the literature investigating the correlates of self-
control, with particular attention paid to emerging adulthood as is relevant for the present 
project. 
 Personality correlates.  Self-control has been linked to a variety of personality 
traits.  For example, several studies have demonstrated associations between trait self-
control and Big Five personality traits (McCrae & Costa, 1987)—including positive 
associations with conscientiousness, openness to experience, and agreeableness (Krueger, 
Caspi, Moffitt, White, & Stouthamer-Loeber, 1996; Tangney et al., 2004), and inverse 
associations with neuroticism (Lange, Wagner, Müller, & Eggert, 2017; Tangney et al., 
2004).  Strong inverse associations have also been demonstrated between self-control and 
the traits of narcissism and aggression (Kim, Namkoong, Ku, & Kim, 2008).   
Psychological functioning.  Given that self-control allows the individual to 
inhibit or alter his or her cognitive and affective states and exert top-down control over 
his or her impulses (Baumeister et al., 1998), it is not surprising that poor self-control has 
been linked to a variety of suboptimal psychological outcomes; one meta-analysis found 
that there was, on average, a medium-sized correlation between self-control and well-
being and adjustment (de Ridder et al., 2012).  For example, university students’ scores 
on a self-report measure of dispositional self-control have been shown to be related to a 
range of psychological outcomes, including internalizing problems (e.g., depression, 
anxiety, obsessive-compulsive symptoms, poor self-esteem, somatization) and 
externalizing problems (anger, hostility; Tangney et al., 2004).  It should be noted that the 
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relation between self-control and psychological well-being may be bidirectional, such 
that stress and distress may limit one’s ability to exert self-control; conversely, those with 
self-control deficits may have poorer control over their internal cognitive and affective 
states (Tangney et al., 2004). 
Low levels of self-control are at the core of several disorders characterized by 
poor impulse control, including conduct disorder, antisocial personality disorder, and 
intermittent explosive disorder (APA, 2013).  Poor self-control is likewise at the core of 
attention-deficit/hyperactivity disorder (ADHD).  This disorder is relatively common 
among children and adults and is characterized by developmentally-inappropriate levels 
of inattention and/or hyperactivity/impulsivity (American Psychiatric Association, 2013).  
One widely-held theory of ADHD suggests that the disorder may reflect a core deficit in 
self-regulation, manifested as inability to successfully direct attention and control 
impulses (Nigg, 2016).  Accordingly, a large body of work has demonstrated associations 
between the symptoms of ADHD and poor trait self-control (Braaten & Rosén, 2000; 
Scheres, Lee, & Sumiya, 2007; Schweitzer & Sulzer-Azaroff, 1995; Unnever & Cornell, 
2003; Wilson, Mitchell, Musser, Schmitt, & Nigg, 2011). 
Eating behavior correlates.  Small-sized relations also appear to exist between 
self-control and health and eating-related behaviours (de Ridder et al., 2012).  For 
example, Peluso and colleagues (1999) found trait self-control to be negatively related to 
disordered eating behaviours and highly restrained eating. A separate study demonstrated 
an inverse association between university students’ dispositional self-control and a range 
of eating disorder-relevant schemata and behaviours, including body dissatisfaction, 
thinness drive, and bulimia (Tangney et al., 2004).  Thus, self-control appears to be a 
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protective factor against both cognitive and behavioural patterns that could jeopardize 
one’s health (particularly those associated with eating disorders). 
Risk-taking and criminality.  Low self-control has been associated with 
criminality and antisocial/delinquent behaviour.  Perhaps the most influential work on the 
topic was conducted by Gottfredson and Hirschi (1990), who suggested that criminal 
behaviour was solely attributable to poor self-control.  Studies have since demonstrated 
that self-control is disproportionately low among incarcerated samples (Longshore, 1998; 
Longshore, Rand, & Stein, 1996; Tittle & Botchkovar, 2005) and predicts youth 
criminality (Baron, 2003).  At both state and trait levels, lower self-control has also been 
associated with greater risk-taking behaviour (Freeman & Muraven, 2010; Keane, 
Maxim, & Teevan, 1993;  Wills, Vaccaro, & McNamara, 1994; Wood, Pfefferbaum, & 
Arneklev, 1993). 
Substance abuse.  An association has likewise been identified between self-
control and substance use.  Individuals with low trait and state self-control have been 
shown to be at increased risk of excessive drinking (Peluso et al., 1999; Tangney et al., 
2004; Wills et al., 1994); in one study, self-control was found to be inversely related to 
university students’ alcohol use problems, such that individuals with higher levels of trait 
self-control had fewer drinking problems—a relation that remained statistically-
significant after controlling for social desirability (Tangney et al., 2004).  Self-control has 
also been shown to be inversely related with risk of illicit substance use (Baron, 2003; 
Wills, Gibbons, Gerrard, Murry, & Brody, 2003; Wills et al., 1994; Wills & Stoolmiller, 
2002; Wills, Walker, Mendoza, & Ainette, 2006), with a sizeable literature specifically 
linking increased delay discounting to substance use risk (de Wit, 2009). 
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Academic difficulties.  One finding with particular relevance to university 
students is the consistent positive relation between self-control and academic outcomes.  
Across numerous studies, this effect is, on average, medium-sized (de Ridder et al., 
2012).  Trait self-control variation has been shown to predict future academic 
functioning; for example, in a classic study of self-control that assessed preschoolers’ 
ability to delay gratification, Mischel and colleagues found that preschoolers’ self-control 
predicted their academic functioning at the end of high school (Mischel et al., 1988).  
Individuals with lower levels of trait self-control have also been shown to earn lower 
grades overall (Tangney et al., 2004;Tibbetts & Myers, 1999; Wolfe & Johnson, 1995), 
engage more frequently in procrastination (Steel, 2007), skip class more frequently 
(Gibbs & Giever, 1995), and be at greater risk of academic dishonesty (Bolin, 2004; 
Cochran, Wood, Sellers, Wilkerson, & Chamlin, 1998; Tibbetts & Myers, 1999).  
Interestingly, self-control has been shown to more strongly predict academic functioning 
than even intelligence (Duckworth & Seligman, 2005), highlighting the important 
association between self-control and students’ functioning in this domain. 
Academic difficulties such as those associated with poor self-control in the 
university setting stand in conflict with the expectation of success placed on many 
students.  In order to meet the demands of the university setting despite self-control 
difficulties, some students may attempt to bolster their cognitive functioning.  
Accordingly, the remainder of this chapter will summarize relevant research from the 
literature investigating “neuroenhancement”, a class of behaviours hypothesized (in the 
current work) to serve as a compensatory routine for poor self-control. 
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Neuroenhancement 
What is Neuroenhancement? 
 Neuroenhancement (also known as “cognitive enhancement” or colloquially as 
“brain doping”; Arria & DuPont, 2010; Bostrom & Sandberg, 2009; Farah, Smith, Ilieva, 
& Hamilton, 2014; Forlini & Racine, 2009; Franke, Bagusat, Rust, Engel, & Lieb, 2014; 
Franke, Bonertz, Christmann, Engeser, & Lieb, 2012; Lucke & Partridge, 2013; Schelle 
et al., 2015) refers to the use of a range of substances with the intention to improve one’s 
cognitive functioning (Eickenhorst et al., 2012).  While neuroenhancement has been 
documented across the lifespan (e.g. Cassidy et al., 2015) and in various professional 
environments (e.g., surgeons: Franke et al., 2013; university faculty: Holloway & 
Bennett, 2015), the most frequent (or well-identified) participants in neuroenhancement 
appear to be university students, who engage in neuroenhancement to support their 
academic achievement (Maier, Haug, & Schaub, 2016b).  However, given concerns about 
the health implications of neuroenhancement (discussed below), this topic is worthy of 
research attention regarding the motives and consequences of engagement in substance 
use for neuroenhancement purposes.   
Historical Foundations of Neuroenhancement 
 Inquiry into the factors that drive neuroenhancement among university students 
must begin with an examination of the greater societal context in which university 
students’ neuroenhancement behaviour occurs.  Neuroenhancement has gained 
considerable attention in recent years.  The subject has been covered widely in the 
empirical literature (Partridge, Bell, Lucke, Yeates, & Hall, 2011), as evidenced by 
publications on the topic in top-tier journals such as Nature (e.g. Greely et al., 2008); 
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however, interest in the subject is also evident in the popular media, with coverage in 
sources such as 60 Minutes (“Boosting Brain Power,” 2010) and the New York Times 
(Petrounin, 2014).  The popularity of the subject highlights the salience of the topic for 
both academics and laypeople alike.  However, interest in expanding the capabilities of 
the human mind is certainly not new to the twenty-first century; as one author has stated, 
“to a large extent, human history is very much the history of enhancement” (Buchanan, 
2011, p. 24).  The known use of naturally-occurring psychoactive substances for 
enhancement of cognitive and affective states dates back millennia (Angrist & 
Sudilovsky, 1978).  As such, neuroenhancement is indeed very much woven into the 
fabric of our global society. 
Alkaloids derived from the herb Ephedra (also known as ma-huang), for example, 
are currently best known for their use as a precursor to methamphetamine and in dietary 
supplements; however, various species of Ephedra have been used throughout history—
as early as 2700 BC in China (Lee, 2011).  Ephedra appears to have been used 
historically for numerous purposes, including the achievement of effects similar to 
modern-day synthetic stimulant drugs (Lee, 2011). Similar histories surround the use of 
other naturally-occurring substances with intent to enhance cognitive and/or affective 
experience, such as the use of khat in Africa and the Arabian peninsula (El-Menyar, 
Mekkodathil, Al-Thani, & Al-Motarreb, 2015) and coca in South America (Martin, 
1970).   
As scientific capabilities for extraction and synthesis of psychoactive compounds 
have increased in recent centuries, so too has interest in use of such substances to 
enhance human cognitive abilities.  For example, amphetamines were first introduced in 
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the early twentieth century for use in medical applications; however, interest soon turned 
to their potential use for cognitive enhancement in neurotypical individuals (Kerley, 
Copes, & Griffin, 2015).  Best known is their instrumental use for such purposes in the 
United States military during World War II, when soldiers were provided with 
amphetamines to use as desired to promote alertness and cognitive performance despite 
sleep deprivation.  However, amphetamines were also widely available to the general 
public during this time and were used widely “for maintaining optimal performance in an 
increasingly fast paced modern life” (Bell, Lucke, & Hall, 2012, p. 26).  Amphetamines 
saw particularly widespread use among workers who perceived them as necessary for 
completion of their work, including laborers, truck drivers, athletes, and—of course—
university students (Kerley et al., 2015).   
Beginning in the 1970s, amphetamines became more tightly-controlled as their 
potential for abuse and addiction became clear; however, around that time, both 
amphetamine- and methylphenidate-based stimulant medications for treatment of ADHD 
began to see increased medical use.  As may be expected, the non-medical use of these 
drugs for enhancement of cognition resurged soon after (Kerley et al., 2015), with 
universities acting as a “hot spot” for illicit/non-medical use (Herman-Stahl, Krebs, 
Kroutil, & Heller, 2007; Smith & Farah, 2011). 
Of course, a parallel exists in the use of legal lifestyle substances, such as coffee 
and nicotine, for their purported central nervous system effects; the use of these 
substances likewise dates back millennia (Mishra & Mishra, 2013; Wood et al., 2013).  
The mythos of coffee as a neuroenhancer, for example, is seen in an Ethiopian legend 
depicting a goatherd who ingested bunn (the fruit and leaves of the coffee plant) after 
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discovering his suddenly-energetic flock chewing the plant.  According to this narrative, 
the goatherd found himself instantaneously full of energy and creativity (Pendergrast, 
2010).  Though this storied discovery of coffee was purportedly an impetus for the spread 
of “coffee culture” throughout Ethiopia (Pendergrast, 2010), it was the forces of 
colonialization (and increased trade throughout the regions in which substances such as 
coffee and tobacco naturally occur) that prompted increased Western—and eventually 
global—use of many of these substances (Mishra & Mishra, 2013; Wood et al., 2013).   
The legacy of legal substances such as caffeine and nicotine has paralleled that of 
now-controlled substances such as amphetamine, and the introduction of new products 
containing these substances has only increased their use as “neuroenhancers”.  For 
example, caffeine also has a history of use by individuals who perceive 
neuroenhancement as a necessary requirement for keeping up with the demands of 
modern society.  This is particularly evident among university students.  While coffee 
and caffeine pills have long been used by students intending to enhance their 
concentration and wakefulness, there has also been a tremendous increase in the use of 
high-caffeine content beverages (e.g. “energy drinks”) since the debut of Red Bull in the 
United states in the late 20th century (Reissig, Strain, & Griffiths, 2009).  In the current 
social context of the “biohacking”/“life hacking” movements and wide marketing of 
“brain training” programs (Wexler, 2017), it may be argued that neuroenhancement using 
lifestyle substances is a common part of life for both university students (Franke et al., 
2014; Mache, Eickenhorst, Vitzthum, Klapp, & Groneberg, 2012) and 
professionals/members of the general public (Wexler, 2017).   
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT 
 
21 
Current Definitions of the Neuroenhancement Construct 
 Although neuroenhancement clearly reflects a constellation of historically-
established and culturally-sanctioned behaviours, this construct has only begun to attract 
substantial scholarly attention in recent years.  A primary task of the recent work 
investigating neuroenhancement has been to elucidate a concrete definition of the 
construct; however, there is no clear consensus within the literature regarding how 
neuroenhancement may best be defined.  A prominent definition  (Maier, Haug, & 
Schaub, 2016a) suggests that neuroenhancement constitutes use of substances with the 
subjective intent to enhance one or more cognitive functions (e.g., alertness, 
concentration, focus, motivation, creativity) or to otherwise facilitate optimal 
academic/work performance (e.g., by reducing negative affectivity).  However, there 
remain discrepancies in the subcategorization of this class of behaviour.  Specifically, 
there are two diverging perspectives on classifying neuroenhancement:  the first defines 
neuroenhancement not as a single construct, but rather as several discrete, substance-
specific categories of behaviour.  In contrast, the second category defines 
neuroenhancement as a unified behavioural construct defined by intent to enhance 
cognition—regardless of the substance used as a means to that end.  Literature 
surrounding these two perspectives is briefly summarized here. 
Neuroenhancement as constituting discrete, substance-specific categories of 
behaviour.  In studying neuroenhancement, the majority of studies have differentiated 
between different modes of neuroenhancement.  According to one framework (Franke et 
al., 2014), three sub-categories of neuroenhancement may be identified: (1) 
neuroenhancement involving the non-medical use of prescription drugs, (2) 
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neuroenhancement involving use of illicit drugs of abuse (e.g., cocaine, cannabis, heroin, 
Speed), and (3) legal neuroenhancement or “soft enhancement” involving legal 
substances such as caffeine, nicotine, and over-the-counter products and supplements.  
The former two categories are often separated from legal neuroenhancement (e.g., 
Eickenhorst et al., 2012; Maier et al., 2016b; Maier & Schaub, 2015) and have been 
referred to collectively as “pharmacological cognitive enhancement” (e.g.  Franke et al., 
2013).  This substance-specific approach to classifying neuroenhancement characterizes 
the majority of existing studies of the neuroenhancement construct; for example, one 
frequent focus of research has been undergraduates’ non-medical use of prescription 
stimulant medications typically used in the treatment of ADHD (e.g., Lookatch, Dunne, 
& Katz, 2012; McCabe, 2008; McCabe & Cranford, 2012; Rabiner, Anastopoulos, 
Costello, Hoyle, & Swartzwelder, 2010; Rabiner et al., 2010; Upadhyaya et al., 2010).   
Neuroenhancement as a unitary behavioural construct.  In contrast to the 
classification of neuroenhancement as comprising multiple substance-specific categories 
(as described above), it has recently been suggested that the notion of neuroenhancement 
should evolve from a substance-based perspective to a behaviourally-based perspective 
(Englert & Wolff, 2015): thus, the use of any substance with the intent to enhance 
cognition would qualify as neuroenhancement.   
This approach draws upon Drug Instrumentalization Theory (Müller & 
Schumann, 2011) as a conceptual framework for understanding neuroenhancement.  
Contrary to other theories that depict substance use as maladaptive, this theory suggests 
that non-addictive use of psychoactive substances may be instrumental and may actually 
increase evolutionary fitness; that is, would-be users identify a discrepancy between their 
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current mental/affective state and a desired mental/affective state, such as successful 
social, sexual, or cognitive/academic performance, euphoria, or successful coping with 
distress.  Would-be users draw upon learned associations of substances with their 
perceived effects, eventually selecting the substance that they believe will effectively 
“enhance” their current state to bring it closer to their desired mental state.   
This perspective would suggest that at the core of all neuroenhancement 
behaviour is the intention to instrumentally enhance one’s cognitive state; as such, all 
neuroenhancement behaviour may be represented as a unitary behavioural construct, 
given that all neuroenhancement behaviour reflects the user’s intention to enhance 
cognition.  The substance used, then, is less important than the user’s perception of the 
substance as effective in bringing them closer to their desired mental state.  In line with 
this theoretical framework, several studies have treated neuroenhancement as a unified 
construct (Englert & Wolff, 2015; Wolff et al., 2013; Wolff & Brand, 2013) or have 
included “soft enhancers” such as caffeine in their definition of neuroenhancement as a 
reflection of this perspective (Franke, Christmann, Fellgiebel, Huss, & Lieb, 2011; 
Franke et al., 2014; Franke, Lieb, & Hildt, 2012; Schelle et al., 2015; Wolff, Baumgarten, 
& Brand, 2013; Wolff et al., 2014).  In support of this view, there is considerable overlap 
between the different “modes” of neuroenhancement, such that an individual who 
engages in one form of neuroenhancement is significantly more likely to engage in 
neuroenhancement using multiple categories of substances (e.g. Wolff & Brand, 2013). 
A note of caution regarding use of the “neuroenhancement” term.  Although 
a considerable body of work has begun to point to the magnitude of the 
neuroenhancement issue—particularly on university campuses—a brief caveat regarding 
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terminology is warranted.  “Neuroenhancement” is termed as such to represent the user’s 
intent (i.e., to “enhance” neurocognitive/affective functioning), and is not intended to 
reflect the outcome of the corresponding substance use.  However, it has been 
(appropriately) suggested that the “neuroenhancement” term may perpetuate the popular 
perception that so-called neuroenhancement substances actually improve cognition in 
neurotypical individuals (Arria, 2016).  As will be reviewed below, this finding has not 
been unequivocally borne out; as such, caution is certainly warranted regarding the use of 
this term. 
Unfortunately, other nomenclatures for the construct in question are likewise 
limited.  Alternatives apply only to the use of specific classes of substances (e.g., “non-
medical use of prescription stimulants”; Blanco et al., 2007; Hanson et al., 2013; Kroutil 
et al., 2006; McCabe, Knight, Teter, & Wechsler, 2005; McCauley et al., 2011; Teter, 
McCabe, Cranford, Boyd, & Guthrie, 2005) and are therefore incompatible with the 
definition of neuroenhancement as a single behavioural construct (Englert & Wolff, 
2015).  It must also be noted that motives for use of a given substance are certainly not 
limited to neuroenhancement.  For example, university students alternately endorse non-
medical use of prescription stimulant medications for recreational use (i.e., to get high) or 
appetite suppression (i.e., weight loss; Rabiner et al., 2009).  Thus, from the perspective 
of motives for substance use, a term such as “non-medical use of prescription stimulants” 
may identify a heterogeneous population, likely including but certainly not limited to 
individuals who use stimulants with the intent to enhance cognitive functioning.   
Given the lack of an acceptable alternative that is inclusive of use of any 
psychoactive substance with the aim of improving cognitive/affective performance, then, 
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the term “neuroenhancement” will be used throughout the present project.  While this 
terminology unites the present investigation with a large extant literature on the topic 
(Eickenhorst et al., 2012; Englert & Wolff, 2015; Maier et al., 2016b, 2016b; Maier & 
Schaub, 2015; Normann & Berger, 2008; Repantis, Schlattmann, Laisney, & Heuser, 
2010; Singh & Kelleher, 2010; Wolff & Brand, 2013; Zelli, Lucidi, & Mallia, 2015), the 
reader is asked to remain mindful of the limitations of this term while reading the ensuing 
discussions of the construct. 
Modes of Neuroenhancement 
This section will briefly review the literature surrounding each of the above-
described categories of neuroenhancement, with specific attention paid to the substances 
most commonly employed for neuroenhancement within each category, their use 
prevalence, and any evidence supporting an enhancing effect on cognition when used in 
neurotypical individuals.  As numerous potential substances fall into each category, 
however, an exhaustive review of all possible neuroenhancement substances is beyond 
the scope of the present chapter.  For excellent recent reviews on the subject, the reader is 
referred to work by Baroni and Castellanos (2015), Fond and colleagues (2015), Franke 
and colleagues (2014), and Maier and Schaub (2015). 
Neuroenhancement involving non-medical use of prescription drugs.  
Research has revealed that university students may pursue neuroenhancement through 
non-medical use of prescription drugs (i.e., use of these drugs without a valid 
prescription; some definitions have also included individuals who possess a valid 
prescription but who use that medication in excess of prescribed dosage; e.g. Arria & 
Wish, 2006).  The most common form of non-medical use of prescription drugs for 
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT 
 
26 
neuroenhancement appears to involve the use of prescription stimulants (e.g. ADHD 
medications such as methylphenidate [e.g., Ritalin, Concerta] and amphetamine 
[Adderall]), with lifetime prevalence estimates among university students ranging from 
5.3% to 35% (reviewed in Weyandt et al., 2013), and with increasing prevalence over the 
past decade (McCabe, West, Teter, & Boyd, 2014). Given that the majority of research 
investigating this category of neuroenhancement has examined the non-medical use of 
prescription stimulants, this section will be devoted to discussion of these substances; 
however, note that although considerably less common, use of other prescription 
medications for neuroenhancement has been documented (e.g., beta blockers, Modafinil; 
Repantis, Schlattmann, Laisney, & Heuser, 2010; Schelle et al., 2015).   
Methylphenidate and medicinal formulations of amphetamine are classified as 
psychostimulants.  Similar to stimulant drugs of abuse such as cocaine and 
methamphetamine, these psychostimulant medications are believed to positively impact 
levels of extracellular dopamine in the brain (Volkow & Swanson, 2003).  However, the 
specific mechanisms by which this is accomplished vary slightly according to each 
specific stimulant; whereas amphetamine stimulates increased release of dopamine in the 
synaptic terminal, methylphenidate blocks the reabsorption of dopamine into the post-
synaptic neuron (Leonard, McCartan, White, & King, 2004; Volkow & Swanson, 2003). 
The resultant influx of dopamine in areas such as the striatum is believed to be 
responsible for reports of an impact of these drugs on attention; in these regions, the 
increase in available dopamine is thought to facilitate neuronal firing relevant to the 
target task and decrease background firing rates (Volkow & Swanson, 2003). 
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As a result of these purported effects on attention, methylphenidate and 
amphetamine formulations represent a cornerstone of treatment of ADHD in children and 
adults alike (Dussault & Weyandt, 2011).  However, though multiple studies have 
demonstrated improvement in the real-world functioning of individuals with ADHD upon 
administration of stimulant medications, the literature has not consistently borne out an 
effect for these drugs on enhancing cognition in neurotypical individuals (Arria, 2016; 
Baroni & Castellanos, 2015; Repantis et al., 2010).  Overall, there is comparatively little 
research investigating the effects of stimulant medications on neurotypical individuals 
(Weyandt et al., 2013), and conclusions drawn from the few existing studies are limited 
by factors such as varying populations studied, differences in dosage between studies, the 
specific medication administered, and inconsistency in cognitive outcome variables 
included (Baroni & Castellanos, 2015).  Further, systematic reviews and meta-analyses 
on the topic  (e.g., Ilieva, Hook, & Farah, 2015; Linssen, Sambeth, Vuurman, & Riedel, 
2014; Smith & Farah, 2011) have often varied considerably with regards to the specific 
studies included, further muddying conclusions drawn from this literature (Baroni & 
Castellanos, 2015). 
Mindful of these limitations, what can be said about the effects of stimulant 
medications on neurotypical individuals’ cognition?  The findings are mixed.  With 
regards to attention, the majority of studies using neurotypical volunteers (71%) failed to 
find any effect of such medications on objective measures of attention and vigilance, 
although nearly half (48%) of studies found a small effect of methylphenidate 
administration on neurotypical individuals’ processing speed (Linssen et al., 2014).  
There is inconsistent evidence for any benefit to neurotypical individuals’ working 
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memory upon administration of these drugs (Smith & Farah, 2011); although an ordinal 
analysis of the literature found that 65% of studies identified a positive effect for working 
memory upon stimulant administration in neurotypical individuals (Linssen et al., 2014), 
a meta-analysis found that, across studies, the effect of stimulants on neurotypical 
individuals’ working memory was essentially null (Ilieva et al., 2015). 
Evidence for an enhancing effect of stimulant medications on objective measures 
of learning and delayed recall is likewise inconsistent.  One systematic review found that 
the effects of stimulants on neurotypical individuals’ cognition were largest in the domain 
of long-term verbal memory (Smith & Farah, 2011); however, another analysis of studies 
on neurotypical individuals found that less than a third (31%) of studies identified any 
effect in this domain (Linssen et al., 2014).  No effects have been identified for visual 
learning and memory upon administration of stimulant medications to neurotypical 
volunteers (Linssen et al., 2014). 
With regards to effects of stimulant medications on higher-order cognitive 
functioning, there is minimal support for the notion that neurotypical individuals benefit 
from stimulant administration.  For example, only a handful (18%) of applicable studies 
found an effect of single-dose methylphenidate on reasoning/problem solving (Linssen et 
al., 2014).  However, there is some evidence to suggest that stimulant medications may 
have a small, positive effect on some aspects of self-control; for example, a meta-analysis 
identified a small effect on neurotypical individuals’ inhibitory/cognitive control (Ilieva 
et al., 2015).  A study by Schmidt and colleagues (2017) likewise demonstrated a 
preferential effect of methylphenidate (versus MDMA and placebo) on neurotypical 
participants’ inhibitory control performance.  Similarly, several studies have suggested 
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that neurotypical individuals feel more motivated following single administration of 
stimulant medication (reviewed in Ilieva & Farah, 2015).  Of particular relevance to the 
strength model of self-control, one study demonstrated that administration of 
methylphenidate to neurotypical volunteers attenuated the effects of self-control 
depletion following a demanding task (Sripada, Kessler, & Jonides, 2014).   
In sum, effects of stimulant medications such as methylphenidate and 
amphetamines (Adderall) are often small, and typically are only identified in a minority 
of studies.  Therefore, there is at best mixed evidence to support the notion that stimulant 
medications such as these constitute “smart pills” when taken by neurotypical 
individuals.  However, there is some evidence to support a motivational or self-regulatory 
effect of stimulant medications in neurotypical individuals.  
Neuroenhancement using drugs of abuse.  The second broad category of 
neuroenhancement is that involving drugs of abuse, including both alcohol and illicit 
drugs of abuse such as cannabis, non-medicinal amphetamines, and cocaine  (Maier & 
Schaub, 2015).  Given that alcohol and illicit drugs appear to be used quite rarely by 
university students with the explicit purpose of cognitive enhancement (in one study, 
lifetime prevalence rates for alcohol and illicit drug neuroenhancement were 1.8% and 
1.3%, respectively; Schelle et al., 2015), the limited literature investigating this form of 
neuroenhancement will be only briefly summarized here. 
This category of neuroenhancement encompasses a broad range of substances 
with varying effects on the central nervous system.  Drugs such as cocaine and non-
medicinal amphetamines are central nervous stimulants which have demonstrated 
potential to enhance users’ level of alertness in a similar fashion to the stimulant 
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medications described above (Maier & Schaub, 2015).  With central nervous system 
depressant properties, the mechanisms of action for alcohol and cannabis differ from 
those of the illicit stimulant drugs (Abood & Martin, 1992; Söderpalm, Ericson, 
Olausson, Blomqvist, & Engel, 2000), and the rationale for using such drugs with the 
intent to enhance cognition may be less intuitive as a result.  However, as Maier and 
Schaub (2015) point out, the mechanism for students’ use of these substances as 
neuroenhancers may be that they facilitate cognitive functioning indirectly via a 
reduction of stress.  Additional research is needed investigating the specific motives of 
the apparently small group of students who use such drugs as neuroenhancement.  
 Legal or “soft” neuroenhancement.  The category of “soft enhancement” 
encompasses the use of  caffeine (including caffeinated beverages such as coffee, tea, and 
energy drinks, as well as caffeine tablets), nicotine, and over-the-counter products (e.g., 
vitamins, gingko biloba) with intent to enhance cognitive functioning (Maier & Schaub, 
2015).  As these substances are widely available and the use of many such substances is a 
routine aspect of many individuals’ day-to-day lives (Maier & Schaub, 2015), this class 
of behaviours is the most common form of neuroenhancement.  Prevalence estimates for 
“soft enhancement” are variable and depend on the scope of the definition (e.g., caffeine 
only vs. inclusion of other substances); for studies adopting a more inclusive definition of 
this behaviour aimed at neuroenhancement (e.g., instrumental use of caffeine-containing 
beverages and tablets, energy drinks, nicotine, and over-the-counter supplements for 
cognitive enhancement), prevalence estimates are quite high; for example, Schelle and 
colleagues (2015) found that 45.6% of university students endorsed a lifetime history of 
use of “soft enhancers” for neuroenhancement.  Similarly, Wolff and Brand (2013) 
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identified a 62.6% lifetime prevalence rate of “soft enhancement”.  In Wolff and 
colleagues’ (2014) study, 83.2% of the sample endorsed this form of neuroenhancement 
behaviour.  Although these rates vary across studies, they share the noteworthy finding 
that a sizeable proportion of undergraduate students self-report use of these substances 
with the specific intent to enhance cognitive functioning.   
Caffeine.  Caffeine is a naturally-occurring, legal stimulant (Wood et al., 2013).  
Caffeine works primarily by blocking the A1 and A2A receptors for the neuromodulator 
adenosine.  As adenosine contributes to drowsiness and fatigue, then, this function of 
caffeine promotes the drug’s known stimulant effects by preventing the action of 
adenosine on postsynaptic neurons (Wood et al., 2013).  Caffeine also appears to prompt 
increased release of dopamine in the prefrontal cortex (in contrast to stimulant drugs with 
a greater addiction potential, such as amphetamines, which also trigger dopamine release 
in the ventral striatum; Fond et al., 2015). 
Caffeine has been demonstrated to have a range of “enhancing effects”; for 
example, moderate amounts of the substance have been demonstrated to improve athletic 
performance  (Burke, 2008).  Medically, the utility of caffeine has been demonstrated for 
some conditions, including migraine (Lipton et al., 1998) and apnea of prematurity 
among infants born preterm or at very low birth weight (Schmidt et al., 2007).  Among 
university students and in society as a whole, however, enhancement of cognition and 
academic/work performance constitutes a primary motive for caffeine use.  Indeed, 
caffeine constitutes the most widely used substance for neuroenhancement (Eickenhorst 
et al., 2012).  While coffee has long held a central role on university campuses, energy 
drinks have quickly gained popularity among university students.  These products are 
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particularly marketed to young adults, often with promises of improved attention, 
concentration, and endurance (Reissig et al., 2009). Accordingly, university students 
endorse use of energy drinks for improved wakefulness, energy, and ability to study or 
complete academic work, along with more recreational motives (Malinauskas, Aeby, 
Overton, Carpenter-Aeby, & Barber-Heidal, 2007).  Finally, a less-common but 
significant form of neuroenhancement via caffeine use is the ingestion of caffeine tablets.  
Many students attempting to increase their attention and vigilance rely upon caffeine-
based products such as these, both to cope with day-to-day academic demands and while 
preparing for larger projects and exams (Maier & Schaub, 2015). 
  In light of the wide use of caffeine with the intention to improve cognitive 
functioning, it is relevant that the expansive literature on caffeine effects has not clearly 
borne out an absolute enhancing effect for caffeine on cognition.  Briefly, caffeine has 
been demonstrated to increase attention and vigilance above placebo with relative 
consistency, although the greatest effects are seen in individuals who are sleep deprived 
or experiencing withdrawal due to abstinence in the context of habitual caffeine use 
(Franke et al., 2014; Wood et al., 2013); as such, it has been suggested that caffeine 
effects may be better represented as a “return to baseline” following sleep deprivation or 
withdrawal rather than an absolute bolstering of cognition above and beyond baseline 
levels (James & Rogers, 2005).  Across studies, the effects of caffeine on higher-order 
cognitive functions such as learning and memory are essentially null when controlling for 
the attention and vigilance effects of the substance (Nehlig, 2010).  Thus, caffeine 
appears to be most effective in restoring attention and vigilance in individuals who are in 
a state of sleep deprivation or withdrawal from caffeine use; however, there does not 
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appear to be significant literature supporting higher-order cognitive enhancement using 
caffeine. 
 Nicotine.  A second common “soft enhancement” substance is nicotine.  Nicotine 
is a naturally-occurring compound with central nervous system stimulant properties. This 
drug broadly works within the central nervous system as a nicotinic acetylcholine 
receptor agonist, although it is also an antagonist in its action on some types of receptors 
(Fond et al., 2015). Nicotine stimulates the release of a range of neurochemicals, 
including dopamine, serotonin, acetylcholine, and glutamate, facilitating change in the 
level of activation of the prefrontal cortex, hippocampus, and amygdala (Heishman, 
Kleykamp, & Singleton, 2010).  Nicotine has been long consumed in the form of tobacco 
products, such as cigarettes, cigars, chewing tobacco, or nicotine chewing gum.  A recent 
addition to this list are so-called “e-cigarettes”, which are marketed broadly to 
adolescents and young adults (de Andrade, Hastings, & Angus, 2013) and which many 
users prefer due to perceived harm reduction over traditional forms of nicotine use 
(although there is no scientific consensus that e-cigarettes are indeed healthier; Pepper & 
Brewer, 2014). 
 Numerous studies have examined the cognitive impacts of nicotine consumption 
on a variety of basic and higher-order cognitive functions.  A meta-analysis of 41 double-
blind, placebo-controlled trials conducted by Heishman and colleagues (2010) 
demonstrated that nicotine facilitated small to medium-sized improvements in human fine 
motor speed and graphomotor output, accuracy and speed of alerting attention, speed of 
orienting attention, speed of working memory output, and accuracy of short-term 
episodic memory.  Studies included sampled non-smokers or non-deprived smokers; as 
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT 
 
34 
such, the authors conclude that the results likely reflect true effects of nicotine (rather 
than withdrawal reversal effects, although it is worth noting that nicotine withdrawal is 
characterized by concentration deficits; Hughes, 2007).  As such, there is evidence from 
high-quality experimental studies that nicotine may prompt small to moderate 
improvements in discrete domains of cognitive functioning. 
  Does “soft enhancement” constitute neuroenhancement?  There is some 
scholarly debate regarding whether “soft enhancers” such as caffeine, nicotine, and over-
the-counter products should be included in the overall neuroenhancement construct.  For 
example, Maier and Schaub (2015) separate “soft enhancement” from so-called 
“pharmacological neuroenhancement”.  Although these authors acknowledge that “soft 
enhancement” substances are frequently used with the intent to enhance cognitive 
functioning, they suggest that “the natural quality of these substances and their ease of 
obtainment via supermarket and pharmacies are the reasons why their use is not classified 
as neuroenhancement” (p. 158).  Others have similarly excluded “soft enhancers” from 
their definition of neuroenhancement (e.g. Eickenhorst et al., 2012).  It should be noted, 
however, that substances in other categories are naturally-derived (e.g., cocaine, 
cannabis, alcohol) and are widely available (certainly alcohol); therefore, the argument 
for the exclusion of “soft enhancers” from “true pharmacological neuroenhancement” 
remains somewhat unsatisfactory.  
 In contrast, several authors have included use of caffeine (either in caffeine-
containing beverages or in tablet form), nicotine, and over-the-counter supplements in the 
construct of neuroenhancement (Franke, Christmann, Fellgiebel, Huss, & Lieb, 2011; 
Franke et al., 2014; Franke, Lieb, & Hildt, 2012; Schelle et al., 2015; Wolff, Baumgarten, 
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& Brand, 2013; Wolff et al., 2014).  This view is in line with the notion that 
neuroenhancement constitutes a single, unitary construct (e.g., Englert & Wolff, 2015).  
Additionally, several studies have demonstrated considerable overlap between 
individuals who engage in so-called “soft enhancement” and those who engage in other 
forms of neuroenhancement, such as non-medical use of prescription stimulants (Arria et 
al., 2010; Eickenhorst et al., 2012; Schelle et al., 2015; Woolsey et al., 2014), supporting 
the notion of a single “neuroenhancement” construct. 
Perceived Effects of Neuroenhancement  
 Given that there is only mixed evidence that commonly-used neuroenhancement 
substances enhance cognitive functioning in neurotypical individuals, why then do 
individuals engage neuroenhancement?  In accordance with Drug Instrumentalization 
Theory (Müller & Schumann, 2011), an important factor may be students’ subjective 
perceptions and expectations of enhancement upon use of such substances. 
 There is evidence to suggest that “soft enhancers” are broadly perceived to be 
effective in enhancing neurotypical individuals’ cognitive functioning.  For example, it is 
widely-believed that caffeine has the ability to sharpen attention and concentration in 
neurotypical individuals (Fond et al., 2015); indeed, the belief alone that one has 
consumed caffeine has been shown to have an impact on both mood and performance 
(Dawkins, Shahzad, Ahmed, & Edmonds, 2011).  Similarly, many smokers cite perceived 
cognitive enhancement as primary benefit of nicotine use (West, 1993).  Like research on 
caffeine, studies of expectancies related to nicotine use demonstrate that the belief that 
nicotine could enhance cognition led to measurably improved motivation to perform well 
on a cognitive task, greater experience of reward, and greater craving reduction (Harrell 
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& Juliano, 2012).  These studies suggest that expectancies of improved cognition 
following use of “soft enhancers” are commonplace and may act as a potential 
mechanism for the use of these substances for neuroenhancement. 
 Research has also supported the idea that students who engage in non-medical use 
of prescription stimulants may similarly expect that these substances positively impact 
cognition.  One of the most commonly-reported motives for university students’ non-
medical use of prescription stimulants is intended enhancement of one or more cognitive 
domains (e.g., improved alertness, motivation, or attention for one’s studies; Carroll, 
McLaughlin, & Blake, 2006; Clegg-Kraynok, McBean, & Montgomery-Downs, 2011; 
DeSantis, Noar, & Webb, 2009; Dussault & Weyandt, 2011; McCabe, Cranford, Boyd, & 
Teter, 2007; Prudhomme White, Becker-Blease, & Grace-Bishop, 2006; Rabiner et al., 
2009; Teter et al., 2005; Teter, McCabe, LaGrange, Cranford, & Boyd, 2006; White, 
Becker-Blease, & Grace-Bishop, 2006).   
Findings from qualitative studies of non-medical prescription stimulant use 
provide further evidence that users perceive these substances as effective for cognitive 
enhancement.  For example, DeSantis, Noar, and Webb (2010) report several students’ 
accounts of their experience of enhancement upon using prescription drugs non-
medically; as one student stated, “‘Sometimes when I cram…I need to study for a long 
period of time and it really helps with that’” (p. 162).  Another student in the same study 
reported that stimulant medication helped to “‘block everybody out around… I get really 
into the details…and I can concentrate like a laser on my organic chemistry, or 
whatever’” (p. 162).  These accounts highlight students’ perceptions of cognitive 
enhancement following non-medical prescription stimulant use.  It is therefore perhaps 
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not surprising that the frequency of nonmedical use of prescription stimulants has been 
shown to be related to one’s positive expectancies regarding stimulant effects (Looby & 
Earleywine, 2011). 
Health Risks Associated with Neuroenhancement 
Often underappreciated by students who elect to engage in neuroenhancement 
behaviour is the resultant risk which accompanies “neuroenhancement”.  Although many 
students are aware of the risks associated with illicit stimulants such as cocaine or 
methamphetamine, for example (Desantis & Hane, 2010), students may perceive non-
medical use of prescription stimulants as low risk given that these drugs are approved by 
the United States Food and Drug Administration for the treatment of ADHD (DeSantis et 
al., 2010).  However, prescription stimulants are associated with potential for adverse 
effects and addiction, suggesting that the use of these substances without the oversight of 
a medical professional may be quite risky (Greenhill et al., 2002; Volkow & Swanson, 
2003).  Even the use of “soft enhancers”, too, can pose risk of negative health 
consequences; although the risks associated with use of nicotine-containing tobacco are 
widely known, less broadly appreciated are the potential medical risks associated with 
high levels of caffeine use, such as physiological dependence, insomnia, tachycardia, 
seizures, and even death  (Clauson et al., 2008; Ogeil & Phillips, 2015).  Thus, while 
neuroenhancement may be perceived as relatively innocuous, this is clearly a dangerous 
misconception. 
Factors Associated with Neuroenhancement Behaviour 
 Considering the increasing prevalence of neuroenhancement and the considerable 
risks associated with neuroenhancement behaviour, efforts have been made to identify 
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characteristics of those individuals who engage in neuroenhancement.  The research on 
this subject is reviewed here.  As a function of the frequent adoption of a “substance-
specific” definition of neuroenhancement and the disproportionate attention paid within 
the literature to some forms of neuroenhancement, the majority of these studies have 
investigated non-medical use of prescription drugs generally, and non-medical use of 
prescription stimulants specifically. When such studies exist, however, research 
investigating the correlates of other forms of neuroenhancement is integrated below. 
 Demographic correlates.  Several studies have investigated the demographic 
correlates of the non-medical use of prescription drugs.  In general, males have been 
found to have higher rates of non-medical use of prescription stimulants than females 
(Franke, Bonertz, et al., 2012; McCabe et al., 2014; Wilens et al., 2008); this finding has 
been mirrored in a study of “soft enhancement” using caffeinated beverages (Franke et 
al., 2011).  Likewise, individuals of Caucasian or Hispanic backgrounds are three times 
more likely to use prescription stimulants non-medically compared to African-American 
students (Wilens et al., 2008).  Involvement in a Panhellenic organization (i.e., fraternity 
or sorority) has also been shown to be a risk factor for neuroenhancement involving the 
non-medical use of prescription stimulants (Desantis & Hane, 2010; DeSantis, Webb, & 
Noar, 2008) and caffeinated beverages (Franke et al., 2011).  Finally, marriage and 
cohabitation appear to be protective against non-medical use of prescription drugs (Dollar 
& Hendrix, 2015). 
Personality correlates.  It has been suggested that the personality of individuals 
who engage in neuroenhancement may be substantially different from that of their 
abstinent peers. For example, individuals who engage in neuroenhancement via non-
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medical prescription drug use have been shown to be less conscientious and more 
neurotic (Benotsch, Jeffers, Snipes, Martin, & Koester, 2013; Sattler & Schunck, 2016); 
one study also demonstrated a relation between openness to experience and nonmedical 
prescription drug use (Benotsch et al., 2013).  Non-medical use of prescription stimulants 
has also been linked to elevated levels of the dark triad personality trait Machiavellianism 
and low levels of empathy (Maier, Wunderli, et al., 2015); it is possible that this pattern 
reflects a selection bias related to a general lack of risk aversion, as non-medically-
utilized stimulants are often obtained illegally (Wilens et al., 2008). Accordingly, a 
relation between non-medical use of prescription stimulants and trait impulsivity has also 
been identified (Lookatch et al., 2012; Maier, Wunderli, et al., 2015).  
Academic functioning.  Individuals who engage in neuroenhancement have been 
shown to have poorer outcomes along several dimensions of academic functioning.  For 
example, individuals who use prescription stimulants non-medically tend to self-identify 
as having greater academic concerns than non-users (Rabiner, Anastopoulos, Costello, 
Hoyle, McCabe, et al., 2009; Rabiner et al., 2010).  Both students who engage in 
nonmedical use of prescription stimulants for neuroenhancement and those who engage 
in “soft enhancement” also report greater study-related stress than non-user peers 
(Schelle et al., 2015).  University students who use prescription stimulants non-medically 
tend to be absent from class more frequently (Arria et al., 2013) and endorse less optimal 
study habits, such as cramming (DeSantis et al., 2008; Ilieva & Farah, 2015).  These 
behaviours may perhaps contribute to the finding that university students who engage in 
non-medical use of prescription stimulants have lower GPA than non-user peers (Arria et 
al., 2013; Clegg-Kraynok et al., 2011; Rabiner, Anastopoulos, Costello, Hoyle, McCabe, 
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et al., 2009; Rabiner et al., 2010) and of poorer grades in individuals who use caffeine 
tablets for neuroenhancement (Franke et al., 2011).   
 Other substance use.  The literature also reveals that individuals who engage in 
non-medical use of prescription drugs are at risk for a range of other substance-use-
related outcomes.  For example, the non-medical use of prescription drugs has been 
linked to greater problems related to cannabis and alcohol use (Arria et al., 2013), greater 
overall use of alcohol and other drugs (Rabiner et al., 2010; Teter, McCabe, Boyd, & 
Guthrie, 2003), increased polysubstance use (Eickenhorst et al., 2012; McCabe et al., 
2005a), and risk of future substance use disorders and binge drinking (Benotsch et al., 
2013).  Likewise, university students who engage in “soft enhancement” have been 
shown to be at increased risk for other categories of neuroenhancement, compared to 
non-user peers (Wolff & Brand, 2013).   
 Psychological functioning.  Associations have been identified between 
neuroenhancement and several aspects of psychological functioning.  For example, non-
medical use of prescription stimulant use and “soft enhancement” have been linked to 
greater perceived stress/strain related to academic demands (Maier, Liechti, Herzig, & 
Schaub, 2013; Wolff & Brand, 2013; Wolff et al., 2014).  Similarly, both “soft 
enhancement” and prescription drug neuroenhancement have been shown to be 
associated with the perception that the individual is faced with overwhelming demands 
(Wolff & Brand, 2013).  Students who use prescription stimulants non-medically also 
endorse greater anxiety overall (Dussault & Weyandt, 2011), greater test anxiety 
specifically (Sattler & Wiegel, 2013), and greater symptoms of depression (Dussault & 
Weyandt, 2011; Rabiner et al., 2010; Wilens et al., 2008).  Overall, this research suggests 
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that those students who engage in neuroenhancement experience greater risk of 
psychological challenges, including those related to their subjective experience of the 
demands of the university environment. 
 Attention-deficit/hyperactivity disorder.  One relevant theme which has emerged 
from studies of the relation between psychological functioning and neuroenhancement is 
an association of the latter with the symptoms of ADHD.  Elevated overall self-report 
symptoms of ADHD have been repeatedly found among nonmedical prescription 
stimulant medication users (e.g., Peterkin, Crone, Sheridan, & Wise, 2011; Upadhyaya et 
al., 2010).  Non-medical use of prescription stimulants has also been shown to relate to 
ratings for the specific ADHD symptom domains of inattention (Arria et al., 2011; Ilieva 
& Farah, 2015; Rabiner et al., 2010) and hyperactivity/impulsivity (Dussault & Weyandt, 
2011; Rabiner et al., 2010).  This finding remains robust after controlling for 
demographic and polysubstance use features of this group (Arria et al., 2011).   
 One possible explanation for this finding is that these individuals actually possess 
subclinical or undiagnosed ADHD (Wilens et al., 2008).  Accordingly, some students 
justify their neuroenhancement via non-medical use of prescription stimulants in terms of 
self-medicating undiagnosed ADHD (Desantis & Hane, 2010).  Relevant to the current 
investigation, however, the elevated symptoms of ADHD reported in individuals who 
engage in neuroenhancement may also be explained in terms of self-control.  Recall that, 
according to a popular theoretical account, ADHD is often characterized by a core deficit 
in self-regulation (Nigg, 2016); thus, it may be suggested that elevated ADHD symptoms 
among students who engage in neuroenhancement may reflect their poorer self-control, 
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which impacts their own self-regulation of their attention, cognition, emotions, and 
behaviour.   
Investigation of this possible relation between neuroenhancement and self-control 
is the chief purpose of this project. As such, the remainder of this chapter will address 
evidence supporting this possibility and will introduce three studies designed to 
investigate the potential relations of self-control with university students’ 
neuroenhancement. 
Self-Control and Neuroenhancement   
 Recent research has begun to expand to consider self-control as potentially 
important factor in university students’ neuroenhancement behaviour.  From a theoretical 
perspective, it is plausible that the perceived motivational effects of neuroenhancement 
may relate to self-control; namely, students engage in neuroenhancement as a means of 
bolstering their motivation for academic tasks when they are unable to rely upon their 
own self-control.  From the perspective of Drug Instrumentalization Theory (Müller & 
Schumann, 2011), university students may identify a discrepancy between their current 
mental state (i.e., insufficient self-control, either as a result of a dispositional deficiency 
in self-control or a situational depletion of self-control) and the desired mental state (i.e., 
sufficient self-control to complete a given academic task).  As a result, students 
instrumentally use substances that they perceive to be effective for neuroenhancement.  
Thus, students’ neuroenhancement may be a means of artificially supplementing self-
control resources when they are insufficient to meet the demands of academic life.   
A similar theoretical account specific to state variation in self-control has been put 
forth by Englert and Wolff (2015).  These authors situate neuroenhancement behaviour 
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within the strength model of self-control, citing research demonstrating that (as would be 
predicted by the strength model) individuals who have no history of neuroenhancement 
revert to their established behavioural response (i.e., abstinence from neuroenhancement; 
Wolff et al., 2013).  Further, it has been demonstrated that neuroenhancement using 
methylphenidate can prevent self-control depletion (Sripada et al., 2014).  Overall, 
however, the prospect of an association between state self-control variation and 
neuroenhancement remains under-investigated in the published literature. 
A parallel argument can be made in support of a relation between dispositional 
(i.e., trait) levels of self-control and neuroenhancement; that is, that individuals who 
possess lower levels of trait self-control are more likely to use neuroenhancement 
(possibly in an attempt to compensate for this deficit).  Though no studies have directly 
examined dispositional self-control in relation to neuroenhancement, a parallel may be 
drawn to the sports performance enhancement literature given comparable performance 
enhancement motives for these two classes of behaviour.  In a study by Chan and 
colleagues (2015), individuals with poorer trait self-control were more likely to endorse 
positive attitudes toward sports-related doping, had greater intent to engage in doping, 
and were less likely to engage in doping avoidance behaviours.  Thus, dispositional self-
control was found to be inversely related to a range of factors related to engagement in 
“enhancement” within the specific context of sport. 
In addition to evidence from the sports doping literature, a number of studies have 
demonstrated a relation between neuroenhancement and traits related to self-control.  As 
described above, neuroenhancement has been shown to be associated with the symptoms 
of ADHD, which have been linked to a core deficit in self-control (Nigg, 2016).  
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Similarly, trait impulsivity has been shown to discriminate between students who engage 
in neuroenhancement and those who do not (Lookatch et al., 2012; Maier, Wunderli, et 
al., 2015).  Although impulsivity and self-control are not synonymous (as described 
above), the high degree of overlap between these traits provides support for the prospect 
of an association between dispositional self-control and neuroenhancement. 
Additionally, the association of neuroenhancement and the Big Five personality 
trait of conscientiousness (Benotsch et al., 2013; Sattler & Schunck, 2016) may likewise 
intimate a relation between self-control and neuroenhancement.  Conscientiousness has 
been shown to be highly correlated with self-control (Tangney et al., 2004), to the extent 
that they are often treated as highly related (Olson, 2005; Steel, 2007) or even 
interchangeable (Moffitt et al., 2011).  Thus, the demonstrated relation between 
conscientiousness and neuroenhancement provides preliminary support for a similar link 
to dispositional self-control. 
The Current Studies 
Although these lines of empirical inquiry have begun to suggest an association of 
both dispositional and state levels of self-control with university students’ 
neuroenhancement, several questions remain unaddressed by the existing literature.  It is 
the aim of the current project to address several limitations in this body of work. 
First, although several studies have implicated constructs related to self-control in 
neuroenhancement behaviour, there have yet been no studies (to this author’s knowledge) 
that have directly measured self-control in its associations with neuroenhancement.  
Further, those studies that have investigated similar constructs have relied primarily on 
self-report questionnaires for the measurement of self-control-related constructs.  Given 
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that best practice in the measurement of self-control employs a multi-method approach 
(Duckworth & Kern, 2011), investigations of how both self-report and performance-
based measures of self-control relate to neuroenhancement are needed.  Questions also 
remain regarding how one’s definition of neuroenhancement (as multiple substance-
specific classes of behaviour versus a single, unified construct) may affect the pattern of 
relations between self-control and neuroenhancement.  In Chapter II, a study is outlined 
that seeks to address these limitations in an examination of the association between 
dispositional self-control and neuroenhancement. 
A second area requiring further inquiry involves the relation between state 
variations in self-control and neuroenhancement.  Overall, this topic remains under-
investigated.  Although one study attempted to experimentally manipulate self-control 
and measure the resultant effects on neuroenhancement (Wolff et al., 2013), the exclusion 
of individuals with a history of neuroenhancement limited the ability of this study to draw 
conclusions about whether these students, too, revert to their “dominant behavioural 
response” (i.e., neuroenhancement) following self-control depletion. Additionally, there 
exists a fundamental need to replicate any effect of “ego depletion” on neuroenhancement 
given overall concerns around the reproducibility of the “ego-depletion” effect (Friese et 
al., 2018).  Chapter III describes a study that aimed to expand upon the work by Wolff 
and colleagues (2013) and potentially provide further credence for a role of self-control 
depletion as an impetus for neuroenhancement behaviour. 
Third, little existing work has directly examined how self-control may contribute 
to the suboptimal real-world outcomes seen in individuals who engage in 
neuroenhancement.  Chapter IV outlines a study that sought to explore a potential role for 
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self-control in the academic difficulties identified in individuals who use prescription 
stimulants non-medically with the intent to enhance cognition. 
In sum, the studies reported herein sought to expand the current knowledge base 
regarding the relations between dispositional and state levels of self-control and 
university students’ neuroenhancement behaviour, and to explore how this relation may 
relate to students’ real-world functioning (i.e., academic outcomes).  In addition to 
contributing data regarding the prevalence and correlates of neuroenhancement in the 
Canadian university setting (which to date remains sparse), it is anticipated these studies 
may both broaden our understanding of why students worldwide may engage in 
neuroenhancement behaviour and assist in identifying students who may be at risk for the 
range of suboptimal outcomes associated with engagement in neuroenhancement.   
Finally, please note that these chapters are each designed to be submitted for peer 
review and scholarly publication as three independent works.  There exists some overlap 
in the literature reviewed in each chapter as a function of this structure.  
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II. EXAMINING ASSOCIATIONS OF NEUROENHANCEMENT 
CLASSIFICATIONS WITH DISPOSITIONAL SELF-CONTROL  
 Human beings have long been captivated by the prospect of enhancing the 
abilities of the mind.  For example, the documented use of naturally-occurring 
psychoactive substances (e.g., coca) for such purposes dates back for centuries (Bell et 
al., 2012).  However, with the synthesis of new psychoactive substances (e.g., cocaine, 
amphetamines) and increased availability of legal products containing high doses of other 
stimulants (e.g., caffeine-based energy drinks; Malinauskas, Aeby, Overton, Carpenter-
Aeby, & Barber-Heidal, 2007), the past century has seen increasingly widespread (and 
socially-sanctioned) use of such substances with the intent to enhance cognitive 
functioning.   
While the use of such substances has allowed for increased cognitive functioning 
for individuals with neurocognitive disorders like attention-deficit/hyperactivity disorder 
(ADHD; e.g. Surman, Hammerness, Pion, & Faraone, 2013), so-called 
“neuroenhancement” by neurotypical individuals—in particular, university students—has 
recently garnered increased research attention.  The neuroenhancement construct, broadly 
defined, constitutes use of psychoactive substances (including legal neuroenhancement 
using “lifestyle” substances such as caffeine and nicotine, and pharmacological cognitive 
enhancement including the non-medical use of prescription drugs and use of illicit drugs 
such as cannabis, cocaine, and Speed; e.g. Eickenhorst et al., 2012; Franke et al., 2013) 
with the intent of enhancing cognition or otherwise bolstering academic/work 
performance (e.g., creativity).  Of note, there is only inconclusive evidence to support 
actual enhancing effects for many of these substances (Baroni & Castellanos, 2015; 
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Nehlig, 2010), and there are considerable and often under-appreciated risks associated 
with their use (including caffeine; Clauson, Shields, McQueen, & Persad, 2008; Greenhill 
et al., 2002; Volkow & Swanson, 2003). Thus, neuroenhancement constitutes a major 
concern for university students’ health and well-being. 
Features Associated with Neuroenhancement 
 Given the gravity of the neuroenhancement issue, previous studies have sought to 
identify risk factors for university students’ engaging in neuroenhancement behaviour.  
One theme that has emerged across such studies is an association of neuroenhancement 
with suboptimal regulation of one’s behaviour, cognition, and emotions, both because of 
situational variation in this important capacity as well as individual differences in ones’ 
general ability to control his or her internal state and behaviour.  This paper proposes that 
these disparate findings may be parsimoniously conceptualized under the construct of 
self-control. 
Dispositional self-control as a potential explanation of university students’ 
neuroenhancement behaviour.  Self-control (also known as self-regulation) is a broad 
construct which reflects an individual’s ability to override or alter impulses in service of 
long-term goals by activating top-down cognitive processes (Duckworth & Kern, 2011).  
A vast literature supports the conceptualization of self-control as a trait or dispositional 
feature that is relatively stable across time and situations and that predicts functional 
outcomes into the future (e.g., Galla et al., 2014; Mischel et al., 1988). 
A wealth of studies using diverse samples have linked trait self-control to such 
important domains as psychological adjustment, relationship functioning and 
commitment, health and eating behaviours, substance use, and risk taking and criminality 
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(reviewed in de Ridder et al., 2012).  Relevant to the present population, dispositional 
self-control has also been implicated in university students’ academic achievement 
(Tangney et al., 2004; Wolfe & Johnson, 1995), academic honesty (Bolin, 2004; Cochran 
et al., 1998) and class attendance (Gibbs & Giever, 1995).  From this line of research, it is 
clear that self-control is vital to success across multiple domains of university students’ 
functioning.   
 To date, no published studies have explicitly demonstrated a relation between a 
measure of dispositional self-control and neuroenhancement behaviour.  However, this 
link may be inferred through studies that have investigated constructs closely related to 
self-control.  Most closely related is the construct of impulsivity.  Although the constructs 
of impulsivity and self-control are typically not viewed as interchangeable, several 
authors have argued that self-control is the antithesis of impulsivity (Duckworth & Kern, 
2011; Tangney et al., 2004);  whereas impulsivity is thought to reflect the “winning out” 
of bottom-up behavioural, emotional, and cognitive impulses, self-control is said to 
emerge from the employment of top-down control to modulate impulses in line with 
goals.   
 One study that has supported an association between neuroenhancement and 
impulsivity was conducted by Lookatch and colleagues (2012); this study demonstrated a 
link between non-medical use of prescription stimulant drugs and self-reported 
impulsivity (as measured by the Urgency, Premeditation, Perseverance, Sensation 
Seeking Positive Urgency [UPPS-P] Impulsive Behavior Scale; Whiteside & Lynam, 
2001).  A similar finding emerged from work done by Maier and colleagues (Maier, 
Wunderli, et al., 2015).  Here, neuroenhancement was shown to be associated with scores 
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on the Barratt Impulsiveness Scale (Patton, Stanford, & Barratt, 1995), a core self-report 
measure of impulsivity.  It should also be noted that the Barratt Impulsiveness Scale is 
frequently employed as a measure of self-control (de Ridder et al., 2012), illustrating the 
intimate conceptual relation between self-control and impulsivity.   
 The symptoms of ADHD represent a second constellation of self-control 
constructs linked to neuroenhancement.  According to a prominent theory of ADHD 
(Nigg, 2016), both the cognitive symptoms (e.g., poor attention/concentration) and 
behavioural symptoms (e.g., hyperactivity, impulsivity) of ADHD may be conceptualized 
as resulting from a central self-regulatory deficit.  The behavioural manifestation of poor 
self-control (e.g., in acting without forethought and in poor control over motor impulses 
such as the urge to fidget or be out of one’s seat) as the hyperactive/impulsive symptoms 
of ADHD is likely self-evident.  Perhaps less apparent, however, is the link between the 
inattentive symptom presentation of ADHD and self-control.  Though the 
hyperactive/impulsive symptoms of ADHD manifest as poor self-control behaviourally, 
individuals with the inattentive symptoms of ADHD are posited to demonstrate poor 
control over their attention (both to external and internal stimuli) and other aspects of 
cognition.  
 Several studies have demonstrated an association between ADHD symptoms and 
neuroenhancement behaviour – to the extent that it has been suggested that individuals 
engage in neuroenhancement (particularly via non-medical use of prescription stimulant 
medications) as an attempt to self-medicate for unidentified or sub-clinical ADHD (e.g., 
Wilens et al., 2008).  For example, overall self-reported ADHD symptoms have been 
shown to be positively related to neuroenhancement (Peterkin et al., 2011; Upadhyaya et 
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al., 2010).  Likewise, neuroenhancement has also been shown to be positively related to 
self-report scores for the specific symptom dimensions of inattention (Ilieva & Farah, 
2015; Rabiner et al., 2010) and hyperactivity/impulsivity (Dussault & Weyandt, 2011).  
Individuals who endorse history of non-medical prescription stimulant use have also been 
shown to perform more poorly on an objective measure of attention (Ilieva & Farah, 
2015).  In sum, these studies support poor self-control of behaviour and cognition in 
individuals who engage in various forms of neuroenhancement.   
 One final source of support for a potential association of dispositional self-control 
with neuroenhancement comes from studies of personality correlates of 
neuroenhancement behaviour.  For example, the Big Five personality trait of 
conscientiousness reflects personality features related to self-discipline, industriousness, 
dependability, and perseverance (McCrae & Costa, 1987).  Conceptually, this construct 
shares many commonalities with the notion of self-control; indeed, these two constructs 
are often treated, at minimum, as highly related (Olson, 2005; Steel, 2007), and at times 
have been used synonymously (Moffitt et al., 2011).  Self-control has also been inversely 
linked to neuroticism, the Big Five trait reflecting negative affectivity and general 
affective distress (McCrae & Costa, 1987).  Conscientiousness and neuroticism 
demonstrate large correlations with self-control in the empirical literature (Tangney et al., 
2004), and both have been implicated in ADHD (Miller, Miller, Newcorn, & Halperin, 
2008)—which, as described above, is likewise relevant to self-control.  
Neuroenhancement (specifically, nonmedical use of prescription drugs in hopes of 
enhancing cognition) has been shown to be negatively related to conscientiousness and 
positively related to neuroticism (Benotsch et al., 2013; Sattler & Schunck, 2016).  Thus, 
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a connection between neuroenhancement behaviour and self-control can again be inferred 
from both constructs’ links with Big Five personality features. 
 Limits of existing work.  Although the reviewed literature has begun to lay the 
foundation for demonstrating an association between neuroenhancement and 
dispositional self-control, gaps remain in the extant body of work in this area.  One 
limitation is the clear heterogeneity in self-control constructs employed across studies, as 
reviewed above.  Though it has been recommended that self-control research employs a 
multi-method approach (Duckworth & Kern, 2011), the emergence of the extant evidence 
from diverse perspectives and research traditions has resulted in a literature that is 
conceptually fragmented.  Therefore, research combining indirect measures of self-
control (e.g., those tapping conscientiousness, ADHD symptoms, and impulsivity) with 
measures designed to directly measure self-control would provide clarity and unity to the 
literature linking neuroenhancement to these self-control-related constructs. 
A second issue limiting the ability draw conclusions about a potential association 
between neuroenhancement and dispositional self-control is the lack of a unified 
definition for the neuroenhancement construct.  A prominent method defines 
neuroenhancement in terms of specific categories of substances used.  One such 
taxonomy subdivides neuroenhancement into three categories: (1) legal 
neuroenhancement (also referred to as “soft neuroenhancement”) using lifestyle 
substances such as caffeine, nicotine, and over-the-counter herbal supplements; (2) non-
medical use of prescription drugs, such as ADHD medications (e.g., methylphenidate, 
amphetamine formulations) and wakefulness-promoting agents used in the treatment of 
disorders such as narcolepsy (e.g., Modafinil); and (3) neuroenhancement using illicit 
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drugs of abuse (Maier, Wunderli, et al., 2015).  Of note, the latter two categories are often 
viewed as distinct from legal/“soft” neuroenhancement and as such are referred to 
collectively as “pharmacological cognitive enhancement” (e.g., Franke et al., 2013).  The 
approach of operationalizing neuroenhancement as distinct, substance-specific categories 
of behaviour is widely used in the research literature; for example, numerous studies have 
specifically investigated the prevalence and correlates of non-medical use of prescription 
stimulant drugs (e.g., Lookatch et al., 2012; McCabe, 2008; McCabe & Cranford, 2012; 
Rabiner et al., 2010, 2010; Upadhyaya et al., 2010).   
 Alternately, it has been suggested that neuroenhancement may be defined as a 
single unitary construct, defined by the use of any psychoactive substance with the intent 
to enhance cognition (Englert & Wolff, 2015).  Informed by Drug Instrumentalization 
Theory (Müller & Schumann, 2011), this approach conceptualizes neuroenhancement not 
in terms of the specific class of substance used, but rather as a “means-end relationship” 
in which individuals identify a discrepancy between their current and desired mental 
states.  This approach suggests, then, that the actual substance used (and the presence or 
absence of any substance-related effects) is not relevant; rather, all neuroenhancement 
behaviour is united under a single intent.  
If, as the first approach suggests, neuroenhancement truly represents discrete 
categories that may be defined on the bases of classes of substances employed for this 
purpose, it would follow that the pattern of variables (e.g., self-control related constructs) 
associated neuroenhancement would potentially vary across categories.  Conversely, if 
neuroenhancement is truly “collapsible” into a unitary behavioural construct, this would 
imply that the constellation of features associated with neuroenhancement as a whole 
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would be consistent across all substance-related categories of neuroenhancement.  
Research is needed to investigate whether potential mechanisms of neuroenhancement, 
such as dispositional self-control, remain consistent across varying definitions of the 
neuroenhancement construct. 
The Current Study 
Overall, the empirical literature has strongly supported a relation between the 
constructs of neuroenhancement and self-control.  However, because these findings 
emerge from different research traditions and from studies with disparate foci, the 
existing literature connecting neuroenhancement to self-control is limited by diverse 
methods of self-control measurement and varying definitions of the neuroenhancement 
construct itself.  The current investigation seeks to bridge this gap by examining whether 
a multivariate array of self-control variables (as defined both by self-report and 
performance-based measures) is differentially associated with various modes of 
neuroenhancement behaviour.   
Through examination of this research question, the present study aimed to achieve 
two goals.  First, planned analyses clarified the relation of self-control with the construct 
of neuroenhancement broadly.  Additionally, examination of the pattern of associations 
of self-control-related variables across classes of neuroenhancement behaviour was 
expected to provide nosological clarity to the construct of neuroenhancement.  
Specifically, demonstration of a consistent pattern of associations of the array of self-
control variables across classes of neuroenhancement would support a conceptualization 
of neuroenhancement as a unitary construct.  If, in contrast, substantial differences exist 
in the pattern of associations of self-control variables across neuroenhancement classes, 
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this result would be more closely aligned with proposed definitions of neuroenhancement 
as a unitary construct.  As such, it is anticipated that the results of the current study will 
both parsimoniously unite the extant literature and clarify the impact of definitional scope 
on research investigating the mechanisms and correlates of the neuroenhancement 
construct.   
Methods 
Participants 
Sample size.  Results of an a priori power analysis using G*Power (Faul, 
Erdfelder, Buchner, & Lang, 2009; Faul, Erdfelder, Lang, & Buchner, 2007) suggested 
that a sample of 166 participants would be needed to detect a medium-sized global effect 
(f2 = .15; Cohen, 1992) across the planned analyses (each consisting of two groups and 
nine response variables).  However, for the purposes of increasing likelihood of detection 
of a smaller effect and ensuring adequate power following removal of any invalid data, a 
target sample size of 200 participants was selected for the current study.   
Recruitment strategy.  Participants were recruited using the University of 
Windsor’s psychology department participant pool.  The participant pool system provides 
students with the opportunity to participate in psychological research in exchange for 
bonus credit in applicable psychology courses (1 credit = 1 hour of participation).  
Although the pool system allows for the use of exclusionary criteria (i.e., participants not 
eligible for a given study will be unable to view that study), exclusionary criteria were 
not deemed necessary for the current study. 
Using these methods, 200 participants were recruited to complete measures used 
in the present study and in the study reported in Chapter IV.  Demographic/background 
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information for the current sample are reported in Table 1; rates of neuroenhancement 
endorsement for the sample are reported in Table 2.  Briefly, slightly more than half of 
participants identified as female (57.5%).  Participants were also primarily Caucasian 
(55.5%) and in an academic program within the university’s Faculty of Arts, Humanities, 
and Social Sciences (68.8%).  Participants were relatively balanced across first year 
(20%), second year (17.5%), third year (32.0%), and fourth year of their university 
studies (21.5%).  A small minority of participants indicated that they were in their fifth 
year and beyond (7.5%). 
Measures 
As part of a larger study (that also included measures used in the study reported in 
Chapter IV), participants completed the self-report and performance-based measures used 
to derive variables of interest for the main analyses, as described below.  Descriptive 
statistics for these measures are reported (both for the total sample and according to 
specific neuroenhancement groups) in Table 3.   
Demographics.  A brief measure sampling several demographic constructs 
relevant to the current study was created for use across the three related studies of this 
project (Appendix A).  Questions included inquiry about a variety of neuroenhancement 
risk/protective factors (e.g., age, gender, Panhellenic affiliation, sports team involvement, 
relationship status; e.g. Dollar & Hendrix, 2015; Dussault & Weyandt, 2011; Ford, 2008).   
History of neuroenhancement behaviour.  On review of the literature, no single 
appropriate measure was available that could meet the needs of the current study (i.e., 
measurement of history of neuroenhancement, as defined broadly and via use of specific 
substances with the intent to enhance cognition).  As such, a series of was assembled for 
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this study.  Similar to the approach described by previous researchers (e.g. Franke et al., 
2011; Gallucci, Martin, & Usdan, 2015; Gallucci, Usdan, Martin, & Bolland, 2014; 
Maier et al., 2013; Schelle et al., 2015), participants were asked to identify whether they 
had used a range of substances for the purpose of neuroenhancement, over the course of 
three time-frames (i.e., lifetime, past year, past 30 days).  Participants were also asked to 
report the frequency of use for each of these substances during these three time-frames 
(Gallucci et al., 2014, 2015). 
Coding history of neuroenhancement.  The primary method used for coding 
neuroenhancement was intended to distinguish specific categories of neuroenhancement 
behaviour.  This was accomplished by creating a variable coding neuroenhancement 
history for each of the three categories put forth by Franke and colleagues (Andreas G. 
Franke et al., 2014): (1) legal/”soft” neuroenhancement (e.g. use of caffeine, nicotine, 
over-the-counter supplements for neuroenhancement), and the two classes collectively 
referred to as “pharmacological cognitive enhancement” (e.g., Franke et al., 2013): (2) 
prescription drug neuroenhancement  (e.g., use of ADHD medications, beta blockers, 
prescription wakefulness promoters such as Modafinil, with the intent to enhance 
cognition) and (3) illicit drug neuroenhancement (e.g., use of illegal substances, such as 
cocaine, speed with the intent to enhance cognition).   
These variables were coded dichotomously, although slightly different approaches 
were taken to classifying the dichotomous nature of the legal vs. pharmacological 
cognitive enhancement variables.  For legal neuroenhancement, a dummy-coded variable 
was created for which the reference group (coded “0”) reflected no endorsed lifetime 
history of legal enhancement.  Participants who endorsed lifetime history of legal 
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neuroenhancement were coded positive (“1”) on this variable.  For the pharmacological 
cognitive enhancement categories, a variable was created for each category (i.e., illicit 
drug neuroenhancement, prescription drug neuroenhancement).  Participants were coded 
positive (“1”) on each variable if they endorsed lifetime history of the corresponding 
behaviour.  For both illicit substance neuroenhancement and prescription drug 
neuroenhancement, the reference group reflected participants who denied any lifetime 
history of pharmacological cognitive enhancement generally (i.e., lifetime history of 
neither illicit drug neuroenhancement nor prescription drug neuroenhancement).  
Participants who denied the use of the target category for neuroenhancement but who had 
engaged in an alternate form of pharmacological cognitive enhancement were therefore 
excluded from comparison (e.g., a participant with no history of illicit substance 
neuroenhancement but positive history of prescription drug neuroenhancement would not 
be included in the reference group for analyses pertaining to the illicit substance 
neuroenhancement category).  This coding scheme was employed in order to reduce any 
confound that would be introduced by including other modes of pharmacological 
cognitive enhancement in the reference group. 
Self-control.  The current study utilized a multi-method approach in the 
measurement of self-control.  Specifically, the included measures sampled a variety of 
foundational self-report measures of self-control.  Performance-based measures of self-
control were also included as a complement to self-report measurement of this construct.  
This decision was guided by research demonstrating that self-report measures may be 
limited by sources of bias in reporting (Podsakoff, MacKenzie, Lee, & Podsakoff, 2003; 
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Van de Mortel, 2008) and that performance-based measures of self-control account for 
variance that is distinct from self-report measures (Duckworth & Kern, 2011).   
Self-Control Scale.  The Self-Control Scale (Tangney et al., 2004) is a 36-item 
questionnaire designed to measure variation in dispositional self-control.  For each item 
(e.g., “I refuse things that are bad for me”), participants are asked to rate the degree to 
which the statement applies to him- or herself on a scale from one (“not at all”) to five 
(“very much”).  The items of the Self-Control Scale generally emphasize one’s capacity 
to “override or change one’s inner responses, as well as to interrupt undesired behavioral 
tendencies (such as impulses) and refrain from acting on them” (Tangney et al., 2004, p. 
274).  Thus, items generally reflect individuals’ ability to regulate attention/cognition, 
emotions, and behavioural impulses, and to persist on tasks. The authors of the Self-
Control Scale report good psychometric characteristics for the measure, including 
internal consistency (α = .89), test-retest reliability (r = .89), and evidence for convergent 
and discriminant validity.  Internal consistency was good in the current sample (α = .86). 
Barratt Impulsiveness Scale. The Barratt Impulsiveness Scale (BIS-11; Patton, 
Stanford, & Barratt, 1995) is a 30-item questionnaire that measures a variety of 
behaviours related to trait impulsivity (and conversely, dispositional self-control).  Items 
of the BIS-11 broadly tap impulsivity related to direction of attention and behaviour, and 
failure to value long-term goals (Stanford et al., 2009); as such, the focus of this measure 
is similar to, but distinct from, that of the Self-Control Scale.  Responses on the BIS-11 
can be used to derive scores for three subscales: Attentional Impulsiveness (e.g. “I don’t 
pay attention”; “I often have extraneous thoughts when thinking”), Motor Impulsiveness 
(e.g., “I act ‘on impulse’”; “I am future oriented”—reverse scored), and Non-Planning 
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Impulsiveness (e.g. “I plan tasks carefully”).  In previous research, internal consistency 
values for the subscales have been variable (αattentional  = 0.74, αmotor = 0.59, αnon-planning = 
0.72; Stanford et al., 2009).  In the current sample, internal consistency of the BIS 
subscales ranged from questionable (αmotor = .67) to acceptable (αattentional = .77, αnon-planning 
= .70). 
Big Five Inventory.  The Big Five Inventory (BFI; John, Donahue, & Kentle, 
1991; John, Naumann, & Soto, 2008)  is a self-report questionnaire measuring variation 
on the five traits comprising the Five Factor Model of personality (McCrae & Costa, 
1987).  For each of the 44 items, participants were asked to rate the degree to which a 
given characteristic applies to him- or herself, using a scale ranging from one (“disagree 
strongly”) to five (“agree strongly”).  In comparison to the Self-Control Scale and the 
BIS-11, the BFI items appear to most often frame the underlying self-control constructs 
in terms of characterological traits, rather than specific behaviours.  From these items, 
factor scores may be calculated for each of the Big Five traits.  Given the scope of the 
present study, only the factor scores for Conscientiousness (e.g., “can be somewhat 
careless”—reverse scored) and Neuroticism (e.g., “is emotionally stable, not easily 
upset”—reverse scored) were utilized.  Test-retest reliability for the BFI 
Conscientiousness and Neuroticism scores has been shown to be acceptable 
(rconscientiousness = .70, rneuroticism = .76; Rammstedt & John, 2007).  The subscale scores have 
demonstrated acceptable-to-good part-whole correlations in previous studies 
(αconscientioousness = .77 - .84; αneuroticism range = .85 - .88; Rammstedt & John, 2007).  
Internal consistency in the current sample was good for both the Conscientiousness 
subscale (α = .80) and the Neuroticism subscale (α = .84). 
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Barkley Adult ADHD Rating Scale.  Also included in the present study was a 
measure of participant’s current ADHD symptoms, the Barkley Adult ADHD Rating 
Scale-IV  (BAARS-IV; Barkley, 2011).  The BAARS-IV quantifies participant’s scores 
for each of the ADHD diagnostic criteria, as originally laid out in the fourth edition of the 
Diagnostic and Statistical Manual for Mental Disorders (American Psychiatric 
Association, 2000) and as remains unchanged in the updated fifth edition (APA, 2013).  
For each of the 27 diagnostic criteria, participants were asked to rate how often that item 
has applied to them over the course of the past six months, using a four-point scale ([1] = 
“never or rarely” to [4] = “very often”).  Researchers may derive both total scores and 
symptom counts for each of four symptom factors (Inattention, Hyperactivity, 
Impulsivity, and Sluggish Cognitive Tempo).  Additionally, a BAARS-IV total score can 
be computed; it was the metric that was used in the present investigation.  According to 
the author, the BAARS-IV total score boasts excellent reliability (α = .91) and evidence 
of construct validity (Barkley, 2011).  Internal consistency of the BAARS-IV total score 
was excellent in the current sample (α = .98). 
Delay Discounting Task.  For the current study, delay discounting was included 
as a performance-based measure of self-control.  Delay discounting refers to individuals’ 
tendency to prefer small, immediate rewards over larger, future rewards, to the extent that 
they begin to devalue rewards that occur after a delay (Mazur, 1987).  Delay discounting 
is implicated in impulsivity and self-control, and there is evidence to suggest that 
individuals’ degree of delay discounting may constitute a trait construct (Kirby, 2009).  
This variance accounted for by performance-based measures of self-control, such as the 
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delay discounting task, has been shown to be considerably distinct form self-report 
measures (Duckworth & Kern, 2011). 
In the present study, participants’ degree of delay discounting was measured via a 
computerized task administered using the Psychopy platform v.1.83.04 (Peirce, 2007).  
This task, designed by Johnson and Bickel (2002), provides participants with a series of 
choices between reward options, delivered immediately and after varying latencies (on 
the order of days, months, and years) and of varying monetary values. In line with the 
majority of research investigating delay discounting (Odum, 2011a), the rewards in this 
study were purely hypothetical.  (It should be noted that there are no observable 
differences in delay discounting on tasks providing hypothetical vs. actual rewards; 
Odum, 2011a).  For each immediate-delayed reward pair, an indifference point is located, 
at which participants choose the smaller, immediate reward approximately as often as 
they choose the larger, delayed reward (i.e., they are indifferent to the smaller vs. larger 
reward). 
Several formulae exist for deriving a representative score from delay discounting 
tasks.  For the current study, use of the “area under the curve” of the discounting function 
(AUC; Myerson, Green, & Warusawitharana, 2001) was selected as the most optimal 
metric of participants’ delay discounting.  The AUC is derived from the following 
equation: 
x2 – x1 [(y1 + y2)/2] 
In this equation, x1 and x2 represent the magnitude of the respective delays.  The y values 
represent the monetary value of the indifference points corresponding to each delay 
(Odum, 2011a).  This equation is applied to each consecutive delay/indifference point 
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pairing, and the resultant values are added together.  Values of the AUC potentially range 
from 0 to 1 (reflecting complete delay discounting and no delay discounting, 
respectively).  The AUC boasts several advantages over other delay discounting derived 
scores (e.g., k), including that it is atheoretical and tends to be more normally-distributed 
than the k statistic (and therefore preferable for inferential analyses; Myerson et al., 
2001).   
Stroop color-word task.  The Stroop color-word task is among the most 
frequently-employed measures of self-control (Duckworth & Kern, 2011). In contrast to 
the delay discounting task, the Stroop task is considered a measure of ability to inhibit 
prepotent responses.  Given high test-retest reliabilities (Franzen, Tishelman, Sharp, & 
Friedman, 1987; Strauss, 2005), there is evidence to suggest that Stroop performance taps 
a trait construct (c.f. Odum, 2011b).  A version of this task was included as a second 
performance-based measure of self-control in the present study.  In keeping with multiple 
previous studies of self-control (e.g. Fennis, Janssen, & Vohs, 2009; Gailliot et al., 2007; 
Gailliot, Schmeichel, & Baumeister, 2006; Inzlicht, McKay, & Aronson, 2006), the 
Stroop task was administered by computer.  The specifics of the Stroop protocol utilized 
in this study were patterned from work by Gailliot and colleagues (2006).   
In each trial of the Stroop task, participants were presented with a color word (e.g. 
RED, BLUE, or GREEN) which was displayed in either a congruent text color (e.g., 
BLUE printed in blue-colored text) or an incongruent color (e.g., BLUE printed in red-
colored text).  Participants were asked to indicate the font color of each displayed word 
using the computer keyboard (i.e., pressing the R, G, or B key), ignoring the word itself.  
Participants first completed a practice phase to ensure that they understood the task.  
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT 
 
64 
Following the practice phase, participants completed three blocks of the main Stroop 
task.  In blocks one and three, participants completed 30 congruent trials per block.  In 
the second block, participants completed 60 incongruent trials.   
In measuring participants’ Stroop task performance, self-control was quantified in 
terms of participants’ reaction time in completing the interference trials, as this metric has 
been demonstrated to be the most stable measure of Stroop-derived self-control (Strauss, 
2005).  Supplementary scores (e.g., total errors on congruent and incongruent trials; 
Gailliot et al., 2006) were also calculated and are reported below in order to remain 
consistent with other studies in the self-control literature.   
Procedure 
 Following approval from the university’s research ethics board, an advertisement 
for the current study was posted to the psychology participant pool website, inviting 
participants to sign up for a timeslot to participate.  At the scheduled time, participants 
came to the lab and completed the informed consent process.  Questionnaire data and 
self-control tasks were then administered on a computer, in random order, with validity 
check items interspersed throughout to ensure included data were valid (i.e., free from 
random / invalid responding).  If invalid responses were detected, a prompt (to check all 
responses prior to proceeding) was automatically administered via the online survey 
platform.  
Data Analysis 
Data preparation.  Before conducting the main analyses, data were examined for 
missing data. Analysis of missing data points revealed a sparse pattern of missing data, 
with 3.73% of values missing across the variables of interest.  According to  Little’s 
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT 
 
65 
(1988) test of patterns of data missingness (i.e., “Missing Completely at Random 
[MCAR]”), these missing data points were missing completely at random (χ2 (12310) = 
9913.09, p = 1.00).  Expectation maximization, a commonly-utilized strategy for missing 
data imputation, was deemed appropriate for imputation of missing data due to the small 
quantity and random pattern of missing data.  All analyses were completed in IBM SPSS 
Statistics for Windows, version 19 (IBM Corp., Armonk, N.Y., USA).   
Data were also checked for violations of the statistical assumptions of 
multivariate analysis of variance (MANOVA; Field, 2009).  MANOVA assumes 
multivariate normality; examination of skew and kurtosis values (i.e. skewness < |2|, 
kurtosis < |3|) and visual inspection of variable histograms suggested that dependent 
variables included in the MANOVA analyses adequately approximated the normal 
distribution.  MANOVA also assumes homogeneity of variance-covariance matrices.  
Box’s test was nonsignificant across models examining the association of multivariate 
self-control with legal substance neuroenhancement (F(45, 187.24) = 0.95, p = .58), illicit 
substance neuroenhancement (F(45, 22547.28) = 0.95, p =.57), and prescription drug 
neuroenhancement (F(45, 25041.72) = 1.00, p = .46), suggesting that this assumption was 
not violated in the present sample.    
The MANOVA assumption of independence of observation was met as a function 
of sampling procedures; participants were permitted to contribute only one case to the 
current dataset.  It should be noted that MANOVA also assumes that data comprise a 
random sample of the overall population (Field, 2009).  As participants were sampled 
from the university’s participant pool, they may not be representative of the general 
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population (Gallander Wintre, North, & Sugar, 2001).  This must be considered when 
interpreting results of the MANOVA analyses. 
MANOVA also assumes absence of outliers; as such, data were examined for 
presence of outliers (z > ± 3.27; Tabachnik & Fidell, 2001).  Three cases constituted 
outliers and were therefore excluded from subsequent analyses.  The data were also 
examined for indicators of invalid responding (i.e., participant failed or did not respond to 
one or more attention check items).  An additional seven cases were removed on this 
basis, resulting in a final sample of N = 190 for subsequent analyses. 
Main analyses.  A series of three MANOVA models was conducted, separately 
examining the multivariate association of the array of self-control variables with the three 
dichotomous neuroenhancement history variables (i.e., legal neuroenhancement, illicit 
neuroenhancement, and prescription drug neuroenhancement).  For each model, the nine 
self-control variables were entered as the dependent variables (Self Control Scale total 
score; BIS-11 Attentional Impulsiveness, Non-Planning Impulsiveness, and Motor 
Impulsiveness; BAARS-IV total score; BFI Conscientiousness and BFI Neuroticism; 
delay discounting AUC; Stroop incongruent trials response time).  As sample size was 
unequal across the cells of the analysis (due largely to the high proportion of participants 
who endorsed legal neuroenhancement; see Table 3), statistical adjustment for unequal 
sample size was undertaken using a built-in feature of SPSS.   
Although the practice of probing statistically-significant MANOVA effects with 
multiple follow-up analyses of variance (ANOVAs) is conventional, it has been 
suggested that this approach ignores the relationship between dependent variables.  
Additionally, the practice of following a statistically-significant MANOVA with multiple 
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ANOVAs does not allow for identification of any dimension(s) that underlie the 
measured constructs and that systematically vary across groups (Field, 2009).  In order to 
enhance ability to establish a theoretical framework for understanding (and 
differentiating) various classes of neuroenhancement behaviour, statistically-significant 
MANOVAs were followed by discriminant function analyses (DFAs).  Loadings (i.e., 
correlations of the standardized discriminant function coefficients with the resultant 
variate in each model) were considered meaningful if they exceeded 0.364, according to 
the guidelines proposed by Stevens (2002) for samples of this size. 
Results  
 Results for each neuroenhancement model are reported below.  As a supplement 
to results reported for each MANOVA model, variable intercorrelations are presented in 
Table 4. 
Legal neuroenhancement.  Results demonstrated a medium-sized, statistically-
significant effect of lifetime history of legal neuroenhancement on the multivariate array 
of self-control variables (λ = .90, F(9, 180) = 2.28, p = .02, partial η2 = .10; observed 
power = .91).  DFA yielded a single discriminant function (canonical R2 = .10) that 
significantly differentiated participants who endorsed legal neuroenhancement from those 
who did not (χ2(9) = 20.06, p = .02).  The correlations between standardized coefficients 
and the discriminant function revealed large loadings of self-rated self-control (r = -.68), 
non-planning impulsiveness (r = .67), motor impulsiveness (r = .63), attentional 
impulsiveness (r = .56), and ADHD symptoms (r = .56) onto the variate.  Associations of 
the variate with neuroticism (r = .36), conscientiousness (r = -.29), delay discounting 
AUC (r = .25), and Stroop response inhibition (r = -.22) did not exceed the a priori 
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threshold (r = 0.364).  Examination of the unstandardized function values at group 
centroids indicated that lower scores on the variate conferred lower risk for legal 
neuroenhancement history endorsement.  Thus, abstinence from legal neuroenhancement 
appeared to be a function of better self-rated self-control (reflected in the linear 
combination of higher self-rated self-control, lower self-rated impulsiveness, and lower 
self-rated ADHD symptoms). 
 Illicit drug neuroenhancement.  There was also a medium-sized, statistically-
significant multivariate effect of lifetime illicit drug neuroenhancement on the array of 
self-control variables (λ = .89, F(9, 151) = 1.94, p = .03, partial η2 = .11).  Although this 
analysis was based on a subset of the sample that was marginally smaller than the a priori 
estimated size needed to detect a medium effect (n = 161 vs. estimated required N = 
166), observed power exceeded the conventional threshold of .80 (observed power = .88).  
DFA identified a single discriminant function (canonical R2 = .11) that significantly 
differentiated participants who endorsed illicit drug neuroenhancement from those who 
did not (χ2(9) = 18.22, p = .03).  The correlations between standardized coefficients and 
the discriminant function revealed large loadings of motor impulsiveness (r = .55), 
ADHD symptoms (r = .52), and self-rated self-control (r = -.50) onto the variate.  Small 
loadings were also observed for attentional impulsiveness (r = .39) and delay discounting 
AUC (r = .38).  Associations of the variate with Stroop response inhibition (r = -.36), 
neuroticism (r = .26), conscientiousness (r = -.24), and non-planning impulsiveness (r = 
.09) did not reach the a priori threshold for interpretation.  Examination of the function 
values at group centroids revealed that positive history of illicit substance 
neuroenhancement was associated with higher scores on the variate.  Thus, illicit 
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substance neuroenhancement appeared to be a function of poorer self-rated self-control 
(reflected in the linear combination of greater motor impulsiveness, greater ADHD 
symptoms, and poorer self-control), but (somewhat paradoxically) less impulsive 
performance on the delay discounting task (i.e., higher AUC values, reflecting a more 
shallow temporal discounting gradient and therefore less decisional impulsiveness among 
participants with history of illicit substance neuroenhancement; Myerson, 2001).   
 Prescription drug neuroenhancement.  In the model comparing individuals 
with positive lifetime history of prescription drug neuroenhancement to those with no 
history of pharmacological cognitive enhancement, the multivariate effect of prescription 
drug neuroenhancement was small-to-medium-sized (partial η2 = .08) but not statistically-
significant (λ = 0.92, F(9, 163) = 1.59, p = .12).  This finding was surprising considering 
the robust body of research demonstrating an association of non-medical use of 
prescription drugs (particularly stimulants) with self-control (see above).  However, it 
should be noted that although the subsample used for these analyses (n = 173) exceeded 
the necessary sample size determined by a priori power analyses (N = 166), observed 
power was slightly lower than the conventional .80 criterion for power (observed power = 
.75), suggesting minimally increased possibility of Type II error in this model.  
Given the unexpected failure to demonstrate a multivariate effect of prescription 
drug neuroenhancement on multivariate self-control and marginally increased Type II 
error probability regarding detection of the multivariate effect in this model, exploratory 
univariate analyses were used to probe for univariate associations of specific self-control 
variables (Table 5).  Results demonstrated statistically-significant (p <.05) associations of 
lifetime history of prescription drug neuroenhancement with self-reported ADHD 
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symptoms, overall self-rated self-control, and attentional impulsiveness.  With the 
exception of ADHD symptoms (p = .005), these results did not withstand application of 
Bonferroni correction for multiple comparisons (p <.006). 
Follow-up analyses after removal of irregular delay discounting data.  
Associations of delay discounting were in the opposite direction than would be 
anticipated on the basis of poorer self-control among individuals who engaged in the 
various classes of neuroenhancement behaviour.  Although this relation was statistically-
significant in Model 2, examination of group means (Table 3) revealed that this pattern 
existed (although was not statistically-significant) across all classes of 
neuroenhancement.  Because of this unexpected pattern, delay discounting data were 
examined for irregular patterns impacting the discounting curve (i.e., curve reflects 
devaluation of larger immediate rewards in favor of smaller delayed rewards).  The 
pattern of results described above was unchanged following removal of affected cases (n 
= 10).   
Discussion 
 The present study aimed to investigate associations of trait self-control variation 
with neuroenhancement.  Multivariate associations of three modes of neuroenhancement 
behaviour (legal neuroenhancement, illicit drug neuroenhancement, prescription drug 
neuroenhancement) with a constellation of self-control variables were explored.   
Results suggested that self-control was associated differentially with the three 
modes of neuroenhancement behaviour.  Specifically, there was a statistically-significant 
multivariate association of self-control with both legal neuroenhancement and illicit drug 
neuroenhancement.  Discriminant function analyses suggested medium-to-large loadings 
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of self-rated self-control (as measured by the Self Control Scale), ADHD symptoms, 
motor impulsivity, and attentional impulsivity onto variates explaining both the legal 
neuroenhancement and illicit neuroenhancement variables.  Another mode of impulsivity 
(non-planning impulsiveness) also loaded heavily onto the variate explaining legal 
neuroenhancement history, but not onto the illicit substance neuroenhancement variate.  
Conversely, a performance-based measure of self-control (delay discounting) loaded 
meaningfully only onto the illicit neuroenhancement variate, although interestingly, the 
observed direction of this relation was in the opposite direction than would be anticipated 
by an association of poor self-control with illicit substance neuroenhancement (i.e., 
higher delay discounting AUC values—typically interpreted as less impulsive delay 
discounting performance—were identified for the illicit substance neuroenhancement 
group relative to participants who had not engaged in pharmacological cognitive 
enhancement).  Finally, although no statistically-significant multivariate effect of 
prescription drug neuroenhancement history on self-control existed, a statistically-
significant (following correction for multiple comparisons) univariate association of self-
rated ADHD symptoms with prescription drug neuroenhancement history was identified.  
Taken together, these results suggested an overall association of self-control with 
neuroenhancement that is identifiable across substance-specific categories of 
neuroenhancement.  This outcome is consistent with the extant literature, which has 
demonstrated an association of various facets of self-control with neuroenhancement 
(e.g., Ilieva & Farah, 2015; Lookatch et al., 2012; Peterkin et al., 2011).  Importantly, 
much of the existing body of work has focused on the substance-specific class of 
neuroenhancement comprising non-medical use of prescription stimulants.  The current 
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study uniquely highlights an association of lower self-control with neuroenhancement 
broadly, including both legal neuroenhancement and two classes of pharmacological 
cognitive enhancement (illicit drug neuroenhancement and prescription drug 
neuroenhancement).   
Notably, the symptoms of ADHD appeared to be a particularly unifying “thread” 
underlying all three classes of neuroenhancement in the current study.  Thus, these results 
lend credence to the hypothesis that neuroenhancement may constitute self-medication 
for undiagnosed, under-treated, or sub-clinical ADHD symptoms—an assertion supported 
by empirical associations of ADHD symptoms with non-medical use of prescription 
stimulants (e.g., Wilens et al., 2008) and in qualitative interviews of students who engage 
in this behaviour (Desantis & Hane, 2010).  As such, students’ perceptions of deficient 
self-control of attention and impulses (as reflected both on self-report ratings and 
qualitative self-report) appears to confer general risk for engagement in 
neuroenhancement.   
Despite a shared association of self-control among the three neuroenhancement 
classes, the pattern of specific self-control associations diverged with regards to 
neuroenhancement mode.  Specifically, a similar array of variables appeared to drive 
associations of both legal and illicit neuroenhancement with multivariate self-control.  
These included motor impulsiveness, attentional impulsiveness, and overall self-rated 
self-control (Self-Control Scale).  Interestingly, these associations did not replicate for 
prescription drug neuroenhancement, suggesting that this latter category may be distinct 
(conceptually, and in the mind of students who engage in neuroenhancement) from legal 
and illicit drug neuroenhancement.   
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Additionally, an association of performance-based measures of self-control with 
neuroenhancement was not consistently demonstrated across various classes of this 
behaviour.  Indeed, response inhibition (Stroop) did not demonstrate meaningful loadings 
onto the variates predicting either legal or illicit drug neuroenhancement histories, and 
delay discounting performance loaded only onto the illicit drug neuroenhancement 
variate.  Surprisingly, the observed relation of delay discounting AUC with the variate 
explaining illicit drug neuroenhancement was in the opposite direction than would be 
anticipated (at the surface, reflecting less severe decisional impulsiveness and therefore 
more robust self-control among students who had history of illicit substance 
neuroenhancement).   
This result is paradoxical, given that self-report measures in the same model 
appear to demonstrate a protective effect of self-control against illicit drug 
neuroenhancement.  However, poor congruence between self-report and performance-
based measures of self-control is not unexpected, and indeed, previous research has 
demonstrated only small correlations between self-report and performance-based 
measures of a range of psychological and behavioural constructs—including self-control 
(Duckworth & Kern, 2011).  In addition to this issue, it bears noting that unequal cell 
sizes may have impacted these results.  Therefore, replication in additional samples 
(particularly samples designed to equally recruit individuals with history of various 
modes of neuroenhancement behaviour) will be necessary to enhance confidence in the 
reliability of this result.  
 Despite these practical concerns, it is interesting that (among the current sample) 
history of illicit substance neuroenhancement most frequently reflected reported use of 
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cannabis for cognitive enhancement purposes.  The variate predicting this behaviour was 
distinct from that predicting legal neuroenhancement; although both models indicated 
that individuals who engage in legal neuroenhancement and illicit drug 
neuroenhancement rate themselves as having poorer self-control, illicit drug 
neuroenhancement was also differentiated on the basis of less decisional impulsiveness 
(delay discounting AUC).  These findings may highlight a meaningful distinction 
between legal and illicit neuroenhancement; namely, that illicit drug neuroenhancement 
may reflect a degree of planful behaviour not required for legal substance 
neuroenhancement (due to the wide availability of legal and over-the-counter 
neuroenhancement substances versus the greater effort and risk associated with obtaining 
cannabis and other illicit drugs).  As such, would-be consumers of illicit substances for 
neuroenhancement may be required to obtain these substances in advance of their use, 
whereas legal neuroenhancement substances are readily available to bolster academic 
work.   
It is interesting to note that, in contrast to research in other substance use groups 
(who generally demonstrate greater temporal discounting than unaffected controls), an 
association between cannabis use (for any purpose) and temporal discounting has not 
been consistently borne out among abstinent users (e.g., Gonzalez et al., 2012) or even 
following acute administration of ∆9-tetrahydrocannabinol (THC), the psychoactive 
compound present in cannabis (McDonald, Schleifer, Richards, & de Wit, 2003).  
Therefore, further research is certainly needed in order to replicate and fully understand 
the clinical importance of this result. 
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It is important to highlight that the use of cannabis for illicit neuroenhancement is 
also differentiated from legal neuroenhancement on the basis of cannabis’s presumed 
functionality.  In addition to the perception that cannabis is able to directly facilitate 
cognitive processes such as attention and creativity (Green, Kavanagh, & Young, 2003), 
users report instrumental engagement in cannabis use for its purported stress- and 
negative affect-reduction effect.  Indeed, existing literature has demonstrated an 
association of anxiety, academic stress, and negative affectivity with cannabis use 
(Middendorff, Poskowsky, & Isserstedt, 2012).  It then seems plausible that, rather than 
engaging in neuroenhancement impulsively, some students may engage in higher-risk 
behaviours such as cannabis use to reduce negative affectivity in support of cognitive 
enhancement.  For example, Maier and colleagues (2013) suggest that “a well-rested 
brain likely learns more efficiently.  Thus, for example, the consumption of cannabis or 
alcohol with the purpose of calming oneself, turning off recurring thoughts, and falling 
asleep would allow one to be more vigilant and increase concentration the following 
morning” (pp. 7-8) and as such may qualify as neuroenhancement behaviour.  However, 
given such prior research, it is interesting that neuroticism did not load highly onto the 
illicit substance neuroenhancement variate in the current study.  Further research 
involving both self-control and a more diverse range of psychological variables will be 
helpful in continuing to lend clarity to the mechanisms that drive neuroenhancement 
substance selection.  
In addition to unequal sample size, further limitations of the current study must be 
noted. First, the decision to utilize pharmacological cognitive enhancement-naïve 
participants (i.e., those who had engaged in neither illicit drug nor prescription drug 
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neuroenhancement) resulted in a somewhat smaller available subsample of data available 
for these analyses.  Thus, although an attempt was made to over-recruit for the present 
study in order to allow for adequate power for each of the three models in the final 
sample, it must be noted that the observed power in for the model explaining prescription 
drug neuroenhancement was slightly lower than the conventional criterion (.80; observed 
power for Model 3 = .75).  Therefore, a minimal increase in Type II error probability 
must be acknowledged for this model.  Replication in a larger sample may clarify the 
failure to identify a multivariate effect of prescription drug neuroenhancement history on 
self-control in the current sample.  
Additionally, in keeping with much of the previous literature in this area (e.g., 
Maier et al., 2013; White, Becker-Blease, & Grace-Bishop, 2006), the current study 
defined neuroenhancement in terms of lifetime history of this behaviour.  However, there 
certainly exist varying degrees of engagement in neuroenhancement behaviour, ranging 
from one-time to occasional and daily use.  Investigation of frequency of 
neuroenhancement behaviour in future studies will be an important factor in 
understanding the neuroenhancement construct (Schleim & Quednow, 2018).   
Although it is representative of the university where participants were recruited, 
the generalizability of the current sample should also be considered.  The current sample 
included a majority of Caucasian (55.0%) participants.  Given previous demonstration of 
effects of ethnicity on neuroenhancement behaviour (Wilens et al., 2008), it remains 
unclear to what extent the current findings are generalizable to more diverse student 
groups.  Additionally, participant gender has been demonstrated to confer 
neuroenhancement risk (Dussault & Weyandt, 2011; Ford, 2008).  Although the current 
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sample did include slightly more female than male participants, it must also be noted that 
gender was, in fact, more equally-distributed in the current study than is common among 
studies utilizing psychology participant pool samples (which tend to be 
disproportionately female; Dickinson, Adelson, & Owen, 2012) despite no specific effort 
to recruit an equal gender distribution in the current study.  Although this feature of the 
current sample likely increases its generalizability to the university student population 
broadly, it likely decreases the ability to compare current findings to studies based on 
more typical undergraduate participant samples. 
Finally, it should be acknowledged that the prevalence of neuroenhancement has 
been shown to vary based on university size and competitiveness of one’s academic 
program/school (Desantis & Hane, 2010; McCabe, Knight, Teter, & Wechsler, 2005).  As 
the current sample was recruited from a mid-sized, public university, prevalence 
estimates may not generalize to more competitive academic environments.  Nonetheless, 
it should be noted that prevalence rates among the current sample were quite high, and in 
the case of legal neuroenhancement, the sample demonstrated near-ubiquitous 
engagement in this behaviour.  
Despite these limitations, results of the current study have important implications 
for the scholarly understanding and use of the neuroenhancement construct.  Per current 
results, a common association self-control (namely, ADHD symptoms) and 
neuroenhancement generally appears to exist.  However, although it has been suggested 
that neuroenhancement may be “collapsible” into a unitary construct (Englert & Wolff, 
2015), current findings contend that doing so may wash out subtle distinctions between 
modes of neuroenhancement.  Based on the current study, prescription drug 
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neuroenhancement appears to be a particularly distinct category, as (unlike legal and 
illicit neuroenhancement) it failed to demonstrate a relation with multivariate self-control.  
Thus, ongoing research may benefit from continued treatment of these constructs as 
distinct in order to enhance ongoing understanding of the risk factors of engagement in 
the range of neuroenhancement behaviours. 
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Table 1 
Study 1 Participant Demographic Characteristics (N = 200) 
  percent endorsed 
Gender Female 57.5 
 Male 41.5 
 No response 1.0 
Ethnic 
background1 
Aboriginal/First Nations 1.0 
Black/African  12.0 
East Asian  3.0 
South Asian/Indian 7.5 
 Hispanic/Latino 2.5 
 Caucasian or non-Hispanic  
     White/European  
55.0 
 Arab/Middle Eastern  12.0 
 Biracial/multiethnic 5.5 
 Other 0.5 
 Prefer not to answer 1.0 
Academic 
faculty 
(program of 
study) 
Arts, humanities, and social sciences 68.0 
Education 1.0 
Engineering 2.5 
Kinesiology 5.0 
Law 0.0 
Nursing 4.0 
Business 8.5 
Science 9.0 
 Undecided 0.5 
 No response 1.5 
Honors status Enrolled in honors program 7.0 
Not enrolled in honors program 91.5 
No response 1.5 
Year of study  First 20.0 
Second 17.5 
 Third 32.0 
 Fourth 21.5 
 Fifth 7.0 
 Sixth and beyond 0.5 
 No response 1.5 
  M (SD) 
Age 21.59 (4.37) 
GPA (%) –university cumulative average* 78.29 (8.16) 
GPA (%) – last semester average** 79.43 (8.48) 
Note.  1Categories are not mutually-exclusive.  Abbreviation: GPA = grade point average. 
*university cumulative average only available for students in their second semester and 
beyond.  **students in their first semester were asked to report last semester of high 
school GPA. 
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Table 2 
Study 1 Descriptive Statistics:  Participant Endorsement of Various Modes of 
Neuroenhancement – Full Sample (N = 200) 
 
Neuroenhancement Category % Endorsed (Lifetime) 
Legal Neuroenhancement  94.0  
     Coffee  84.5  
     Energy Drinks  60.5  
     Caffeine Supplements  19.5  
     Herbal Supplements  33.5  
     Probiotics  16.0  
     Alcohol  28.0  
     Nicotine  17.5  
Pharmacological Cognitive Enhancement  37.0  
Illicit Drug Neuroenhancement  22.5  
     Marijuana  21.0  
     Other Illicit Substances  6.0  
Neuroenhancement via Non-Medical Use of 
Prescription Stimulant / ADHD Medication 
 23.5  
     Methylphenidate (e.g. Ritalin)  6.0  
     Amphetamines (e.g., Adderall)  18.5  
     Modafinil (e.g. Provigil)  0.5  
     Omecetin (e.g., Cognient) – Foil  0.0  
     Other/unknown ADHD medication  11.5  
Neuroenhancement via Non-Medical Use of 
Any Prescription Medication1 
 28.0  
     Beta-blockers  0.5  
     Other prescription medication  8.0  
Any Neuroenhancement  95.5  
Note.  Neuroenhancement categories are not mutually-exclusive. 1Includes 
neuroenhancement via non-medical use of prescription stimulant/ADHD medications and 
beta-blockers and other prescription medications.   
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Table 5 
Post-Hoc Univariate Analyses – Lifetime History of Prescription Drug 
Neuroenhancement vs. No History of Pharmacological Cognitive Enhancement (n = 173) 
 
 t df p d 
SCS Total Score 2.25 171 .025 .37 
BFI Conscientiousness 1.21 171 .229 .20 
BFI Neuroticism -1.25 171 .213 -.21 
BIS Attentional Impulsiveness -2.43 171 .016 -.41 
BIS Motor Impulsiveness -1.67 171 .097 -.28 
BIS Non-Planning Impulsiveness -1.39 171 .167 -.23 
BAARS-IV Total Score -2.86 171 .005* .47 
Stroop Incongruent Trial RT 1.17 171 .245 .19 
DDT AUC -1.78 171 .078 -.29 
Note. Abbreviations: BIS = Barratt Impulsiveness Scale 11; BAARS-IV = Barkley Adult 
ADHD Rating Scale – Fourth Edition; SCS = Self Control Scale; BFI = Big Five 
Inventory; RT = Reaction Time; AUC = Area Under the Curve. *statistically-significant 
after Bonferroni correction (p < .006). 
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III. SELF-CONTROL AND NEUROENHANCEMENT:  INVESTIGATING THE 
EFFECTS OF SELF-CONTROL DEPLETION ON NEUROENHANCEMENT 
ACCEPTABILITY AND INTENT 
 Success in the university setting requires that students consistently apply a 
constellation of cognitive skills to meet academic demands and work toward long-term 
goals. In recent decades, considerable research has documented an increased trend for 
university students’ use of a range of substances with the intent of bolstering these 
requisite cognitive functions.  This behaviour is broadly termed neuroenhancement: the 
use of psychoactive substances (including soft enhancers—i.e., legal, lifestyle drugs such 
as caffeine, nicotine, and over-the-counter herbal supplements; prescription drugs, such 
as attention-deficit/hyperactivity disorder [ADHD] medications and beta blockers; and 
drugs of abuse, such as alcohol, cannabis, cocaine, heroin, and non-medicinal 
amphetamines) with the intent to improve one or more domains of cognitive functioning 
(e.g., concentration, attention, alertness, vigilance, or memory; Maier & Schaub, 2015). 
Although prevalence estimates are lower for neuroenhancement involving non-medical 
use of prescription drugs and drugs of abuse—particularly using illicit drugs (e.g., 
Kaloyanides, McCabe, Cranford, & Teter, 2007; Maier & Schaub, 2015; McCabe, West, 
Teter, & Boyd, 2014), prevalence estimates for the most common form of 
neuroenhancement (“soft enhancement” using lifestyle substances) indicate that nearly 
90% of university students engage in this form of neuroenhancement (Mache et al., 
2012).  This statistic reveals that, in contexts like the university, neuroenhancement may 
be a near-universal phenomenon.   
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Although the majority of neuroenhancement research has investigated specific 
modes of neuroenhancement behaviour (e.g., non-medical use of prescription stimulants; 
Arria et al., 2011; Donaldson, Siegel, & Crano, 2016; Egan, Reboussin, Blocker, 
Wolfson, & Sutfin, 2013; Gallucci, Usdan, Martin, & Bolland, 2014; Lookatch, Dunne, 
& Katz, 2012; Rabiner, Anastopoulos, Costello, Hoyle, & Swartzwelder, 2010; Sattler & 
Schunck, 2016), it has been suggested that neuroenhancement behaviour is united under a 
shared motive and may thus be best considered a single behavioural construct (Brand & 
Koch, 2016; Englert & Wolff, 2015; Wolff et al., 2013).  In this model, the actual 
mechanism of action—and whether the mechanism is indeed effective for 
neuroenhancement—is deemed unimportant.  This assumption appears to be supported 
by the fact that many of these drugs boast only little or mixed evidence of actually 
enhancing cognition in neurotypical individuals (e.g. Baroni & Castellanos, 2015; Nehlig, 
2010).  
Importantly, limited evidence of support for the “neuroenhancing effect” among 
many such substances suggests that the benefit of neuroenhancement fails to outweigh 
the significant risk associated with reliance on these substances to meet the demands of 
day-to-day life.  Indeed, there is considerable risk of adverse effects associated with 
misuse even of common, legal neuroenhancement substances.  For example, caffeine—
commonly consumed with the intent to enhance cognition in the form of coffee, energy 
drinks, or caffeine tablets—has been associated with insomnia, tachycardia, seizures, and 
even death in some instances (Clauson et al., 2008).  The prospect of addiction and other 
life-altering medical complications associated with use of other neuroenhancement 
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compounds likewise highlights the gravity of the issue (Greenhill et al., 2002; Volkow & 
Swanson, 2003).   
Given the weight of this issue, there is great need for studies moving beyond 
description of the neuroenhancement phenomenon and its correlates into work identifying 
potential causal mechanisms for neuroenhancement (which may lay the groundwork for 
intervention and prevention efforts).  In support of this aim, the present study builds on 
emerging research implicating variations in state levels of self-control as a potential 
framework for understanding intent to engage in neuroenhancement behaviour. 
Self-Control and Neuroenhancement 
The construct of self-control shows promise as a potential mechanism for 
neuroenhancement behaviour.  Self-control may be defined as an essential human 
capacity to employ higher-order cognitive processes to sublimate or inhibit behavioural, 
emotional, and cognitive urges.  This regulatory process is conducted with the primary 
goal of moving the individual closer to his or her goal state (de Ridder et al., 2012; 
Duckworth & Kern, 2011).  Variables overlapping with dispositional (i.e., trait) levels of 
self-control have been frequently found to be inversely related to neuroenhancement 
behaviour (Dussault & Weyandt, 2011; Lookatch et al., 2012; Maier, Haug, & Schaub, 
2015; Rabiner et al., 2010; Sattler & Schunck, 2016).  Additionally, similar research 
regarding doping in sports demonstrated an inverse relation of trait self-control with both 
athletes’ attitudes toward sports-related performance enhancement, and their ratings of 
intent to engage in the same (Chan et al., 2015). Overall, such findings suggest the 
importance of the overall ability to regulate one’s cognition and behaviour as a factor that 
protects against engagement in neuroenhancement.   
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State variation in self-control and its relation to neuroenhancement.  Beyond 
trait-level variation in self-control, it has been suggested that state levels of self-control 
may explain both inter-individual and intra-individual differences in intent to engage in 
neuroenhancement.  Previous authors (Englert & Wolff, 2015; Wolff et al., 2013) have 
posited that the self-regulatory strength model of self-control may be a particularly 
relevant theoretical framework for conceptualizing neuroenhancement behaviour in terms 
of state self-control depletion. 
The self-regulatory strength model of self-control (also known as the resource 
model of self-control or the ego strength model of self-control; e.g., Baumeister, 
Bratslavsky, Muraven, & Tice, 1998; Baumeister, Vohs, & Tice, 2007; Baumeister & 
Heatherton, 1996) provides a perspective on state variability in self-control that, despite 
recent controversy surrounding its replicability, has gained status over the past few 
decades as an influential theory regarding human behaviour.  The strength model 
suggests that exercise of self-control draws on limited resources; much like a muscle, 
self-control resources (popularly referred to as “willpower”) become taxed through 
repeated or intensive acts of self-control.  When an individual has sufficiently “fatigued” 
his or her capacity for self-control, he or she is said to be in a state of ego depletion (or 
self-control depletion), in which self-control failure (and therefore reversion to the 
individual’s dominant behavioural regime) on further tasks requiring self-control is likely 
(Baumeister et al., 1998).   
Importantly, this model posits that all acts of self-control—regardless of the 
specific behavioural, emotional, or cognitive act involved—draw on the same limited 
reserve.  A wealth of studies has demonstrated that a range of “depleting” acts of self-
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT  
88 
control (e.g., choosing a healthy food option over sweets; engaging in a task requiring 
sustained vigilance and mental effort; filtering out distracting background stimuli during 
a primary cognitive task; suppressing unwanted thoughts) reduce self-control on 
subsequent, unrelated acts (Hagger et al., 2010).  Thus, an individual may be expected to 
be incrementally more likely to experience self-control depletion following other acts 
requiring “willpower”. 
State self-control depletion and neuroenhancement. Emerging research (Wolff 
et al., 2013) has experimentally linked state depletion in self-control to 
neuroenhancement behaviour.  Importantly, the strength model posits that when self-
control is depleted, individuals revert to their “dominant behavioural response”.  Thus, 
individuals with a history of neuroenhancement are more likely to engage in 
neuroenhancement when they are in a state of self-control depletion.  Conversely, 
individuals who are naïve to neuroenhancement (and therefore have an established 
dominant behavioural repertoire which does not include neuroenhancement) would be 
less likely to engage in neuroenhancement in a state of self-control depletion (Englert & 
Wolff, 2015; Wolff et al., 2013).  Despite the apparent promise of state self-control 
depletion in explaining neuroenhancement behaviour, however, there remains a relative 
paucity of work causally linking depleted self-control to the neuroenhancement construct. 
The study conducted by Wolff and colleagues (2013) stands as an exception to the 
general lack of research in this domain. As the only study to date investigating the effect 
of state self-control depletion on neuroenhancement behaviour, this work was 
instrumental in supporting application of the strength model of self-control to 
neuroenhancement behaviour. It utilized a sample of undergraduate students, all of whom 
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were neuroenhancement-naïve (i.e., reported that they had never used a substance with 
the intent to engage in neuroenhancement).  Half of these participants were assigned to a 
control task (not predicted to “deplete” self-control), in which they were asked to quickly 
and accurately transcribe a passage of text.  The other half of the sample was assigned to 
a self-control depletion condition, in which they were instructed to transcribe the same 
passage of text (as in the control group), although with the additional instruction to 
exclude the letters “n” and “e” from their transcription.    
Following the experimental manipulation, all participants were told that they 
would next be asked to engage in a sham concentration task.  Participants were then 
offered a caffeinated product advertised as a means of cognitive enhancement in order to 
bolster their performance on the upcoming task; their acceptance or refusal of the 
neuroenhancement product was recorded.  In line with the strength model of self-control, 
the neuroenhancement-naïve participants who had undergone self-control depletion were 
found to be more likely revert to their dominant behavioural response: abstinence from 
neuroenhancement (Wolff et al., 2013).  Indeed, the depletion group was significantly 
less likely to accept the opportunity for neuroenhancement when compared to their non-
depleted peers.  Thus, the strength model of self-control was supported in these 
neuroenhancement-naïve students’ increased likelihood of abstinence from 
neuroenhancement in a state of ego depletion.   
Although Wolff and colleagues’ (2013) work constitutes an important first step in 
implicating state self-control depletion in neuroenhancement, further work is certainly 
warranted to explore the validity of the strength model in explaining university students’ 
neuroenhancement behaviour.  Importantly, Wolff and colleagues’ (2013) study did not 
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yet conclusively demonstrate a causal link between these two constructs.  First, the use of 
only neuroenhancement-naïve participants limits the scope of the authors’ conclusions.  
This aspect of the authors’ experimental design was critical for supporting the assumption 
of the strength model described above: namely, that neuroenhancement-naïve individuals 
tend to revert to their dominant behavioural response (abstinence) when in a state of self-
control depletion.  However, additional work is needed to support the application of this 
assumption to individuals for whom neuroenhancement constitutes a dominant 
behavioural response--that is, that individuals who have previously engaged in 
neuroenhancement would be more likely to engage in neuroenhancement following self-
control depletion.  Research into this central assumption is needed in order for self-
control depletion to be considered a viable mechanism for neuroenhancement. 
 Additionally, the dependent measure in the study by Wolff and colleagues 
(2013)—acceptance or refusal of the caffeinated product for neuroenhancement—
constituted a novel, in vivo measure of neuroenhancement intent.  However, it is 
important to note that direct assessment of willingness to engage in neuroenhancement 
may be limited by participants’ hesitation to disclose neuroenhancement (particularly in 
so public a manner as accepting a neuroenhancement substance in a research setting) and 
social desirability bias (Chan et al., 2015). Indeed, it has been demonstrated that 
endorsement of neuroenhancement is more likely in studies using a methodology that 
ensures anonymity of responses (i.e., randomized response technique; Franke, Bagusat, 
Rust, Engel, & Lieb, 2014).  Therefore, though the direct measurement of 
neuroenhancement intent is valuable—and indeed, Wolff and colleagues (2013) found 
support for their hypothesis using this methodology—it is feasible that participants may 
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be more likely to disclose neuroenhancement in a less personal format.  Given these 
limitations, use of computerized assessment of intent to engage in neuroenhancement 
may be a helpful supplement to the work done by Wolff et al. (2013), as computerized 
data collection has been demonstrated to produce increased endorsement of risky or 
stigmatized behaviours (e.g., Booth-Kewley, Larson, & Miyoshi, 2007).  
The goal of unobtrusively measuring willingness to engage in neuroenhancement 
may likewise be accomplished by measuring participants’ willingness indirectly via 
measurement of attitudes toward neuroenhancement.  Assessment of attitudes constitutes 
an important secondary avenue for assessment of behaviour; among rigorous studies, 
attitudes toward a given behaviour tend to overlap considerably with actual instance of 
the corresponding behaviour and may precede an individual’s initial entry into that 
behaviour (Ajzen & Fishbein, 1977; Wolff & Brand, 2013).  In the neuroenhancement 
literature, attitudes toward neuroenhancement have been shown to predict history of 
lifestyle neuroenhancement, prescription drug neuroenhancement, and illicit substance 
neuroenhancement beyond the variance attributable to age and gender (Wolff & Brand, 
2013).  Moreover, the same study by Wolff and Brand demonstrated that attitudes were a 
robust predictor of the frequency of lifestyle drug neuroenhancement.  These findings 
highlight the importance of attitudes regarding neuroenhancement and emphasize the 
need for inclusion of this important variable in future studies of neuroenhancement. 
Finally, there is increased need for independent attempts at replication of the self-
control depletion effect given current debate regarding its replicability (Blázquez et al., 
2017; Friese et al., 2018; Martin S. Hagger & Chatzisarantis, 2016).  Thus, further 
attempts at exploring the self-control depletion effect in the context of neuroenhancement 
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(using well-validated self-control depletion paradigms) have the potential to speak both 
to the relation of state self-control variation and neuroenhancement, as well as the de 
facto ability of self-control to be depleted.   
The Present Study 
 Utilizing a quintessential self-control depletion paradigm from the experimental 
ego depletion literature (Hagger et al., 2010), this study sought to extend the existing 
work using the strength model of self-control as a conceptual framework for 
neuroenhancement.  Specifically, this study furthers the existing knowledge of 
neuroenhancement and self-control by investigating the effect of self-control depletion on 
individuals’ intent to engage in neuroenhancement and their professed attitudes toward 
neuroenhancement.   
In line with demonstrated associations of state self-control variables with 
neuroenhancement, it was predicted a priori that students’ (baseline) trait self-control 
would be significantly associated with neuroenhancement intent and attitudes.  Beyond 
trait self-control, an interaction between self-control depletion condition (i.e., depletion or 
control task) and baseline history of neuroenhancement was anticipated to predict 
neuroenhancement intent and attitudes. Specifically, it was expected that individuals with 
a history of neuroenhancement would be more likely to endorse intent to engage in 
neuroenhancement and would report more positive attitudes toward neuroenhancement 
following ego depletion.  Conversely, following ego depletion, participants with no 
history of neuroenhancement would be less likely to endorse intent to engage in 
neuroenhancement and would report less favorable attitudes toward neuroenhancement.  
Importantly, the present study aimed to recruit a heterogeneous sample of individuals 
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with and without history of neuroenhancement, allowing for investigation of the 
moderating effects of neuroenhancement history on the data relations.   
Methods 
Participants 
Sample size.  Based on an a piori power analysis conducted using G*Power (Faul 
et al., 2009, 2007), it was estimated that a sample size of 146 would be required to detect 
a medium-sized effect.  Considering this result—and in order to preserve ability to detect 
such an effect following removal of any invalid data, a target sample size of 200 (100 
participants per experimental condition) was selected for the current investigation.   
All undergraduates who were registered in the psychology participant pool were 
considered eligible to participate; no exclusionary criteria were implemented for study 
recruitment.  However, in order to maintain a balanced distribution of gender and 
neuroenhancement history in the experimental vs. control groups, data collection was 
stratified on the basis of gender and neuroenhancement history.  This was accomplished 
as follows:  four versions of the study sign-up platform were created in the online 
participant pool (one for each stratification group; see Table 1) in order to control relative 
recruitment volume for each stratification group.  Participants completed pre-study 
screening questions (including gender and neuroenhancement history) upon enrolment in 
the participant pool; on the basis of responses to these questions, only the version of the 
study for which they qualified was made visible to them on the online participant pool 
platform.  For example, a male who reported no prior history of neuroenhancement 
would screen into Group B and therefore be eligible to sign up for one of the 32 available 
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timeslots for participants with those characteristics.  Conversely, a female who screened 
positive for neuroenhancement history would be eligible for one of 68 Group C timeslots. 
Balancing sample distribution (gender, neuroenhancement history).  Given 
the experimental design of the present study, it was critical to balance participants across 
the experimental and control conditions on the basis of characteristics that could 
potentially influence the study’s findings.  Specifically, male gender appears to confer 
greater risk for both neuroenhancement (Franke, Christmann, Fellgiebel, Huss, & Lieb, 
2011; Franke, Bonertz, Christmann, Engeser, & Lieb, 2012; McCabe et al., 2014; Wilens 
et al., 2008) and trait impulsivity/risk-taking behaviours (Cross, Copping, & Campbell, 
2011).  Although not consistently demonstrated, there has also been some work 
suggesting a moderating effect of gender on outcomes following ego depletion (e.g., 
Gailliot & Baumeister, 2007; Lemay, 2013; c.f. Moller, Deci, & Ryan, 2006).   
Because of these considerations, it was deemed appropriate to maintain an equal 
ratio of males to females in the experimental versus control conditions to avoid any 
confound resulting from greater representation of males or females in one condition.  The 
target ratio (approximately 2.1 females per male) was determined on the basis of 
distribution of males and females registered in the participant pool at large.  It was also 
considered ideal to maintain equal representation of neuroenhancement history (i.e., 
participants with history of neuroenhancement vs. neuroenhancement-naïve participants), 
both across the experimental and control groups and within each gender group.  A target 
sample distribution was constructed along these parameters (i.e., gender X 
neuroenhancement history) to guide recruitment of the study sample (200 participants).   
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 Experimental group assignment.  In order to achieve optimal experimental 
control, participants were randomly assigned to the experimental and control conditions.  
Because data were collected in a group format, this was achieved by first scheduling 
group data collection sessions and then randomly assigning each session to either the 
experimental or control condition via coin flip.  For each session, a pre-determined 
number of timeslots were opened to participants in each screening group (as outlined in 
Table 1) in order to retain distribution of screening variables across the experimental and 
control conditions.  For example, a data collection session may include two participants 
each from screening Group A and Group B, and four participants each from screening 
Group C and Group D.  A coin flip would determine whether these participants would 
participate in either the experimental or control condition. This method sought to 
preserve a proportional distribution of participant screening characteristics (gender, 
neuroenhancement history) across the experimental and control groups, as described in 
Table 2. 
A summary of the demographic characteristics of the final sample (in the overall 
sample and within each experimental group) is included in Table 3.  Participants were 
approximately two-thirds female (68%) and predominantly Caucasian (55%).  Year of 
university study was relatively evenly represented across participants, with 27% of 
participants indicating that they were in their first year, 25.5% indicating second year, 
21% indicating third year, and 17.5% indicating fourth year of university studies.  A 
small minority indicated that they were in their fifth year and beyond (8.5%).   
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Materials  
 State self-control manipulation. The present study utilized a dual-task paradigm 
for experimental depletion of self-control, whereby participants completed either a 
depleting (experimental) or non-depleting (control) version of the same task.  Although 
the dual task methodology has appeared in numerous iterations across the ego depletion 
literature, the specific paradigm selected for use in the current study was originally 
developed by Baumeister and colleagues in a foundational study of self-control depletion 
(Baumeister et al., 1998).  This method differs slightly from the computerized task used 
by Wolff and colleagues (2013), as described above.  The current task was selected over 
the computerized letter transcription task because the latter has been criticized as being a 
poor means of achieving self-control depletion effects (Baumeister & Vohs, 2016) 
following a failure to replicate a depletion effect using this paradigm in a recent, large-
scale pre-registered replication trial.  In contrast, the paradigm in the current study has 
been widely used to produce self-control depletion effects in the published literature.  At 
the time of its publication in 2010, a meta-analysis by Hagger and colleagues identified 
twenty published studies that had employed this task in order to experimentally 
manipulate state self-control, with an additional six studies employing similar versions.  
As such, it is one of the most common and well-studied depletion paradigms in the self-
control literature, and has robustly produced the so-called “ego depletion effect” (Hagger 
et al., 2010).   
 In this task, participants performed two variants of a letter vigilance task, which 
entails locating and crossing out all letter e’s on a page of printed text.  While the specific 
stimuli utilized in this task vary across studies, stimuli are typically selected from 
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technical scholarly works (Baumeister et al., 1998; DeWall, Baumeister, Gailliot, & 
Maner, 2008; DeWall, Baumeister, Stillman, & Gailliot, 2007; Tyler & Burns, 2009).  
The dense, technical nature of such texts is thought to minimize participant engagement 
with the content of the text, allowing optimal attention to the task itself. The stimuli for 
this task were adapted for the current study from a scholarly journal article on statistical 
methodology that was published in an open-source journal (Tellaroli, Bazzi, Donato, 
Brazzale, & Drăghici, 2016).   
 In both the self-control depletion condition and the non-depletion (control) 
condition, participants completed identical practice tasks.  During the practice task, 
participants were presented with a page of text and were asked to find and cross out all 
letter e’s on the page.  Given the high frequency and quantity of responses the task 
requires from participants, it has been suggested that this practice task successfully 
establishes a dominant behavioural set (Baumeister et al., 1998).   
After completing the practice task, the non-depletion (control) group was 
presented with a second page of text and was instructed to complete this page in the same 
manner as was done for the practice task.  By contrast, participants in the self-control 
depletion condition were given a second page of text that, although identical in content to 
that used by the control group, was printed in a smaller and lighter font and therefore 
required increased effort to read.  Additionally, participants assigned to the self-control 
depletion condition were asked to complete this second page using a more difficult, 
effortful set of rules: participants were instructed to cross out the letter e’s on the page, 
except for those e’s that met either of two conditions (DeWall et al., 2008, 2007).  First, 
e’s were not considered targets if they were directly preceded by a vowel (for example, 
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the e in the word skies would not be crossed).  Second, e’s were not considered targets if 
they came two letters after a vowel (for example, the e in space would not be crossed).  
According to its creators, the letter vigilance task has the advantage of preferentially 
taxing self-control within the experimental group versus the control group (Baumeister et 
al., 1998).   
As poor comprehension of instructions (or failure to adhere to task instructions) 
on the letter task could interfere with fidelity of the dual task manipulation, several 
variables were derived from participants’ letter task performance in order to identify 
potentially invalid responding.  These included the total number of omission errors (i.e., 
target letters which were not crossed by the participant) and commission errors (i.e., non-
target letters which were incorrectly crossed by the participant), determined in 
accordance with the rules for each respective task.  Time spent on each page of the task 
(the practice page and either the experimental or control version of the second page) was 
also recorded via the online survey platform.  Standardized scores (z scores) for the 
variables reflecting practice task performance (practice task omission and commission 
errors, practice task time on page) were computed relative to all 200 participants, as 
participants in both the experimental and control conditions completed identical versions 
of the practice task. In contrast, standardized scores for variables reflecting performance 
on the second page of the letter task were computed relative only to the other participants 
in the same experimental condition.   
 Manipulation checks.  Manipulation checks are a critical component of 
experimental designs, in that they increase researchers’ confidence that the desired 
conditions of the experiment had the intended effect (Kazdin, 2003).  Several 
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manipulation checks were included in the present study, including both self-report 
questions and a performance-based measure purported to be sensitive to variations in 
state self-control (handgrip task). 
 Manipulation check questions.  A series of manipulation check questions was 
adopted from Tyler and Burns (2009) for the present study.  First, to ensure participants’ 
comprehension of the instructions for their assigned condition (i.e., letter vigilance 
depletion vs. control condition), participants were asked to identify the instructions they 
were asked to follow while competing the letter vigilance task.  Second, participants were 
asked to rate the perceived difficulty of the task on a scale from one (“not at all difficult”) 
to seven (“extremely difficult”).  Additionally, participants were asked to rate their 
motivation to complete the task on a scale from one (“not at all motivated”) to seven 
(“extremely motivated”).  This latter check was included in the original experimental 
examination of the impact of self-control depletion on neuroenhancement (Wolff et al., 
2013) as a means of identifying any confound due to differential motivation to complete 
the respective experimental tasks.  
 Following completion of the assigned letter vigilance task, participants also 
completed the Positive/Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen, 
1988).  Consistent with previous studies of ego depletion (e.g., Baumeister et al., 1998; 
DeWall et al., 2008, 2007; Tyler & Burns, 2009), this measure was included in order to 
probe for any differential effect of the experimental condition on mood in the 
experimental versus control condition.  For the 20 items of the PANAS, participants were 
asked to rate the degree to which their current affective state matched a given adjective 
(e.g., “enthusiastic”; “upset”).  Responses are on a Likert scale ranging from 1 (“very 
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slightly or not at all”) to 5 (“extremely”).  Internal consistency for the PANAS in the 
current sample ranged from excellent (for the positive affect subscale; α = .90) to good 
(for the negative affect subscale; α = .80). 
 Handgrip persistence task. As a supplement to question-based manipulation 
checks, the present study also measured participants’ stamina in squeezing a handgrip as 
a measure of state self-control, as described by Muraven and colleagues (Muraven et al., 
1998).  At each testing point (i.e., both pre- and post-depletion), participants were asked 
to squeeze a handgrip exerciser, continuously holding a coin between the handles of the 
handgrip as long as possible.  Handgrip persistence was coded as the number of seconds 
the participant could retain sufficient grip pressure required to keep the coin continuously 
suspended between the handles of the handgrip apparatus.  Inclusion of the coin provided 
a reliable means of assessing a standardized point of release for the handgrip; when the 
coin dropped from the handgrip, timing was stopped.  Time was recorded 
inconspicuously (i.e., away from the participant’s work station). 
 Like the letter vigilance task, this task is broadly utilized in the study of self-
control depletion (used in 18 studies per the analysis by Hagger et al., 2010).  At its face, 
this task appears to measure bodily strength; however, inter-individual variability on this 
task has been shown to be nearly completely attributable to self-control, with little 
variance in handgrip persistence actually relating to body strength (Rethlingshafer, 1942; 
Thornton, 1939; as cited in Muraven et al., 1998).  Indeed, to persist in squeezing the 
handgrip, individuals must override sensations of discomfort and urges to quit (Muraven 
et al., 1998). Thus, the handgrip persistence task has the benefit of being a relatively 
subtle measure of self-control, unlikely to be detected as such by participants (Alberts, 
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Martijn, Greb, Merckelbach, & Vries, 2007).  Evidence for the construct validity of the 
handgrip task as a measure of self-control (particularly affective self-regulation) was 
recently demonstrated (Goldberg et al., 2017).  Accordingly, several studies have 
documented decline in handgrip persistence following self-control depletion tasks (e.g., 
Alberts et al., 2007; Finkel et al., 2006; Muraven et al., 1998; Tyler & Burns, 2009), 
suggesting that this measure may be sensitive to experimental manipulations targeting 
self-control depletion (such as that adopted in the present study).   
Self-report data.  Self-report questionnaires were utilized to measure several 
variables of interest in the current study: demographic variables, dispositional self-
control, history of neuroenhancement, intent for future neuroenhancement, and attitudes 
toward neuroenhancement. 
Demographics.  A series of demographic questions was included in the current 
study (and in the other studies in this project).  These questions sample a range of 
characteristics of potential relevance to self-control and neuroenhancement, including 
age, gender, academic standing, and history of mental health diagnosis.  The 
demographic questionnaire used in the present study is included in Appendix A. 
Dispositional self-control.  To examine impact of baseline levels of self-control 
on the outcome variables of interest, participants were asked to complete the Self-Control 
Scale (SCS; Tangney, Baumeister, & Boone, 2004).  This measure’s 36 items (e.g., “I am 
good at resisting temptation”; “I refuse things that are bad for me”) broadly tap 
individuals’ ability to override impulses in favor of long-term goals and values. 
Responses for this measure are on a five-point scale (1 = “not at all”; 5 = “very much”).  
In the original validation study for this measure, the authors reported evidence for the 
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SCS’s convergent and discriminant validity, good internal consistency (α = .89), and 
good test-retest reliability (r = .89).  Internal consistency in the current sample was good 
(α = .84). 
 Neuroenhancement.  The design of the current study requires measurement of 
several variables related to neuroenhancement behaviour: history of neuroenhancement 
behaviour, intent to engage in future neuroenhancement behaviour, and attitudes toward 
neuroenhancement behaviour.   
History of neuroenhancement behaviour.  In line with the behavioural definition 
of neuroenhancement (Englert & Wolff, 2015), history of neuroenhancement behaviour 
was coded as a dichotomous variable (i.e., history of neuroenhancement vs. no history of 
neuroenhancement) and operationalized as endorsement of lifetime history of use of any 
substance with the intent to enhance cognition.  As no appropriate measures were found 
to measure the broad, behaviourally-defined construct of neuroenhancement history (i.e. 
neuroenhancement using any substance), a series of questions was assembled for the 
present study.  In the first section, participants were asked to indicate whether they have 
used a series of common substances for neuroenhancement in three time-frames (i.e., 
lifetime, past year, past 30 days).  Participants were then asked to indicate how frequently 
they have used these substances during each time period, using a scale used in prior 
neuroenhancement research (ranging from “never” to “40+ times”; (Gallucci, 2011; 
Gallucci et al., 2015, 2014).  A fictional ADHD drug (“omecetin, e.g., Cognient”) was 
also included as a foil to identify potential over-endorsement of neuroenhancement 
substance use (and otherwise invalid responding).  
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Intent to engage in future neuroenhancement behaviour.  Future intent to engage 
in neuroenhancement was measured using a set of four items adapted from a study by 
Donaldson, Siegel, and Crano (2016).  The original items, which were designed to tap 
future intent to use prescription stimulants non-medically, were broadened to measure 
neuroenhancement as a global construct for the current study.  Internal consistency in the 
current sample was excellent (α = .91). 
Attitudes toward neuroenhancement.  Participants were asked to complete the 
Performance Enhancement Attitude Scale (Petróczi & Aidman, 2009), as adapted by 
Wolff and Brand (2013).  The adapted measure consists of nine items tapping attitudes 
toward neuroenhancement (e.g., “Neuroenhancement is an unavoidable part of learning 
and working”).  Participants are asked to rate their agreement on a scale from one 
(“strongly disagree”) to six (“strongly agree”).  Wolff and Brand (2013) report acceptable 
internal consistency (α = .79) and provide evidence (i.e. principal component analysis) 
for a unidimensional factor structure.  Consistent with findings of the scale’s authors, 
internal consistency for the scale was acceptable in the current study (α = .77). 
Procedure 
 After obtaining Research Ethics Board clearance for the proposed investigation, 
the study was registered in the online participant pool.  Participants were scheduled for 
group collection of study data via the participant pool website, as described above. All 
participants provided informed consent prior to participation in accordance with ethical 
research principles.    
As illustrated in Figure 1, the order of presentation of the tasks was as follows:  
first, questionnaires measuring neuroenhancement history, demographic and dispositional 
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constructs (e.g., trait self-control) were completed.  Next, participants completed the 
baseline handgrip task (administered by researcher or trained research assistant), their 
assigned letter vigilance task (depletion or non-depletion/control), and the post-test 
handgrip task (administered by researcher or trained research assistant), respectively.  
Participants then completed other manipulation check measures, as described above, and 
questionnaires measuring the dependent variables (i.e., neuroenhancement intent; 
neuroenhancement attitudes).  Note that items assessing response validity were embedded 
in questionnaires (e.g., “Please select ‘3’ for this item”) in order to identify any potential 
cases of random/invalid responding; if invalid responses were detected on any measure, 
participants were prompted to check each item prior to proceeding with the study.  
 
 
Figure 1.  Order of data collection in each timeslot. 
 
  
Materials were presented in random order within each phase of the data collection, as 
depicted in Figure 1.  For example, at the beginning of data collection, participants were 
administered the demographic questionnaire, the Self-Control Scale, and the 
neuroenhancement history question, in random order.  Likewise, measures administered 
within the manipulation check phase and at the end of the study were presented in 
random order within that phase.  Progress through the study was self-paced by 
participants. 
Questionnaire 
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(administered in 
random order): 
Demographics, 
Self-Control, 
Neuroenhancement 
History
Baseline       
Handgrip Task
Vigilance    
Depletion Task
Vigilance             
Non-Depletion  
(Control) Task
Manipulation Checks
(administered in 
random order)
Questionnaire 
Measures 
(administered in
random order): 
Neuroenhancement 
Intent, Attitudes
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Group size for data collection sessions varied based on participant interest and 
attendance; on average, sessions included about five participants (M = 4.82) and never 
more than 12 participants.  Each timeslot was run by the author and either one or two 
highly-trained, directly-supervised research assistant(s).  Due to the self-paced nature of 
the study and availability of multiple research personnel, there was typically minimal 
delay for researcher-administered tasks (i.e., handgrip pre-test and post-test).  When 
participants incurred a delay, it was brief (no longer than a few minutes).  
Data Analysis 
Data preparation.  Prior to conducting the planned main analyses, the dataset 
was checked for missing data points.  Analysis of missing data points revealed a sparse 
pattern of missing data, with 1.45% of values missing across the variables of interest.  
According to Little’s (1988) test, these missing data points were missing completely at 
random (MCAR; χ2 (152) = 3.54, p = 1.00).  Given the negligible quantity and quality of 
missingness, missing values were imputed using expectation maximization.  This analysis 
– and all subsequent analyses – was conducted using IBM SPSS Statistics for Windows, 
version 19 (IBM Corp., Armonk, N.Y., USA).   
In order to address the statistical assumption of absence of outliers/influential 
observations in multiple regression analysis (Tabachnik & Fidell, 2001), cases were 
examined for presence of outliers (z > ±3.27) on one or more of the independent 
variables to be included in the main analysis.  While four cases included outliers on X, 
none of these data points represented influential observations (Cook’s d < 1.0; Stevens, 
2002).  As a result, these cases were retained for final analyses in order to preserve the 
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integrity of the regression parameters (Stevens, 2002).  There was no evidence of outliers 
on Y (i.e., zresidual > ±3.27; Tabachnik & Fidell, 2001) for either planned regression model. 
Additionally, the dataset was examined for indicators of invalid responding and 
poor engagement in self-control depletion task, as the latter could impact the purported 
experimental effect.  Invalid data and/or letter task performance was operationalized a 
priori as participants’ meeting one or more of the following conditions:  
1) the participant included incorrect response to a validity check item (i.e., 
“select 3 for this item”) despite prompting as described above (n = 1);  
2) the participant did not correctly identify the instructions they had been asked 
to follow while completing the letter task (n = 8);  
3) the participant endorsed use of the fictional (foil) neuroenhancement 
substance (n = 0); 
4) the case contained an outlier (z > ±3.27) on omission and/or commission 
errors for either page of the letter task (n = 5); or  
5) the case contained an outlier (z > ±3.27) on time to complete either page of the 
letter task (n = 2). 
Fifteen cases (ten in the experimental group) met one or more of these criteria and were 
therefore excluded from final analyses.  As such, a final sample size of N = 185 was used 
for subsequent analyses.   
 Preliminary analyses.  Prior to completion of the main multiple regression 
analyses,  
group equivalence was confirmed across the experimental and control conditions on the 
basis of potentially important variables (e.g., gender, age, history of engagement in 
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various classes of neuroenhancement behaviour, trait self-control) using chi-square 
analyses.  To ensure that the experimental manipulation had the intended effect, the 
experimental and control groups were compared using a series of independent samples t-
tests comparing the two groups’ perceived difficulty of the task, their motivation to 
complete the task, and their self-rated affect following completion of the experimental 
task.  A 2x2 mixed ANOVA with one within-subjects factor (i.e., handgrip duration at 
baseline and following the depletion task) and one between-subjects factor (experimental 
vs. control group) was used to probe for changes in state self-control (as measured by the 
handgrip task) between the experimental groups. 
 The data were also checked for any potential violation of the assumptions of 
multiple regression (Field, 2009).  In addition to assuming absence of outliers/influential 
observations (discussed above; Cohen, Cohen, West, & Aiken, 2003; Tabachnik & Fidell, 
2001), multiple regression also assumes a sample that is adequately sized, so as to allow 
generalizability to the population (Cohen et al., 2003).  Although the current sample size 
well exceeds the conventional requirement of fifteen cases per predictor (Stevens, 2002), 
a post hoc power analysis was conducted using G*Power (Faul et al., 2007) in order to 
verify adequate power based on the specific model parameters and observed effect sizes.  
For the model predicting neuroenhancement attitudes, observed power exceeded the .80 
threshold proposed by Cohen (1992; i.e., 1 – β = .86).  Likewise, observed power was 
adequate for the model predicting neuroenhancement intent (1 – β = .99).  Thus, it is 
likely that the current analyses were adequately powered to detect the hypothesized 
effects, if such effects existed. 
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 Multiple regression also assumes lack of perfect collinearity.  Derived collinearity 
diagnostic statistics were all within range (i.e., all tolerance values > .1, all variance 
inflation factor [VIF] values < 10; Field, 2009; Stevens, 2002).  Additionally, visual 
inspection of histograms and bivariate scatterplots indicated that the residuals adequately 
approximated the normal distribution, that predictors were linearly related to residuals, 
and that no heteroscedasticity was present (Field, 2009).  Multiple regression also 
assumes independence of errors.  Examination of the Durbin-Watson statistic for the 
model predicting neuroenhancement attitudes and the model predicting 
neuroenhancement intent were within acceptable bounds (Durbin-Watson = 2.40 and 
2.26, respectively).  Cronbach’s α values for variables of interest (ranging from good to 
excellent; reported above for each measure) suggest that the current data adequately 
address the assumption that variables are measured without error.  Finally, multiple 
regression assumes independence of observations.  Given that each variable included in 
the main analyses reflected a single case, violation of this assumption in the current 
sample was considered unlikely.   
 Variable effect coding.  Categorical independent variables were transformed into 
dummy-coded or effect-coded variables, as appropriate, in preparation for use in multiple 
regression analyses.  Given the unequal distribution of gender (i.e., 68% female) and 
neuroenhancement history (94% endorsed) in the overall sample, these dichotomous 
variables were transformed into weighted effect-coded variables using the procedure 
described by te Grotenhuis and colleagues (2017b).  An unweighted effect code was used 
to code experimental condition, as sample size discrepancy between the two groups was 
minimal (95 vs. 90) and resulted from study characteristics rather than sampling effects 
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(Cohen et al., 2003). Interaction effects pertaining to these variables were estimated using 
procedures described by te Grotenhuis and colleagues (2017a). 
Multiple regression analyses.  A hierarchical multiple regression analysis was 
conducted for each of the dependent variables (intent to engage in neuroenhancement; 
attitudes toward neuroenhancement).  Demographic variables potentially related to the 
constructs of interest (gender, age) were entered in the first block of each multiple 
regression model in order to control for potentially confounding effects of these variables 
on the outcome.  Dispositional self-control scores were entered in the second block.  In 
the third block of each regression model, participants’ baseline history of 
neuroenhancement was entered as an effect-coded variable, and experimental condition 
(depletion vs. non-depletion/control) was entered as an effect-coded variable in the fourth 
block.  Finally, to assess whether participant history of neuroenhancement moderates the 
relation between self-control depletion and future neuroenhancement intent / attitudes 
toward neuroenhancement, the interaction term of participant neuroenhancement history 
* experimental condition was entered in the fifth block.  
Results 
 Results for the current study are reported below.  Variable intercorrelations for 
variables of interest in the present study are presented in Table 5. 
Preliminary Analyses 
Check for group equivalence.  The experimental and control groups were 
equivalent with regards to age (t(183) = -1.08, p = .28) and gender (χ2(1) = 0.01, p = .92).  
Groups were also equivalent with regards to neuroenhancement history reported at the 
time of study completion, including history of engagement in any neuroenhancement 
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(χ2(1) = .18, p = .67), legal neuroenhancement (χ2(1) = .25, p = .62), illicit 
neuroenhancement (χ2(1) = 1.00, p = .32), neuroenhancement via non-medical use of 
prescription ADHD medication (χ2(1) = .13, p = .72), and neuroenhancement via non-
medical use of any medication (χ2(1) = 1.43, p = .23).  The groups did not differ on self-
rated trait self-control (t(183) = 1.27, p = .21). 
Manipulation checks.  Following the depletion task, the groups did not 
significantly differ on self-rated positive mood (t(183) = -1.26, p = .21) or negative mood 
(t(183) = -1.22, p = .23).  Consistent with the intent to provide the experimental group 
with a more challenging (and therefore depleting) version of the depletion task, 
participants in the experimental group rated the task as significantly more difficult (t(183) 
= -6.68, p < .001).  However, there was no significant difference between groups in 
ratings of motivation to complete the letter vigilance task (t(183) = 1.50, p = .14).   
Descriptive statistics for participants’ handgrip task performance are presented in 
Table 6.  Statistical analysis revealed a main effect of handgrip measurement occasion 
(baseline vs. post-depletion) on handgrip task persistence, with significantly shorter 
handgrip duration observed following the letter vigilance task in general (F(1, 183) = 
13.177, p < .001).  However, there was no main effect of experimental condition on 
handgrip task persistence (F(1, 183) = 0.23, p = .63), nor was the interaction between 
measurement occasion and experimental condition statistically significant (F(1, 183) = 
0.29, p = .59).  Thus, in the current sample, the handgrip persistence task was unable to 
validate the presence of a differential “self-control depletion” effect in the experimental 
vs. control group.  
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Multiple Regression Analysis Predicting Neuroenhancement Intent 
Results of the regression model predicting future neuroenhancement intent are 
presented in Table 7; variable intercorrelations (including partial correlations, semi-
partial correlations, and structure coefficients) for the model are reported in Table 8.  
Variables entered in the first block (age, gender) did not account for significant variance 
in neuroenhancement intent scores (F(2, 181) = 1.51, p = .224).  However, addition of 
SCS total score in the second block resulted in significant improvement in the model 
(Fchange(1,180) = 11.94, p = .001).  Addition of the effect-coded neuroenhancement 
history variable in block three likewise significantly improved the model (Fchange(1, 179) 
= 10.56, p = .001).  However, addition of the experimental condition in block four and 
the interaction term in block five (neuroenhancement history*condition) failed to 
significantly increase the variance accounted for by the model (Fchange (1,178) = 0.46, p = 
.50 and Fchange (1,177) = 0.00, p = .97, respectively).  The final model significantly fit the 
data (F (1, 177) = 4.46, p < .001), accounting for 13.1% of the variance in future 
neuroenhancement intent scores.   
In the final model, the strongest predictor of higher ratings of neuroenhancement 
intent was history of neuroenhancement (β = .23), followed by SCS total score (β = -.21).  
Accordingly, examination of the pattern of squared structure coefficients revealed that 
participants’ baseline neuroenhancement history (squared structure coefficient = .53) and 
the Self-Control Scale total score (squared structure coefficient = .49) drove the model’s 
prediction of neuroenhancement intent.   
Exploratory post-hoc analyses.  Given previous demonstration of an association 
of state self-control depletion with intent to engage in neuroenhancement (Wolff et al., 
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2013), the failure to demonstrate an association of experimental condition with 
neuroenhancement intent in the current analysis was surprising (particularly given use of 
a self-control depletion paradigm that was similar to that employed by Wolff and 
colleagues and that has been widely used in the strength model literature).  It was 
hypothesized that one factor contributing to this discrepancy may be the use of a 
summary measure of neuroenhancement intent in the present study (i.e., the derived 
variable is the sum of items reflecting both immediate and future intent to engage in 
neuroenhancement).  By comparison, the method used in the study by Wolff and 
colleagues (offering participants an “energy stick”) measured immediate intent only.  In 
order to examine evidence for this hypothesis, exploratory analyses were conducted to 
probe for effect of experimental condition on immediate versus delayed 
neuroenhancement intent.  Independent samples t-tests were conducted comparing the 
experimental to control group on each of the four neuroenhancement intent items 
(reflecting intent to engage in neuroenhancement now, in the next 6 months, in the next 
12 months, and “sometime in the future”).  Difference between the groups on ratings of 
willingness to engage in neuroenhancement immediately approached statistical 
significance at the .05 level (t(183) = -1.93, p = .055) and was in the predicted direction 
(i.e., greater willingness among the experimental depletion group), although it was not 
below threshold required for multiple comparisons (p  < .013, per Bonferroni correction).  
There was no significant difference between the groups on items measuring 
neuroenhancement intent at various future intervals (p = .638 - .777).   
Similarly, exploratory replication of the above model using specific item scores 
(reflecting “immediate” intent and intent to engage in neuroenhancement “sometime in 
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the future”) as the dependent variables was undertaken (as absence of a main effect of 
experimental condition on the specific intent item scores does not rule out the interaction 
of condition with neuroenhancement history).  These analyses did not produce significant 
changes in the pattern of predictors. Indeed, in these models, the interaction term again 
failed to account for significant variance in intent ratings. 
Multiple Regression Analysis Predicting Neuroenhancement Attitudes 
Results of the regression model predicting participant’s neuroenhancement 
attitudes are presented in Table 9; variable intercorrelations for the model are presented 
in Table 10.  Age and gender did not account for significant variance in 
neuroenhancement attitudes when entered in the first block (F(2,181) = 1.43, p = .242).  
Addition of SCS total scores in the second block of the analysis significantly improved 
the variance accounted for by the model (Fchange(1, 180) = 11.36, p = .001).  However, 
addition of neuroenhancement history in block three did not significantly improve the 
variance accounted for by the model (Fchange(1, 179) = 0.54, p = .46), nor did addition of 
experimental condition in block four (Fchange(1, 178) = 0.44, p = .51) or addition of the 
interaction term (neuroenhancement history*condition) in block five (Fchange (1, 177) = 
0.27, p = .61).  The final model significantly fit the data (F(6, 177) = 2.58, p = .02), 
accounting for 8.0% of the variance in neuroenhancement attitudes.  
In the final model, the Self-Control Scale total score was the strongest predictor of 
neuroenhancement attitudes (β = -.23).  No other variables significantly (p < .05) 
contributed to the prediction of neuroenhancement attitudes.  As in the model predicting 
neuroenhancement intent, examination of squared structure coefficients again 
demonstrated that participants’ baseline neuroenhancement history and the Self-Control 
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Scale total score together accounted for the majority of variance in the model’s predicted 
scores.  However, in this model, Self-Control Scale scores accounted for the majority of 
variance in predicted outcomes (squared structure coefficient = .77), while baseline 
history of neuroenhancement accounted for a much smaller proportion of the variance in 
predicted attitudinal outcomes (squared structure coefficient = .14).   
Discussion 
The current study aimed to extend the scholarly understanding of students’ 
neuroenhancement behaviour by examining the impact of state variation in self-control 
on neuroenhancement.  This work drew upon the strength model of self-control 
(Baumeister et al., 2007), which posits that state self-control draws from a limited store 
and, as such, may be depleted following repeated exertion of self-control.  Accordingly, 
the current study examined whether experimental depletion of self-control (using a 
commonly-implemented self-control depletion paradigm) was associated with alteration 
in students’ intent to engage in neuroenhancement and their attitudes toward 
neuroenhancement behaviour.  In line with previous work in this domain (Wolff et al., 
2013), it was hypothesized that participants randomly-assigned to a state self-control 
depleting task would revert to their dominant behavioural response; that is, students with 
history of neuroenhancement behaviour would endorse greater intent to engage in 
neuroenhancement behaviour and more positive attitudes toward neuroenhancement.  
Conversely, it was anticipated that participants with no baseline history of 
neuroenhancement would be less likely to endorse neuroenhancement intent and pro-
neuroenhancement attitudes.  This interaction effect was expected to predict the 
neuroenhancement-associated outcome variables above and beyond the anticipated 
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association of demographic variables (age, gender) and trait self-control with 
neuroenhancement intent and attitudes.   
In the final model predicting neuroenhancement intent, students’ baseline history 
of neuroenhancement and their self-rated trait self-control significantly predicted 
neuroenhancement intent outcomes in the expected direction (i.e., students were more 
likely to endorse intent to engage in neuroenhancement if they had previously engaged in 
neuroenhancement and/or if they had lower trait self-control).  Contrary to hypotheses, 
however, neither the experimental condition nor its interaction with baseline 
neuroenhancement history accounted for significant variance in students’ ratings of their 
intent to engage in neuroenhancement.  Exploratory post-hoc analyses replicated this 
finding with regards to intent to engage in neuroenhancement at different intervals (i.e. 
immediately or at an undefined future time point); although a trend emerged associating 
immediate neuroenhancement intent with experimental depletion of self-control, this 
effect did not survive statistical correction for multiple comparisons.   
Results were similar in the model predicting students’ attitudes toward 
neuroenhancement.  Here, only trait self-control was a significant predictor of students’ 
attitudes toward neuroenhancement (with lower trait self-control predicting more positive 
attitudes toward neuroenhancement); unlike the results obtained in the model predicting 
neuroenhancement intent, participants’ neuroenhancement history was not a significant 
predictor of neuroenhancement attitudes.  Again, neither the experimental condition nor 
its interaction with baseline neuroenhancement history accounted for significant variance 
in participants’ ratings of their attitudes toward neuroenhancement. 
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT  
116 
The present study produced several important findings which extend the current 
understanding of the neuroenhancement phenomenon.  First, this study builds upon 
existing literature that demonstrates an association of students’ neuroenhancement history 
with constructs related to self-control, such as conscientiousness, trait impulsivity, and 
the symptoms of attention-deficit/hyperactivity disorder (e.g., Dussault & Weyandt, 
2011; Lookatch et al., 2012; Maier, Haug, & Schaub, 2015; Rabiner et al., 2010; Sattler 
& Schunck, 2016).  By demonstrating an association of the higher-order trait of self-
control with neuroenhancement (both attitudes and intent), the current study may offer a 
unifying framework for understanding the extant body of work. 
Interestingly, these findings mirror those of a similar study conducted to examine 
sports-related “doping”.  Using a sample of young athletes, Chan and colleagues (2015) 
demonstrated that ratings of trait self-control were inversely associated with athletes’ pro-
doping attitudes and their self-rated intent to engage in athletic performance 
enhancement.  The comparable findings in the current study suggest that those with lower 
self-control may be more accepting of the broad class of performance-enhancing 
behaviours and may be more likely to enact these behaviours in day-to-day life. 
Perhaps unsurprisingly, participants in the current study who endorsed history of 
neuroenhancement were more likely to endorse intent to engage in neuroenhancement in 
the future.  However, neuroenhancement history was not a significant predictor of self-
rated neuroenhancement attitudes.  This finding is unexpected given that attitudes were 
selected for the current study as a more innocuous metric for neuroenhancement 
behaviour.  The lack of an association between neuroenhancement history and attitudes is 
also contrary to work by Wolff and Brand (2013) linking history and frequency of 
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engagement in a range of classes of neuroenhancement (including lifestyle 
neuroenhancement) to greater pro-neuroenhancement attitudes.  Additionally, findings 
related to this variable must be interpreted with caution due to the grossly unequal cell 
sizes (i.e., low proportion of sample reporting negative history of neuroenhancement).    
Given the association of poor (self-reported) self-control with neuroenhancement 
outcomes, it is possible that neuroenhancement constitutes an impulsive act which may 
occur despite possible conflict with the individual’s beliefs regarding the acceptability of 
the behaviour.  This perspective is in line with the Theory of Planned Behavior (Ajzen, 
1991), which asserts that behaviour is shaped not only by attitudes toward the behaviour 
and perceived norms, but also by one’s perceived control over a given behaviour.  
Indeed, it has been suggested that the Theory of Planned Behavior (and other social 
cognitive approaches) may provide a relevant framework for the study of 
neuroenhancement (Zelli et al., 2015).  With regards to neuroenhancement, the current 
findings suggest a dissociation between attitudinal factors and one’s perceived control 
over their behaviour (i.e., self-rated self-control, which was associated with actual 
neuroenhancement history). Future work is needed in order to replicate this unexpected 
result and to better understand differential associations of attitudinal and personality 
factors with students’ neuroenhancement.   
Although supporting an association of trait self-control with neuroenhancement, 
the current study was not able to satisfactorily demonstrate the hypothesized association 
of state variation in self-control with neuroenhancement behaviour. This outcome was 
surprising, given a theoretical expectation that self-control depletion prompts individuals 
to revert to their established behavioural response (Baumeister et al., 2007; Englert & 
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Wolff, 2015).  In line with theoretical predictions, previous work specific to the topic of 
neuroenhancement has demonstrated a tendency of students to revert to their established 
behavioural response to a neuroenhancement opportunity when in a state of depleted self-
control (Wolff et al., 2013).   
Several possible explanations exist for the current study’s failure to produce 
predicted findings. First, it is possible that a depletion effect did exist in the current study 
(consistent with ratings of greater task difficulty among the experimental group), but did 
not relate as predicted to neuroenhancement outcomes and was not captured by the 
handgrip task. The failure to identify an effect of experimental condition on handgrip task 
performance was unexpected, as this task is among the most frequently utilized outcome 
variables in the self-control depletion literature (Hagger et al., 2010).  Indeed, it has been 
utilized in much of the earliest and most foundational work on the subject (e.g. Muraven 
et al., 1998; Vohs & Heatherton, 2000).   
One possible explanation may be that idiosyncratic characteristics of the current 
sample impacted participants’ approach to the handgrip task.  Such concerns were 
initially raised by Murtagh and Todd (2004), who were unable to identify effect of self-
control depletion on handgrip task performance.  The authors noted that high motivation 
may impact self-control depletion effect (and indeed, may override it), in accordance with 
their observation of participants who attempted (successfully) to improve their handgrip 
performance on post-test.  During data collection for the present study, there was likewise 
frequent subjective observation of strong participant motivation to outperform their 
baseline handgrip time.  Indeed, participants frequently stated that they were trying to 
“beat their time” despite researcher efforts to mask handgrip duration (e.g., times were 
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inconspicuously recorded; if participants wished to learn their handgrip duration, they 
could only see their time following completion of the entire study). It is also possible that 
the group format for data collection in the current study (although utilized in many other 
similar studies that did not result in null findings, e.g., Alberts et al., 2007; Finkel et al., 
2006; Muraven et al., 1998; Tyler & Burns, 2009) contributed to a desire of participants 
to “outlast” other participants, despite attempts to provide privacy (i.e., participants 
worked in cubicles).  Future studies may benefit from inclusion of “effort check” items 
(e.g., “how important was it to you to hold the handgrip as long as possible?”; “how 
important was it to you to beat your first time?”).  
While it is possible that the handgrip task failed to capture a depletion effect that 
truly existed, the possibility that a self-control depletion effect was not successfully 
produced on the current study (despite use of foundational self-control depletion 
methods) must also be considered and may indeed more parsimoniously explain the 
current results. Indeed, discussion of the current null findings within the context of self-
control depletion must be situated within recent debate regarding the conceptual 
underpinnings of the theory and the replicability of the “ego depletion effect”.  These 
issues will be summarized here; however, for a full outline of the current status of this 
debate, the reader is directed to more comprehensive discussions of various perspectives 
on the topic (Baumeister & Vohs, 2016; Blázquez, Botella, & Suero, 2017; Hagger & 
Chatzisarantis, 2016; Lurquin et al., 2016). 
Briefly, the published literature includes precedent for null findings with regard to 
the handgrip task.  Indeed, a series of studies aimed at replicating the self-control 
depletion effect in community and student samples failed to identify any effect of 
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experimental condition on outcome measures (Xu et al., 2014).  Of note, the 
methodology selected in these studies included the letter task (as experimental 
manipulation of state self-control) and the handgrip task (as a manipulation check 
measure).  A similar failure to demonstrate an effect of self-control depletion on handgrip 
times was demonstrated by Murtagh and Todd (2004).  Other studies have failed to 
replicate the self-control depletion effect using alternate methodologies (e.g., Lurquin et 
al., 2016), notably including a large, multi-site pre-registered replication effort (Hagger et 
al., 2016); however, the methodology of the pre-registered replication has been criticized, 
and a more recent unpublished pre-registered replication attempt did produce an effect 
(Baumeister & Vohs, 2016; Garrison, Finley, & Schmeichel, 2018).  
Conflicting findings among recent studies of self-control depletion have led to 
increased concern regarding the validity and replicability of the self-control depletion 
effect.  In conjunction with these results, confidence in the “ego depletion” literature has 
been eroded through inconsistent meta-analytic results.  While some meta-analyses have 
demonstrated that the depletion effect exists (Blázquez et al., 2017) and is, in fact, large 
(Hagger et al., 2010), other analyses have indicated that the pooled effect may be smaller 
or non-significant (Carter et al., 2015; Carter & McCullough, 2014; although notably, 
these studies producing null findings have also been subject to methodological 
limitations; Friese et al., 2018).  Aside from the replicability of this effect, concerns have 
been raised regarding the conceptual foundations of the theory; for example, it has been 
argued that there is not compelling evidence to suggest that the “ego depletion effect” is 
distinct from more ordinary phenomena (e.g., fatigue; Hagger et al., 2010).  In summary, 
recent investigations of the self-control depletion effect have led to a lack of clarity 
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regarding the nature and existence of self-control depletion (Friese et al., 2018).  Thus, 
the implications of the current failure to support an impact of self-control depletion on 
neuroenhancement are not fully clear, although they appear to provide some support for 
the notion that the ego depletion effect (at least as produced in the laboratory) may not be 
as ubiquitous and impactful (on attitudes and behaviour) as once thought.  Further work 
is certainly needed to clarify whether self-control is indeed depletable and the nature of 
its impact (if any) on neuroenhancement susceptibility.   
 Several limitations of the current investigation must be acknowledged.  First, 
despite extensive attempts to do so, the current sample was unable to achieve equal cell 
sizes with regards to neuroenhancement history and gender.  Indeed, participants were 
screened for baseline history of neuroenhancement prior to study enrolment and were 
randomly assigned into the experimental and control groups with intent that each group 
would be comprised equally of participants with and without prior history of 
neuroenhancement.  However, as detailed in Table 4, a significant majority of 
participants endorsed history of neuroenhancement upon presentation to the study, even 
though initial screening should have led to equal distribution of neuroenhancement 
history.  It is unclear what factors contributed to the discrepancy between participants’ 
screening responses and their endorsed neuroenhancement history during study 
participation.  It is possible that some students may be unwilling to endorse 
neuroenhancement in the screening question format (completed upon registration for the 
participant pool at large); because answers to screening questions impact the studies for 
which participants are eligible to participate, they necessarily cannot be anonymous and 
are tied to participants’ pool accounts.  In contrast, post-study anonymization of study 
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data may have encouraged more open reporting of neuroenhancement history upon study 
participation. Alternately, interim changes in students’ neuroenhancement history 
(between screening and study participation) are likewise plausible.   
Although the distribution of the neuroenhancement variable was similar to (albeit 
slightly higher than) that previously reported by other authors (e.g., Wolff et al., 2014) 
and therefore allowed for estimation of effects as they exist in the student population 
(Cohen et al., 2003), recruitment of a group that is balanced with respect to 
neuroenhancement history (positive vs. negative) may allow for improved power for 
detection of an effect for this variable (which did not occur for the present study’s model 
predicting neuroenhancement attitudes).  Similarly, it was not possible to recruit equal 
proportions of males and females due to gender distribution within the participant pool.  
Future studies may attempt to better appreciate the impact of these variables on 
neuroenhancement attitudes and intent by continued efforts to recruit equal cell sizes with 
respect to neuroenhancement history and gender. 
 Additionally, the current study relied heavily on self-report methods for 
measurement of variables of interest.  It must be noted that use of primarily self-report 
measures may introduce bias due to common method variance (Podsakoff et al., 2003).  
As such, scholarly understanding of neuroenhancement and its mechanisms may be made 
more robust through inclusion of both self-report and more objective measures of key 
constructs in future studies.  This may include actual in vivo offering of purported 
neuroenhancement substances in lab-based studies, as was done by Wolff and colleagues 
(2013), but may also include other objective measures such as urinalysis (which may 
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sample past use of some neuroenhancement substances, such as prescription stimulants; 
Burgard, Fuller, Becker, Ferrell, & Dinglasan-Panlilio, 2013).   
Finally, the present study examined neuroenhancement history as defined as a 
broad, behaviourally-based construct (i.e., a macroconstruct encompassing all use of 
substances for cognitive performance enhancement) to remain consistent with prior work 
in this area.  However, in light of emerging evidence that various categories of 
neuroenhancement may be conceptually and/or etiologically distinct (i.e., Chapter II, this 
work), future studies may benefit from fine-grained examination of the impacts of self-
control depletion and category-specific neuroenhancement history on attitudes and future 
neuroenhancement risk. 
Conclusions 
 The current study has extended the existing literature regarding the association of 
self-control with students’ neuroenhancement behaviour.  Using a commonly-employed 
self-control depletion paradigm derived from the model surrounding the strength model 
of self-control (Baumeister et al., 2007), the current study was unable to clearly produce 
the predicted state self-control depletion effect (as determined by a second task taken 
from the strength model literature) and was unable to document an association of state 
self-control variation with neuroenhancement.  As such, the present study is unable to 
add clarity to the current conversation regarding the validity and utility of the strength 
model of self-control.   
However, present findings were able to demonstrate an association of trait self-
control with neuroenhancement; students with low trait self-control were more likely to 
endorse both pro-neuroenhancement attitudes and future intent to engage in 
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neuroenhancement.  Additionally, prior history of neuroenhancement behaviour was also 
shown to prognosticate future intent to engage in neuroenhancement.  Thus, the current 
study stands as an important addition to the neuroenhancement literature by directly 
highlighting trait self-control and established neuroenhancement behaviour as risk factors 
for substance use with the intent to enhance cognitive functioning.  By providing greater 
insight into these risk factors, prevention efforts may more effectively target the roots of 
neuroenhancement behaviour and therefore promote health and wellness for university 
students. 
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Table 1 
Target Distribution of Sample on the Basis of Gender x Neuroenhancement History 
 
 
Neuroenhancement History 
 
Total 
Endorsed Not Endorsed  
Gender Male Group A 
N = 32 
Group B 
N = 32 
64 
Female Group C 
N = 68 
Group D 
N = 68 
136 
Total 100 100 200 
Note.  Selection of participants into groups was accomplished by creating four versions of 
the study in the online participant pool system, with each version available to only 
participants meeting criteria for inclusion in either Group A (i.e., males with positive 
history of neuroenhancement), B (males with no history of neuroenhancement), C 
(females with positive history of neuroenhancement), or D (females with no history of 
neuroenhancement).  The appropriate study was made available to participants on the 
basis of responses to participant pool screening questions.  In each group data collection 
timeslot, space was made available to participants in proportion to the target size of the 
stratified groups (i.e., a timeslot may include 2 participants each from Groups A and B 
and four participants each from Groups C and D).   
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Table 2 
Timeslot Randomization Procedure 
 Experimental Group Control Group Sample 
Total Neuroenhancement 
History 
Neuroenhancement 
History 
Endorsed Not 
Endorsed 
Endorsed Not 
Endorsed 
 
Gender Male Group A 
N = 16 
Group B 
N = 16 
Group A 
N = 16 
Group B 
N = 16 
64 
Female Group C 
N = 34 
Group D 
N = 34 
Group C 
N = 34 
Group D 
N = 34 
136 
Total 50 50 50 50 200 
Note.  Approach to balancing of participants in the experimental and control groups in the 
final sample as a result of timeslot randomization procedure. 
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT  
127 
Table 3 
Participant Demographic Characteristics 
  % 
  Overall 
Sample 
Experimental 
Group 
Control 
Group 
Gender Female 68 68 68 
 Male 32 32 32 
Ethnic background Aboriginal/First Nations 1.5 2 1 
 Black/African  11 7 15 
 East Asian  7.5 7 6 
 South Asian/Indian 8.5 8 9 
 Hispanic/Latino 1.5 2 1 
 Caucasian or non-
Hispanic  
     White/European  
55 55 55 
 Arab/Middle Eastern  13 12 14 
 Biracial/multiethnic 3.5 4 3 
 Other 2.5 3 2 
 Prefer not to answer 1.5 3 0 
Year of study  First 27 23 31 
 Second 25.5 27 24 
 Third 21 23 19 
 Fourth 17.5 15 20 
 Fifth 6.5 8 5 
 Sixth and beyond 2 3 1 
 No response 0.5 1.0 0 
  M (SD) 
  Overall 
Sample 
Experimental 
Group 
Control 
Group 
Age  21.5 (4.9) 22 (3.8) 21.1 (5.8) 
GPA (%)  75.6 (10.0) 75.8 (9.4) 75.3 (10.5) 
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Table 4 
Descriptive Statistics:  Participant Endorsement of Various Modes of Neuroenhancement 
Neuroenhancement Category % Endorsed 
 Total 
Sample 
Experimental 
Group 
Control 
Group 
Legal Neuroenhancement 94 95 93 
     Coffee 84.5 82 87 
     Energy Drinks 53 53 53 
     Caffeine Supplements 16 17 15 
     Herbal Supplements 23.5 28 19 
     Probiotics 6 9 3 
     Alcohol 21.5 17 26 
     Nicotine 10.5 11 10 
Illicit Drug Neuroenhancement 17.5 15 20 
     Marijuana 16 13 19 
     Other Illicit Substances 2.5 4 1 
Neuroenhancement via Non-Medical Use 
of Prescription Stimulant / ADHD 
Medication 
10.5 11 10 
     Methylphenidate (e.g. Ritalin) 1.5 2 1 
     Amphetamines (e.g., Adderall) 8.5 11 6 
     Modafinil (e.g. Provigil) .5 0 1 
     Omecetin (e.g., Cognient) – Foil 0 0 0 
     Other/unknown ADHD medication 3 3 3 
Neuroenhancement via Non-Medical Use 
of Any Prescription Medication1 
14 17 11 
     Beta-blockers .5 1 0 
     Other prescription medication 4 7 1 
Any Neuroenhancement 95.5 95 96 
 
Note.  1Includes neuroenhancement via non-medical use of prescription stimulant/ADHD 
medications and beta-blockers and other prescription medications. 
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Table 6 
Handgrip Performance in the Final Sample (N = 185) 
 T1  
M (SD) 
T2  
M (SD) 
Δ  
M (SD) 
Experimental group 55.15 (49.72) 46. 38 (36.71) -8.77 (29.28) 
Control group 51.36 (37.81) 44.82 (35.18) -6.54 (27.55) 
Overall sample 53.21 (43.93) 45.58 (35.84) -7.63 (28.35) 
Note.  T1 = baseline handgrip duration.  T2 = post-depletion handgrip duration.  Δ = T2 – 
T1. 
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Table 7 
Hierarchical Regression -- Future Neuroenhancement Intent (N = 185)  
 B SE B β ΔR2 
Step 1    .016 
     Constant 23.461 2.363   
     Age -0.166 0.107 -.114  
     Gender1    0.288 0.368 .058  
Step 2    .061** 
     Constant 35.736 4.229   
     Age -0.135 0.104 -.093  
     Gender1 0.313 0.357 .063  
     SCS total score -0.109 0.032 -.248**  
Step 3    .051** 
     Constant 22.448 4.181   
     Age -0.122 0.101 -.084  
     Gender1 0.424 0.350 .085  
     SCS total score -0.092 0.031 -.210**  
     Neuroenhancement history1 0.380 0.117 .231**  
Step 4    .002 
     Constant 32.965 4.247   
     Age -0.127 0.102 -.088  
     Gender1 0.429 0.351 .086  
     SCS total score -0.090 0.031 -.205**  
     Neuroenhancement history1 0.383 0.117 .234**  
     Experimental condition2 0.698 1.026 .048  
Step 5    .000 
     Constant 32.9335 4.312   
     Age -0.127 0.103 -.088  
     Gender1 0.429 0.352 .086  
     SCS total score -0.090 0.032 -.205**  
     Neuroenhancement history1 0.383 0.117 .234**  
     Experimental condition2 0.698 1.029 .048  
     
Condition*Neuroenhancement  
          history 
0.089 2.047 .003  
Note.  Model R2 = .131; R2adj = .102. 
1 weighted effect-coded variable.  2dummy-coded 
variable.  *p < .05; **p < .01; ***p < .001.  Abbreviations:  SCS = Self-Control Scale.  
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Table 8 
Model Variable Intercorrelations for the Final Regression Model Predicting 
Neuroenhancement Intent 
 
 r pr pr2 sr sr2 structure 
coefficient 
structure 
coefficient2 
Age -.11 -.09 -.01 -.09 -.01 -.32 .10 
Gender1 .06 .09 .01 .09 .01 .16 .03 
SCS total score -.25** -.21 .04 -.20 .04 -.70 .49 
Neuroenhancement 
history1 
.26* .24 .06 .23 .05 .73 .53 
Experimental 
condition2 
.05 .05 .00 .05 .00 .14 .02 
Neuroenhancement 
history*Experimental 
condition 
.03 .00 .00 .00 .00 .09 .01 
Note. 1 weighted effect-coded variable.  2dummy-coded variable. Abbreviations:  SCS = 
Self-Control Scale.  Abbreviations:  r = zero-order correlation, pr = partial correlation, sr 
= semi-partial correlation.    °p < .10; *p < .05; **p < .01; ***p < .001.  
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Table 9 
Hierarchical Regression – Neuroenhancement Attitudes (N = 185)  
 B SE B β ΔR2 
Step 1    .073** 
     Constant 31.621 2.579   
     Age -0.109 0.116 -.069  
     Gender1    -0.564 0.402 -.104  
Step 2     
     Constant 44.705 4.622   
     Age -0.077 0.114 -.049  
     Gender1 -0.537 0.391 -.099  
     SCS total score -0.116 0.034 -.243**  
Step 3    .003** 
     Constant 44.124 4.695   
     Age -0.074 0.114 -.047  
     Gender1 -0.509 0.393 -.093  
     SCS total score -0.112 0.035 -.234**  
     Neuroenhancement history1 0.096 0.131 .054  
Step 4    .003* 
     Constant 43.593 4.769   
     Age -0.080 0.115 -.051  
     Gender1 -0.504 0.394 -.093  
     SCS total score -0.109 0.035 -.229**  
     Neuroenhancement history1 0.100 0.132 .056  
     Experimental condition2 0.768 1.152 .048  
Step 5    .001* 
     Constant 43.984 4.834   
     Age -0.089 0.116 -.056  
     Gender1 -0.513 0.395 -.094  
     SCS total score -0.111 0.035 -.232**  
     Neuroenhancement history1 0.098 0.132 .055  
     Experimental condition2 0.769 1.155 .048  
     
Condition*Neuroenhancement  
          history 
-1.183 2.297 -.038  
Note.  Model R2 = .080; R2adj = .049. 
1weighted effect-coded variable.  2dummy-coded 
variable.  *p < .05; **p < .01; ***p < .001.  Abbreviations:  SCS = Self-Control Scale. 
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Table 10 
Model Variable Intercorrelations for the Final Regression Model Predicting 
Neuroenhancement Attitudes (N = 185) 
 r pr pr2 sr sr2 structure 
coefficient 
structure 
coefficient2 
Age -.07 -.06 .00 -.05 .00 -.25 .06 
Gender -.10 -.10 .01 -.09 .01 -.37 .14 
SCS total score -.25** -.23 .05 -.23 .05 -.88 .77 
Neuroenhancement 
history 
.11 .11 .01 .05 .00 .37 .14 
Experimental condition .07 .07 .00 -.01 .00 .23 .05 
Neuroenhancement 
history*Experimental 
condition 
.07 
 
.07 .00 .04 .00 -.00 .00 
Note.  1dummy-coded variable. 2effect-coded variable.  Abbreviations:  r = zero-order 
correlation, pr = partial correlation, sr = semi-partial correlation.  *p < .05; **p < .01; 
***p < .001.   
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IV. THE CONTRIBUTION OF SELF-CONTROL TO THE RELATION BETWEEN 
ACADEMIC PERFORMANCE AND NON-MEDICAL PRESCRIPTION STIMULANT 
USE 
Prescription stimulant drugs, such as methylphenidate (e.g. Ritalin) and 
formulations of amphetamine (e.g. Adderall) are among the most commonly-prescribed 
and efficacious treatments for adults and children experiencing neurocognitive 
difficulties associated with attention-deficit/hyperactivity disorder (ADHD; Dussault & 
Weyandt, 2011).  This disorder, principally characterized by poorer attention and impulse 
control compared to same-age peers, is critically related to impaired functioning across 
life domains (American Psychiatric Association, 2013; Barkley, 2015).  For many with 
ADHD, prescription stimulants may play a critical role in attenuating the impact of 
attention and impulse control problems on day-to-day functioning (Surman et al., 2013). 
Thus, the appropriate use of prescription stimulant drugs is a vital component in the 
evidence-based management of ADHD.  
A significant concern surrounding patterns of use for prescription stimulants, 
however, involves university students’ nonmedical use of prescription stimulants 
(NMUPS).  NMUPS is defined by use of prescription stimulant medications without a 
valid ADHD diagnosis and/or prescription, or for individuals with a valid prescription, 
taking the medication in excess of prescribed dosage (Arria & Wish, 2006).  When 
individuals engage in NMUPS in order to improve their attention, motivation, 
wakefulness, or other cognitive faculties, this behaviour fits within the overarching 
construct of “neuroenhancement” – that is, use of a range of psychoactive substances 
(i.e., lifestyle drugs, such as caffeine, nicotine, and commercially-available herbal 
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supplements; drugs of abuse; prescription drugs) with the intent to enhance cognitive 
functioning (Maier & Schaub, 2015). Lifetime prevalence of NMUPS ranges from 5.3% 
to 35% (reviewed in Weyandt et al., 2013), with trends toward increasing prevalence over 
the past decade (McCabe et al., 2014); given the more than 2 million college and 
university students in Canada (Government of Canada, 2015), this suggests that up to 
716,800 young Canadians may have engaged in this problematic behaviour in their 
lifetimes. 
Despite an overall lack of evidence that prescription stimulants effectively 
enhance cognitive functioning in neurotypical individuals (reviewed in Arria, 2016; 
Baroni & Castellanos, 2015; Repantis, Schlattmann, Laisney, & Heuser, 2010), 
enhancement of one or more specific cognitive domains (e.g., improved attention, 
alertness, or motivation for academic work) is among the most commonly-reported 
motives for using these drugs non-medically (Clegg-Kraynok, McBean, & Montgomery-
Downs, 2011; DeSantis, Noar, & Webb, 2009; Dussault & Weyandt, 2011; Prudhomme 
White, Becker-Blease, & Grace-Bishop, 2006; Rabiner, Anastopoulos, Costello, Hoyle, 
& Swartzwelder, 2009; Teter, McCabe, Cranford, Boyd, & Guthrie, 2005; Teter, 
McCabe, LaGrange, Cranford, & Boyd, 2006; White, Becker-Blease, & Grace-Bishop, 
2006).  Indeed, perception of academic benefit has been shown to be an important 
predictor of engagement in NMUPS (Arria et al., 2018), despite evidence that students 
who engage in NMUPS do not actually demonstrate improved academic performance 
(Arria et al., 2017).  Regardless of the motive driving NMUPS, the potential for adverse 
effects and addiction due to unmonitored use of these medications (Greenhill et al., 2002; 
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Volkow & Swanson, 2003) qualifies NMUPS as a major public health concern for 
university campuses. 
Apart from medical risk associated with non-medical use of these drugs, 
individuals who engage in NMUPS tend to have poorer outcomes across a number of 
psychosocial domains.  For example, NMUPS has been linked to increased likelihood of 
test anxiety (Sattler & Wiegel, 2013), stress (Wolff & Brand, 2013; Wolff et al., 2014), 
and dysphoric mood (Rabiner, Anastopoulos, Costello, Hoyle, & Swartzwelder, 2009).  
Individuals who engage in NMUPS are also more likely to report increased frequency 
of—and problems associated with—cannabis, alcohol, and polydrug use (Arria et al., 
2013, 2018; Barrett, Darredeau, Bordy, & Pihl, 2005; Lookatch et al., 2012; McCabe et 
al., 2005a; Rabiner et al., 2010; Teter et al., 2003).  In sum, NMUPS constitutes a risk 
factor for a range of poor outcomes in university students. 
The existence of academic difficulties for individuals who engage in NMUPS is 
well-documented.  Individuals who engage in NMUPS self-report a greater number of 
academic concerns (Rabiner, Anastopoulos, Costello, Hoyle, McCabe, et al., 2009; 
Rabiner et al., 2010).  Most frequently, studies have demonstrated an association between 
NMUPS and lower GPA (Arria et al., 2013, 2017; Clegg-Kraynok et al., 2011; Rabiner, 
Anastopoulos, Costello, Hoyle, & Swartzwelder, 2009; Rabiner et al., 2010). Students 
who engage in NMUPS have been shown to skip class more frequently (Arria et al., 
2013), have poorer study habits (Ilieva & Farah, 2015), and admit to “cramming” for 
exams (DeSantis, Webb, & Noar, 2008).  Overall, the literature provides strong support 
for poor academic outcomes in the presence of NMUPS.   
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While the occurrence of academic difficulties among individuals who engage in 
NMUPS is well-documented, little work has examined potential mechanisms or 
psychological factors that may contribute to this established effect.  The present study 
seeks to further current knowledge of the mechanisms contributing to the above-reviewed 
academic difficulties frequently observed in university students who engage in NMUPS.  
Specifically, low overall self-control (both global self-control and self-control as relates 
to academic tasks) is investigated as a potential contributor to the link between global 
academic functioning (i.e., GPA) and NMUPS.  
Self-Control as a Potential Contributor to the GPA-NMUPS Relation  
 Self-control, broadly defined, constitutes a collection of top-down cognitive 
abilities that act to override or modulate impulses, allowing the individual to think, feel, 
and act in a way that is consistent with his or her goals, beliefs, and moral principles 
(Duckworth & Kern, 2011).  Whereas impulses tend to drive organisms to seek 
immediate gratification, self-control allows individuals to forgo immediate gratification 
in pursuit of longer-term gains (de Ridder et al., 2012).   
One’s level of self-control has been identified as an important source of inter-
individual variation; though some argue that self-control is subject to depletion following 
exertion of self-control resources (Baumeister et al., 2007), individuals appear to differ in 
terms of their overall “stores” of self-control (i.e., dispositional self-control; Englert & 
Wolff, 2015).  Thus, in this framework, individuals with low dispositional self-control 
may experience self-control failure (i.e., reversion to one’s dominant behavioural 
response) after relatively few acts of willpower exertion (as posited by the strength model 
of self-control; Baumeister, Vohs, & Tice, 2007).  As such, dispositional self-control is a 
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critical component of success in contexts that require the ability to consistently delay 
gratification in pursuit of one’s goals, such as the university setting.   
To this author’s knowledge, it has not yet been directly tested whether the relation 
between academic performance and NMUPS may be accounted for on the basis of self-
control.  However, strong support for this association may be inferred from a recent study 
by Munro and colleagues (Munro, Weyandt, Marraccini, & Oster, 2017).  This study 
examined associations between academic performance, NMUPS, and executive 
functioning skills (which serve as an important prerequisite for successful self-control; 
Bridgett, Oddi, Laake, Murdock, & Bachmann, 2013; Hofmann, Schmeichel, & 
Baddeley, 2012).  Results demonstrated both poorer academic performance (GPA) and 
greater self-reported difficulties with executive functioning among participants who 
endorsed NMUPS.  In addition to the more direct support provided by this study, indirect 
support for this hypothesized relation may be gleaned from a wealth of literature on these 
constructs. This section aims to briefly review the extant work linking academic 
functioning to self-control and implicating self-control in NMUPS.   
Self-control and academic functioning.  A substantive body of work has 
highlighted the importance of self-control to students’ ability to successfully function 
academically.  In a landmark study on this construct, Mischel and colleagues found that a 
preschooler’s ability to delay gratification predicted their relative academic achievement 
in adolescence (Mischel et al., 1988).  Self-control in adolescence has been shown to 
predict a range of academic outcomes, including grade 12 grade point average (GPA), 
graduation from high school, achievement test scores, and full-time university enrollment 
at one-year follow-up (Galla et al., 2014).  Indeed, self-control has been shown to be a 
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more robust predictor of academic achievement than even intelligence (Duckworth & 
Seligman, 2005).  Relatedly, low dispositional self-control has repeatedly shown strong 
relationships with procrastination—a prototypical example of self-control failure 
(reviewed in Steel, 2007).   
A sizeable body of scholarly work has also implicated self-control in university 
students’ academic success.  Self-control has been shown to be positively related to GPA 
(Tangney, Baumeister, & Boone, 2004; Tibbetts & Myers, 1999; Wolfe & Johnson, 
1995).  Further, low self-control has been shown to be associated with frequency of 
skipped classes (Gibbs & Giever, 1995), increased likelihood of academic dishonesty, 
and perceived acceptability of dishonest academic behaviour (Bolin, 2004; Cochran, 
Wood, Sellers, Wilkerson, & Chamlin, 1998; Tibbetts & Myers, 1999).  
The relation between self-control and university students’ academic functioning 
may also be reflected by excessive engagement in a range of behaviours that have the 
potential to interfere with academic functioning—again reflecting choice of immediate 
gratification over long-term academic pay-offs. For example, there exists an inverse 
relation between university students’ self-control and problematic drinking behaviour 
(Gibson, Schreck, & Miller, 2004; Tangney et al., 2004) and other substance use 
(Tibbetts & Whittimore, 2002).  University students who report areas of poorer self-
control (i.e., disinhibition) have also been shown to be at increased risk for pathological 
internet use (Niemz, Griffiths, & Banyard, 2005) and gaming addiction (Mehroof & 
Griffiths, 2010), increasing the likelihood of academic difficulties (Li, O’Brien, Snyder, 
& Howard, 2015). 
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Self-control and non-medical prescription stimulant use.  The above-reviewed 
literature clearly suggests that self-control is critical for university students’ academic 
success.  Additionally, an emerging field of research has begun to link NMUPS to low 
dispositional self-control and related constructs. 
With exception of Chapter II (this work), no existing studies have directly 
investigated the relation between dispositional self-control and NMUPS.  Although one 
previous peer-reviewed study explored the relationship between depleted state levels self-
control and willingness to engage in “neuroenhancement” (Wolff & Brand, 2013), the use 
of NMUPS-naïve participants limits the extension of this study to the present 
investigation.  Specifically, as self-control becomes depleted, individuals are thought to 
revert to their typical patterns of behaviour—which, for non-users, is abstinence (Englert 
& Wolff, 2015). For individuals who have a history of NMUPS (the group of interest in 
the present investigation), the opposite may be expected.  However, this supposition has 
not yet been tested in the published literature (although see Chapter III for an 
investigation of the applicability of the strength model to the broader construct of 
neuroenhancement). 
Despite the relative lack of literature directly investigating the relation between 
self-control and NMUPS, considerable support for this association can be gleaned from 
studies linking NMUPS to constructs related to self-control.  First, an inverse association 
has been demonstrated between the Big Five personality dimension of conscientiousness 
and non-medical use of prescription drugs with the intent to enhance cognition (Benotsch 
et al., 2013; Sattler & Schunck, 2016).  Research has revealed that conscientiousness 
overlaps significantly with self-control (Tangney et al., 2004) to an extent that these 
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constructs are at times used interchangeably (e.g., Moffitt et al., 2011) or as sub-
dimensions of the other (Olson, 2005; Steel, 2007).  Thus, studies that have identified low 
conscientiousness in non-medical prescription stimulant users may have been tapping a 
relation between NMUPS and the overlapping construct of self-control, as is 
hypothesized in the current study. 
A link between NMUPS and impulsivity has also been demonstrated.  For 
example, in a study utilizing a particularly severe sample (i.e., students who reported 
frequent engagement in NMUPS; Maier, Wunderli, et al., 2015), NMUPS was found to 
be associated with elevated scores on the Barratt Impulsiveness Scale, a questionnaire 
frequently invoked in the measurement of impulsivity (and importantly, also used as a 
measure of self-control; de Ridder et al., 2012).  Similarly, others have found an 
association between NMUPS and trait impulsivity (Lookatch et al., 2012).  Like 
conscientiousness, impulsivity is a construct intimately related to self-control; indeed, it 
has been suggested that impulsivity may be conceptualized as the absence or 
ineffectiveness of the top-down regulatory processes which inhibit impulses in line with 
longer-term goals (Duckworth & Kern, 2011).  In short, individuals who frequently act 
impulsively lack self-control.   
Nonmedical stimulant use has further been associated with elevated self-reported 
symptoms on both the inattentive and hyperactive/impulsive symptom dimensions of 
ADHD (Chapter II, this work; Dussault & Weyandt, 2011; Peterkin, Crone, Sheridan, & 
Wise, 2011; Rabiner et al., 2010).  Importantly, a prominent theory of ADHD implicates 
self-control in the deficits associated with both the inattention and 
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hyperactivity/impulsivity symptom dimensions (Nigg, 2016), providing additional 
credence to the hypothesis that self-control may be an important correlate of NMUPS. 
Support for the potential link between dispositional self-control and NMUPS may 
be inferred from a study investigating associations between dispositional self-control and 
sports-related performance enhancement (Chan et al., 2015).  Here, the authors 
demonstrated that individuals with lower levels of dispositional self-control tended to 
endorse greater acceptance of, and intent to engage in, sports-related performance 
enhancement.  Though sports-related “doping” and NMUPS are not wholly equivalent—
for example, university students view NMUPS as more acceptable than athletic 
performance enhancement (Dodge, Williams, Marzell, & Turrisi, 2012)—conceptually, 
these behaviours may both be linked to failure to resist temptation and willingness to 
transverse legal and ethical norms as a result. 
The Current Study 
 To summarize, much work has indicated an association between low academic 
achievement and NMUPS, and between academic achievement and self-control.  
Additionally, research indirectly points to an association between self-control and 
NMUPS.  This study sought to probe the relations between these constructs and to 
provide a novel hypothesized model explaining these relationships.  Specifically, it was 
hypothesized that the association between academic functioning and NMUPS may be 
accounted for on the basis of measures representing dispositional self-control (i.e., both a 
global self-control measure as well as measures which particularly tap aspects of self-
control relevant to academic functioning—academic diligence and procrastination).  If 
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empirically supported, this model would highlight importance of self-control as a driving 
factor for the previously-identified GPA-NMUPS relation. 
Methods 
Participants 
 Estimated sample size needed.  Sample size determinations were established a 
priori per recommendations of Peduzzi and colleagues (1996).  These guidelines 
(developed on the basis of a series of simulation studies) suggest that the conventional 
equation for logistic regression sample size determinations (N = 10k, where k represents 
the number of independent variables in the model) should be adjusted for the proportion 
of positive/negative cases in the sample.  Thus, the optimal sample for logistic regression 
may be derived from the equation 𝑁 = 10
𝑘
𝑝
,  where p reflects the smaller value of either 
the proportion of positive cases in the sample, or the proportion of negative cases in the 
sample.  According to Long (1997), a minimum sample size of 100 should be used in 
cases where this equation yields N < 100.  In the present model, k = 4 predictors.  In the 
participant pool portion of the current sample (recruited for co-participation in the study 
reported in Chapter II and therefore available to guide a priori sample determination), 
23.5% endorsed lifetime history of NMUPS; thus, p = .235.  Using Peduzzi’s equation, 
then, a minimum sample size of 170 participants would be needed to adequately power 
the current analyses.  As such, it was expected that the sample reported for Study 1 
(Chapter II) possessed adequate power for the proposed logistic regression model, even 
after removal of any invalid data.   
Recruitment strategy.  Because the relative proportion of individuals who 
engage in NMUPS vs. non-users is considerably smaller (see discussion of NMUPS 
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prevalence above), attempting to recruit equally-sized groups for the present study would 
inevitably produce results that inaccurately reflect the actual relation between variables in 
the population (Cohen et al., 2003).  As such, no restrictions were placed on the relative 
size of the NMUPS vs. non-user subgroups.   
Following Research Ethics Board approval, (n = 200) participants were recruited 
through the university’s psychology department participant pool in conjunction with 
recruitment for Study 1 (reported in Chapter II).  A small number of additional 
participants (n = 10) were recruited for the current study through advertisement on 
campus in an attempt to sample a broader population with regards to academic program 
and NMUPS patterns/motives.  Thus, a total of 210 cases were available for use in the 
current study.   
Demographic/background information for the sample and descriptive statistics on 
variables of interest (reported for the entire sample and stratified by recruitment source) 
are reported in Table 1.  In the overall sample, slightly more than half of participants 
identified as female (58.6%).  Approximately half identified as Caucasian (52.9%); 
12.9% of the entire sample identified their ethnicity as Arab/Middle Eastern, and 11.9% 
indicated that they identified as Black/African.  The majority (67.6%) of the overall 
sample was enrolled in a program in the university’s Faculty of Arts, Humanities, and 
Social Sciences (67.6%).  Participants were approximately evenly distributed across their 
first year (20.5%), second year (17.6%), third year (30.5%), or fourth year of study 
(22.9%), although a small number of participants indicated that they were enrolled in 
their fifth year or beyond (7.2%).   
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Measures 
 Demographic information.  A series of demographic questions was compiled for 
use in the three studies comprising the current project (see Appendix A).  Questions 
sample a range of demographic constructs, including participant gender, age, ethnicity, 
marital status, and history of learning disability or mental health diagnosis.   
Academic functioning.  The demographic questionnaire also includes information 
relevant to academic status (e.g., year of study, program of study, fraternity/sorority 
affiliation) and, of particular importance to the proposed study, academic functioning 
(operationalized as GPA, consistent with previous research; e.g., Galla et al., 2014; 
Tangney et al., 2004; see Appendix A).  Note that participants were prompted to log into 
their university academic account to confirm their current GPA when reporting this 
variable in order to reduce bias associated with estimation and increase validity.  
Participants were asked to report their GPA for the past semester only and their 
cumulative GPA. For participants who were in their first semester of university at the 
time of study participation (n = 35), cumulative GPA at the end of high school was 
substituted for the latter variable (as this variable is highly correlated with university 
cumulative GPA; Richardson, Abraham, & Bond, 2012) .   
 Non-medical use of prescription stimulants.  Participants’ stimulant use was 
measured via a series of questions developed by Gallucci (2011).  Relevant to the 
proposed study, this measure includes items tapping individuals’ history of NMUPS 
(either by exceeding prescribed dosage or using stimulant medication without a valid 
prescription), both in their lifetime and in the past thirty days.  To allow for optimum 
participant experience, five demographic items were deemed redundant with those 
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included in the demographic form (Appendix A) and were therefore removed from this 
measure for the current study.  For the purpose of coding dichotomous logistic regression 
outcome variables (reflecting lifetime and past 30 day history of NMUPS), endorsement 
of any positive history in either one’s lifetime or the past 30 days was coded as positive 
NMUPS for that variable (Gallucci et al., 2015, 2014).  
 Timeline follow-back assessment of NMUPS.  As a supplement to the measure of 
NMUPS created by Gallucci (2011), a timeline follow-back (TLFB) assessment of 
NMUPS was administered.  TLFB is a common method for measuring substance use 
frequency, with well-established validity for a range of substances and populations 
(Hjorthøj, Hjorthøj, & Nordentoft, 2012). The TLFB assessment method (developed by 
Sobell & Sobell, 1996) utilizes calendar-based prompts in order to facilitate recall of 
substance use occasions. In the present study, an online TLFB assessment of alcohol and 
marijuana use described by Pedersen and colleagues (2012) was adapted for 
measurement of neuroenhancement substance use; in the original study, the online TLFB 
demonstrated good congruence with more traditional (in person) TLFB administration 
overall, although there was some indication of more honest responding in the online 
format (Pedersen et al., 2012).  Participants were first asked to indicate which substances 
they had used in the past 30 days for neuroenhancement as part of a larger measure of 
neuroenhancement substance use.  For each substance participants endorsed using for 
neuroenhancement in the past 30 days, participants were directed to complete a timeline 
follow-back assessment of their 30-day neuroenhancement use patterns for that 
substance; for example, if participants endorsed neuroenhancement via use of caffeine 
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pills and NMUPS, participants completed a separate 30-day calendar for caffeine pills 
and prescription stimulants. 
 Procedures for completing the neuroenhancement TLFB were as follows.  
Participants were asked to list up to ten marker days for the 30-day timeframe assessed.  
Examples relevant to the university population (e.g., university course withdrawal 
deadlines, midterm and final exam dates) and holidays were also provided.  After 
participants provided their marker days, these were auto-populated onto each applicable 
calendar.  On each substance-specific calendar, participants were asked to report on their 
neuroenhancement substance use for each day. Guidelines (adapted from Pedersen et al., 
2012) were provided to indicate substance quantities that were to be considered 
equivalent to one “use” (Appendix B); for example, participants reported NMUPS with 
regards to number of pills taken each day (e.g. two Adderall pills = “2”).  For days when 
participants did not engage in neuroenhancement using a given substance, participants 
entered “0” into the calendar.   
A sum was computed for each substance, reflecting the total score across all thirty 
days.  An aggregate score was also derived for classes of substances (i.e., legal 
neuroenhancement, illicit substance neuroenhancement, NMUPS).  This metric is a 
beneficial complement to dichotomous variables reflecting neuroenhancement history 
(i.e., history endorsed/denied), as it allows for increased specification of the degree of 
neuroenhancement that occurred among users (and use of this variable as a continuous 
outcome in a linear multiple regression model).  Given the current study’s focus on 
NMUPS, the thirty-day TLFB aggregate score for NMUPS was utilized. 
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT   
149 
 Self-control.  Given the diversity of definitions of the self-control construct (de 
Ridder et al., 2012), measurement of this important variable is likewise diverse 
(Duckworth & Kern, 2011). A variety of measures was selected to assess self-control in 
the present study, including the Self-Control Scale, a general measure of self-control 
which has seen relatively wide use.  Given the focus of the current study on academic 
functioning, two additional measures of self-control were included that boast enhanced 
relevance for academic functioning.  These include the Tuckman Procrastination Scale 
and the Academic Diligence Test. 
 Self-Control Scale. The Self-Control Scale (SCS; Tangney et al., 2004) is a 
domain-general self-report measure of self-control that broadly assesses individuals’ 
ability to supersede their own immediate emotional state or behavioural drives in favor of 
longer-term goals.  As such, it coincides with generally-accepted definitions of self-
control (de Ridder et al., 2012).  The measure consists of 36 items assessing self-control 
behaviours (e.g., “I am good at resisting temptation”; “I refuse things that are bad for 
me”). Using a five-point Likert scale (1 = “not at all”; 5 = “very much”), participants are 
asked to rate the degree to which each statement reflects their typical self.  The authors 
report good internal consistency (α = .89), good test-retest reliability (r = .89), and 
sufficient convergent and discriminant validity (Tangney et al., 2004).  Internal 
consistency in the current sample was likewise good (α = .81).   
 Tuckman Procrastination Scale.  The 16-item Tuckman Procrastination Scale 
(TPS; Tuckman, 1991) is a self-report questionnaire measuring tendency to procrastinate 
on tasks. Using a four-point Likert scale (1 = “that’s me for sure”; 2 = “that’s my 
tendency”; 3 = “that’s not my tendency”; 4 = “that’s not me for sure”), participants are 
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asked to rate the extent to which each item applies to him- or herself (e.g., “I postpone 
starting things I don’t like to do”; “I promise myself I’ll do something and then drag my 
feet”).  This measure demonstrated good-to-excellent internal consistency in the original 
study (α = .89; Tuckman, 1991) and in subsequent studies (e.g., α = .92, Howell & 
Watson, 2007; .88, Klassen, Krawchuk, & Rajani, 2008).  Internal consistency was 
excellent in the current sample (α = .91).  This measure has also demonstrated good 
convergence with other self-report and behavioural measures of procrastination (e.g. 
Howell & Watson, 2007; Tuckman, 1991).  Following administration, scores on the 
Procrastination Scale were reversed such that high scores on the measured greater 
tendency to procrastinate.  
 Academic Diligence Task.  The Academic Diligence Task (ADT; Galla et al., 
2014) is a performance-based, domain-specific measure of self-control in the academic 
setting.  Specifically, the ADT taps one’s ability to persist in an ostensibly boring task 
(i.e., arithmetic problems) in pursuit of the long-term benefit of skills improvement.  
Uniquely, this task allows participants to self-direct between the tedious math practice 
and activities which are more immediately engaging but have no long-term benefit to the 
participant (e.g., computer games), such that participants are free to complete as much or 
as little arithmetic practice as they desire within the 20-minute test phase timeframe. This 
design parallels many students’ experience working on schoolwork; to efficiently study 
or complete assignments, student must self-direct to prioritize long-term skill 
development over more immediately-rewarding distractions (e.g., social media, streaming 
television and movies, parties).   
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 The structure of the ADT is as follows (Galla et al., 2014): first, participants are 
given brief instructions and complete a one-minute practice block of simple arithmetic 
problems (with no opportunities to divert attention to a “more engaging” task).  Next, 
participants receive instructions for the full task, accompanied by a prompt describing the 
personal long-term benefits of arithmetic practice to the student (namely, that arithmetic 
practice over time improves problem-solving abilities; Royer, Tronsky, Chan, Jackson, & 
Marchant, 1999, as cited in Galla et al., 2014).  During the test phase, participants 
complete a series of five four-minute, self-directed intervals.    
Although a number of scores may be derived from ADT data, the primary metric 
of interest in measurement of self-control is participants’ mean time “on task” (i.e., 
average time spent solving arithmetic problems” per block).  Psychometric data for the 
ADT are reported by the task’s creators (Galla et al., 2014).  Although correlations with 
self-report measures of self-control were generally small (as is generally the case for the 
relation between self-report and performance-based self-control; Duckworth & Kern, 
2011, as cited in Galla et al., 2014), analyses overall demonstrated adequate reliability for 
ADT time on task scores. 
Procedure 
 Following clearance by the university’s Research Ethics Board, participants were 
recruited through the online participant pool (per procedure reported in Chapter II) and 
through advertisement on campus.  All undergraduate students were deemed eligible to 
participate.  Participants who were recruited through the university’s psychology 
participant pool completed measures for the current study as part of a larger battery (i.e., 
also including those measures reported in the study described in Chapter II).  In exchange 
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for participation, participants recruited from the university’s psychology participant pool 
received course credit (1 hour = 1 credit) in accordance with participant pool policy.  
Participants recruited from the university at large completed a smaller battery intended 
for use in the present study alone.  Non-pool participants were awarded a $15 gift card in 
exchange for their participation.   
 On presenting at an on-campus computer lab for their appointment, all 
participants completed the informed consent process.  Next, participants completed the 
battery of measures designated for their recruitment source (i.e., participant pool vs. non-
pool), administered on a computer in random order.  Validity check items were 
interspersed throughout the battery (e.g., “select ‘2’ for this item”).  As in studies 
reported in Chapter II and III, participants were prompted to check responses prior to 
proceeding if invalid responses were detected.   
Analyses 
 Statistical models.  Three separate statistical models were constructed in order to 
assess the role of self-control in the previously-specified relation of GPA with NMUPS.  
These three models are identical with regards to the array of possible independent 
variables included (i.e., GPA, Self-Control Scale, ADT average time on task, TPS total 
score) and differ only with regards to the NMUPS outcome variable, as follows: 
dichotomous measurement of lifetime history of NMUPS (Gallucci, 2011, Model 1); 
dichotomous measurement of 30-day history of NMUPS (Gallucci, 2011, Model 2); and 
continuous measurement of 30-day history of NMUPS (TLFB; Model 3).  Independent 
variables not correlated with the outcome variable (a more liberal cutoff of p < .10 was 
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used to guide variable inclusion decisions) were removed prior to construction of the 
final model in order to reduce possibility of suppression effects. 
As Models 1 and 2 specify categorical NMUPS outcome variables, these models 
were examined using logistic regression (LR).  In contrast, the continuous nature of the 
NMUPS outcome variable in Model 3 prompted use of multiple regression analysis 
(MRA).  These three models are depicted in Figure 1.   
 
Figure 1.  Hypothesized hierarchical models regressing academic performance and self-
control-related variables onto non-medical use of prescription stimulants (NMUPS) 
history, defined dichotomously in Models 1 and 2 (Model 1: lifetime history of NMUPS; 
Model 2: 30-day history of NMUPS), and continuously in Model 3 (30-day timeline 
followback frequency of NMUPS).  Across the three models, it was anticipated that the 
array of self-control variables would partially or fully account for variance in NMUPS 
outcomes associated with GPA.  Note that independent variables not correlated with the 
dependent variable (at p <.10 level) were removed prior to final model construction. 
 
 
A consideration particularly relevant for use of LR in this sample is the issue of 
data sparseness (i.e., small sample size in each cell).  In assessing goodness of fit for the 
logistic regression analysis, the χ2 test for goodness-of-fit in logistic regression may be 
biased by data sparseness (Cohen et al., 2003).  Given the likelihood of data sparseness as 
a result of the relatively low proportion of participants who endorsed NMUPS, 
supplemental fit indices robust to data sparseness (e.g. Hosmer-Lemeshow Index of Fit) 
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were calculated for the LR models and were preferentially utilized in interpreting model 
goodness-of-fit.  
Statistical assumptions of LR and MRA.  Following data preparation, data were 
examined for violations of the main statistical assumptions of LR and MRA analyses, per 
guidelines described by Field (2009).  Some statistical assumptions (independence, 
linearity, absence of multicollinearity) are common to both LR and MRA.  First, the 
assumption of independence was met as a result of the study design (i.e., participants 
were permitted to provide data for only one case included in analyses).  Additionally, 
both MRA and LR assume linearity, with the former assuming a linear relation between 
the dependent and independent variables, and the latter assuming a linear relation 
between the logit and continuous independent variables.  For the LR models predicting 
lifetime and thirty-day history of NMUPS (Models 1 and 2), each continuous 
independent variable was linearly associated with the log of the outcome variable (i.e., 
derived variables reflecting the interaction of each independent variable with the log of 
itself did not contribute statistically-significant variance to the models; Field, 2009).  For 
the MRA model predicting 30-day TLFB NMUPS frequency (Model 3), visual inspection 
of bivariate scatterplots demonstrated linear relations of the independent variables with 
the outcome variable.  Finally, both LR and MRA assume absence of multicollinearity 
among independent variables.  Examination of collinearity diagnostic values for both LR 
and MRA models suggested that this assumption was met (i.e., tolerance > 0.1). 
Beyond these assumptions shared among both LR and MRA, data were explored 
for violations of additional assumptions of MRA (Model 3).  Visual inspection of 
bivariate scatterplots suggested adequate homoscedasticity among standardized residuals 
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and predicted values.  MRA also assumes absence of outliers or influential observations.  
Statistical exploration of the dataset demonstrated 3 cases that represented outliers on y (z 
> ± 3.27).  For these cases, the offending value was substituted for the highest non-outlier 
response on the corresponding variable.  No data points represented outliers on x.  
Diagnostic statistics identified one influential observation (Cook’s d > 1.00), which was 
removed for main analyses.   
Despite these adjustments, histograms and inspection of skewness/kurtosis 
statistics (of standardized residuals) demonstrated violation of the assumption of 
multivariate normality.  As Williams and colleagues (2013) describe, MRA is robust to 
violations of this assumption because, as sample size increases, the central limit theorem 
posits that the sampling distribution will become normalized.  Indeed, “normally 
distributed errors are not required for regression coefficients to be unbiased, consistent, 
and efficient” (p. 10); however, although the model itself may remain unbiased, 
significance tests may be subject to bias in smaller samples.  Statistical transformation of 
the data is generally discouraged in such cases, as interpretability tends to be sacrificed 
(Cohen et al., 2003).  As such, in order to address the violation of the assumption of 
normality in the current sample, statistical tests were supplemented with more robust 
estimates of effect (e.g., structure coefficients, effect sizes).   
Data preparation.  Analysis of validity check items indicated that 6.7% of 
participants (fourteen cases) provided invalid responses to one or more validity check 
item (3.3% failed one, 1.0% failed two, 1.4% failed three, 0.5% failed four, and 0.5% 
failed six items).  As exclusion of participants who fail validity checks has been shown to 
improve data validity and statistical power (Oppenheimer, Meyvis, & Davidenko, 2009), 
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main analyses were conducted after excluding cases which included one or more validity 
check failures (N = 195).  
Data were examined for missing data points prior to execution of planned 
analyses.  Analysis indicated a sparse pattern of missingness overall; data were missing 
across 1.52% of values, impacting 5 variables (7.69%) and 71 cases (33.81%).  Little’s 
(1988) test indicated that data were missing completely at random (MCAR; χ2 (41) = 
53.15, p = .10).  Therefore, missing values were imputed using expectation maximization. 
Results 
Model 1.  Variable intercorrelations for the current study are reported in Table 3.  
All four proposed independent variables were significantly correlated with lifetime 
NMUPS at the p < .10 level and were therefore included in the model.   
Results of the hierarchical logistic regression analysis predicting the binary 
variable reflecting lifetime engagement in NMUPS (yes/no) are reported in Table 4.  
Entry of GPA in the first block resulted in a statistically-significant improvement in 
model fit beyond entry of the constant alone (-2LLblock0 = 206.47, -2LLblock1 = 191.76); 
the resultant model demonstrated adequate fit for the data, as demonstrated by the 
statistically-significant omnibus chi-square test (p < .001) and the nonsignificant Hosmer-
Lemeshow test (p = .17).  The block 1 model correctly classified 76.9% of participants.  
However, it must be noted that the model correctly classified 0% of participants with 
positive history of NMUPS. 
In the second block, addition of SCS total score resulted in further improvement 
in the model’s fit (-2LLblock2 = 184.60) and good model-data fit as demonstrated by the 
omnibus chi-square test (p = .01) and the Hosmer-Lemeshow statistic (p = .36).  The 
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model correctly classified 77.9% of participants overall, and correctly classified 9.3% of 
participants with history of NMUPS.  SCS total scores contributed unique variance above 
and beyond that accounted for by GPA, but GPA continued to contribute statistically-
significant variance to prediction of NMUPS group membership.  Thus, GPA and self-
reported self-control independently contributed to lifetime NMUPS outcomes in this 
model.   
In the third block, addition of ADT time on task did not lead to substantial change 
in the model overall (-2LLblock3 = 182.76); model-data fit at this step was moderate per 
the Hosmer-Lemeshow statistic (p = .55), but did not reach statistical significance as 
measured by the omnibus test (p = .18).  ADT time on task was not a statistically-
significant predictor of lifetime NMUPS outcomes (p = .17).  The model correctly 
classified 77.9% of participants overall, and correctly classified 14.0% of participants 
with history of NMUPS.   
In the fourth block, addition of Procrastination Scale total scores likewise did not 
result in substantial improvement in the model (-2LLblock4 = 182.09).  The fit of the model 
to the data was improved per the Hosmer-Lemeshow statistic (p = .92) but did not reach 
statistical significance when quantified via the omnibus chi-square test (p = .41).  
Procrastination scores were not a statistically-significant predictor of lifetime NMUPS (p 
= .42) beyond variables already accounted for in the model.  Consistent with relatively 
unchanged log likelihood values in this step following addition of procrastination scores, 
the predictive accuracy of the model was unchanged vs. block 3 (overall accuracy = 77.9, 
predictive accuracy for participants with positive history of NMUPS = 14.0%).  The final 
model was statistically-significant overall (χ2model (1) = 23.65, p < .001).  
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In summary, both GPA and Self-Control Scale total score were statistically-
significant factors in the model explaining lifetime history of NMUPS.  However, these 
variables contributed unique variance to explanation of lifetime NMUPS, suggesting that 
they are separate risk factors for lifetime engagement in NMUPS.  ADT time on task and 
Procrastination Scale scores did not account for unique variance in lifetime NMUPS 
beyond that accounted for by GPA and SCS total scores. 
Model 2.  Inspection of point-biserial correlations (Table 3) revealed that 
dichotomously-measured past 30-day history of NMUPS was not correlated (p < .10) 
with ADT time on task (p = .83) or Procrastination Scale total scores (p = .81); as such, 
these variables were excluded from final analyses.   
Results of the hierarchical logistic regression analysis predicting the binary 
variable reflecting past-30-day engagement in NMUPS (yes/no) are reported in Table 5.  
Entry of GPA in the first block of the analysis resulted in minimal improvement in model 
prediction beyond entry of the constant alone (-2LLblock0 = 95.52, -2LLblock1 = 92.29); the 
resultant model demonstrated adequate model-data fit according to the Hosmer-
Lemeshow test (p = .15) and approached statistical significance per the omnibus chi-
square test (χ2(1) = 3.23, p = .07).  GPA approached significance as a predictor of 30-day 
NMUPS outcomes (p = .08). The block 1 model correctly classified 93.3% of participants 
overall, although it correctly classified 0% of participants with positive past 30-day 
history of NMUPS. 
In the second block, addition of SCS total score resulted in modest improvement 
in model prediction overall (-2LLblock2 = 89.39).  Model-data fit was marginally improved 
per the nonsignificant Hosmer-Lemeshow test (p = .46), and approached statistical 
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significance as measured by the omnibus chi-square test (p = .09).  Notably, predictive 
accuracy of the model was unchanged; the model continued to classify 93.3% of 
participants correctly overall, although it did not correctly classify any participants with 
past 30-day history of NMUPS.  In the final block, SCS total scores alone approached 
significance as a predictor of 30-day NMUPS history (p = .09); GPA no longer 
demonstrated marginal statistical significance in the model after entry of SCS scores (p = 
.25).  The final model fit was marginally statistically-significant (χ2(2) = 6.14, p = .05). 
In summary, GPA demonstrated marginal statistical significance in explanation of 
30-day NMUPS outcomes, with lower GPA tending to confer greater risk for engagement 
in NMUPS.  However, SCS total scores (which approached statistical significance) 
tended to predict 30-day NMUPS outcomes above and beyond GPA.  Neither ADT time 
on task nor Procrastination Scale scores was significantly (p < .10) associated with 30-
day history of NMUPS.  
Model 3.  Bivariate correlations between hypothesized independent variables and 
TLFB 30-day NMUPS frequency scores are reported in Table 6.  Surprisingly, inspection 
of bivariate correlations revealed that TLFB frequency of NMUPS was not significantly 
(p < .10) associated with GPA (p = .49), SCS total scores (p = .22), ADT time on task (p 
= .16), or Procrastination Scale total scores (p = .33).  As such, the planned regression 
model was not executed.  Examination of partial and semi-partial correlation coefficients 
(Table 6) indicated that each of these variables accounted for only negligible variance in 
TLFB frequency scores.  Thus, the array of academic and self-control variables does not 
appear to drive variance in the frequency with which participants in this sample engaged 
in NMUPS in a 30-day span. 
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Post-hoc exploratory analysis of measure equivalency.  Due to the discrepancy 
in models 2 and 3 (ostensibly reflecting multiple levels of analysis of the same behaviour, 
i.e., dichotomous coding of 30-day NMUPS history vs. continuous coding of 30-day 
NMUPS history), it was hypothesized that differences in measurement technique (i.e., 
free recall vs. more specific, calendar-prompted recall) may drive the discrepancy across 
models 2 and 3.  In order to test consistency across the two assessment modalities, a 
dichotomous categorical variable was derived from the 30-day TLFB data, reflecting 
positive history of NMUPS (i.e., one or more instances of NMUPS) or negative history 
(no instances of NMUPS) on the 30-day TLFB assessment.  This variable should 
hypothetically be analogous to the dichotomous 30-day NMUPS variable derived from 
the Gallucci (2011) questionnaire if the two measurement methods are comparable (i.e., a 
participant who endorsed past 30-day NMUPS on the Gallucci measure should endorse 
one or more instances of NMUPS on the past 30-day TLFB assessment of NMUPS).  
Chi-square analysis demonstrated discordance between the two 30-day history variables 
(χ2(1) = 138.64, p < .001), suggesting that the TLFB method produced a unique pattern of 
NMUPS endorsement versus the single-item method derived from Gallucci (2011).  As is 
evident in Table 2, the TLFB assessment resulted in slightly higher rates of past 30-day 
endorsement of NMUPS compared to the comparable single-item measure (7.7% versus 
6.7%, respectively). 
Discussion 
 The current study builds upon prior work demonstrating an association of poorer 
academic performance among individuals who engage in non-medical use of prescription 
stimulants (NMUPS) as a means of cognitive and academic performance enhancement.  
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The current study investigated a novel hypothesis regarding this finding: that the 
association between academic performance and NMUPS may be accounted for (either 
wholly or in part) by self-control.  In the present study, self-control was quantified both 
via self-report measures of dispositional self-control (Tangney, Baumeister, & Boone, 
2004) and the related construct of procrastination (Tuckman, 1991), and via the 
Academic Diligence Task, a performance-based measure designed to assess real-world 
application of self-control that is relevant to the academic setting (Galla et al., 2014).  To 
test this hypothesis, three models were constructed utilizing as outcome indicators three 
measures of NMUPS history, including dichotomous (yes/no) measurement of lifetime 
NMUPS history and dichotomous measurement of past 30-day NMUPS history.  A novel 
adaptation of timeline follow-back methodology (widely used and well-validated for 
measurement of general substance use; Pedersen et al., 2012) was included as a third 
measure of NMUPS, providing a dimensional measure of 30-day NMUPS history (i.e., 
reflecting “severity” of  NMUPS in past 30 days). 
 Results partially supported the a priori hypothesis, as results were discrepant 
across the three models (reflecting a differential pattern of associations of self-control and 
academic achievement with the three NMUPS measurement variables).  Specifically, in 
the logistic regression model differentiating students who had engaged in NMUPS in 
their lifetime from those who had not, self-ratings of dispositional self-control 
contributed unique variance to the statistical prediction of NMUPS history beyond that 
accounted for by students’ GPA.  However, performance-based self-control measurement 
and procrastination self-ratings did not contribute additional variance above and beyond 
that associated with self-control and GPA.  In the logistic regression model 
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differentiating students who had engaged in NMUPS in the past 30 days from those who 
had not, a non-significant trend (p < .10) was identified whereby SCS fully accounted for 
the variance in NMUPS outcomes initially accounted for by GPA (as demonstrated by 
reduction in p value; it must be noted, however, that the initial association of GPA with 
NMUPS was of marginal statistical significance). 
Although trait self-control (and in the case of lifetime NMUPS history, also GPA) 
predicted entry into NMUPS and whether participants had engaged in this behaviour in 
the past 30 days, surprisingly, GPA and the array of self-control variables (self-rated 
dispositional self-control, performance-based measurement of academic self-control, and 
self-rated procrastination) were not significantly associated with the frequency with 
which participants reported that they had engaged in NMUPS (measured via TLFB) in 
the past 30 days. 
 The results derived from models predicting categorical measures of NMUPS 
history in this study unite the extant literature by highlighting both poor dispositional 
self-control and poor academic performance as risk factors for engagement in NMUPS.  
Interestingly, these factors appear to confer separate risk for students’ entry into NMUPS 
behaviour (i.e., lifetime engagement in NMUPS), in accordance with prior work 
demonstrating higher rates of NMUPS among both individuals with lower GPA (Arria et 
al., 2013; Clegg-Kraynok et al., 2011; Rabiner, Anastopoulos, Costello, Hoyle, & 
Swartzwelder, 2009; Rabiner et al., 2010) and those who endorse traits related to poor 
self-control (e.g. Sattler & Schunck, 2016).   
However, in the case of past 30-day history of NMUPS, the initial association of 
GPA and NMUPS appeared to be fully accounted for by self-reported self-control.  The 
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discrepancy between these models (i.e., separate vs. overlapping variance associated with 
GPA) is relevant, as lifetime history reflects a different pattern of substance use 
compared to past 30-day use.  Indeed, while lifetime history includes single-
occasion/experimental substance use patterns, past 30-day history is thought (in 
aggregate) to reflect more “active” use of a substance (e.g., Wickersham et al., 2016).  
Thus, although academic underachievement may be an additional distinct motivator for 
NMUPS experimentation, it can be hypothesized that self-control appears to be a primary 
driving force among individuals who initiate NMUPS and continue to actively engage in 
this behaviour.  
Taken together, these findings support the prospect that individuals with both 
poor academic performance and poor self-regulatory skills may engage in NMUPS as a 
means of propelling themselves toward their academic goals.  As proposed by Englert & 
Wolff (2015), this finding supports the application of Drug Instrumentalization Theory 
(Müller & Schumann, 2011) to neuroenhancement behaviour broadly and NMUPS more 
specifically.  In this model, individuals engage in substance use (and specifically, 
neuroenhancement behaviours such as NMUPS for this purpose) in order to reduce 
discrepancy between their perceived current state and their goal state.  Current results 
suggest that individuals may indeed perceive discrepancy between their current academic 
performance and their academic goal state, leading to entry into NMUPS.  Further, when 
students perceive discrepancy between their available self-control resources and those 
required to achieve their academic goals, they may engage in NMUPS with intent to 
“bridge the gap” and bring them closer to their long-term goals. 
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The current findings may also be understood within a related framework proposed 
by Wolff and colleagues (Wolff et al., 2014).  This model applies the Job Demands-
Resources Theory (JD-R theory; Demerouti, Bakker, Nachreiner, & Schaufeli, 2001) to 
students’ engagement in neuroenhancement behaviour, positing that in circumstances 
when resources (including both external resources, such as study support, and internal 
resources, which could include self-control) are inadequate to meet school-related 
demands, students experience burnout which leads to poor academic performance.  
Students may turn to neuroenhancement as a means of ameliorating the impact of high 
academic demands on their school performance (Wolff et al., 2014).  Notably, however, 
the authors found that “such attempts might backfire” (p. 6); in their study, high academic 
demand was more strongly associated with burnout among students who engaged in 
prescription drug neuroenhancement.  Additionally, students with higher internal 
resources (which would normally enhance motivation and protect against burnout) who 
engaged in prescription drug neuroenhancement experienced reduction of these 
protective effects.  Thus, the present demonstration of poorer academic performance and 
poorer self-control among individuals who have engaged in NMUPS in their lifetime 
could suggest that individuals at greater risk for burnout may turn to NMUPS as a 
(possibly unhelpful) strategy to increase available resources in order to meet academic 
demands. 
 The failure to demonstrate an association of academic performance and the array 
of self-control variables with the dimensional variable reflecting NMUPS severity 
(derived from an adapted TLFB assessment) has key implications for NMUPS research.  
The preponderance of studies of NMUPS (and of neuroenhancement in general) has 
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measured these behaviours dichotomously (i.e., lifetime, past year, past 30-day history).  
While those who have engaged in NMUPS (or other forms of neuroenhancement) appear 
to be distinct from lifetime abstainers (see Chapters II and III), frequency appears to be a 
distinct facet of the NMUPS/neuroenhancement construct.  In the current study, a pattern 
of associations of self-control and academic achievement was identified that 
discriminated participants with and without history (lifetime, past 30-day) of NMUPS.  
However, these factors did not appear to explain variance in frequency of engagement in 
NMUPS.  Thus, frequency with which individuals engage in NMUPS—and factors 
which differentiate those who engage rarely vs. frequently – remains an empirical 
question in need of further exploration.  Although not permitted in the current study due 
to cell sizes, it may be interesting to explore in future work the academic and 
dispositional factors that differentiate low and high frequency of engagement in NMUPS 
among users.   
Post-hoc analyses suggested that individuals endorsed different patterns of past 
30-day use on the TLFB versus single-item assessment methods.  This result echoes 
previous work highlighting subtle differences in substance use endorsement on TLFB 
versus global measures of substance use.  For example, a comparison of TLFB and a 
global measure of cigarette use among college students who engaged in non-daily 
smoking (Harris et al., 2009) demonstrated minor (yet statistically-significant) 
differences in patterns of endorsement across measures.  This effect was moderated by 
overall intensity of smoking; heavier smokers tended to report smoking more cigarettes 
(overall and per day) on TLFB than on a global measure.  Unlike the current study, 
however, Harris and colleagues found that derived dichotomous variables of past 30-day 
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smoking history (akin to that derived for NMUPS in the current study) were comparable 
for TLFB and the global measure.  In contrast, the current study demonstrated modest 
differences in the participants identified by the dichotomous measures of 30-day history 
derived from the TLFB and global measures. 
Factors contributing to the discrepancy between TLFB and single-item 
measurement of dichotomous, 30-day history in the case of NMUPS require further 
investigation.  Importantly, the illicit nature of NMUPS may introduce additional bias in 
students’ reporting.  This prospect is supported by the psychometric properties of the 
National Survey on Drug Use and Health (Substance Abuse and Mental Health Services 
Administration, 2010), which demonstrated an overall trend toward lower reliability for 
measures of illicit drug use compared to legal drug use methods.  It should also be noted 
that, for students recruited through the participant pool, the battery of measures (which 
included those for both the current study and the study reported in Chapter II) was 
somewhat lengthy.  Although random ordering of measures was implemented in order to 
alleviate effects of fatigue on any specific measure, participant fatigue may have 
nonetheless resulted in more inconsistent responding as the study progressed (thus 
introducing error into study data).   
Additional limitations of the current investigation must be acknowledged.  First, it 
must be noted that a heterogeneous measure of cumulative GPA was used in the current 
study.  For the majority of participants, this variable reflected university cumulative 
GPA; however, for a small subset of the sample who were in their first semester of 
university study at the time of participation (n = 35), university cumulative GPA data 
were not available and high school cumulative GPA were instead used.  As described 
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above, there is an extensive literature demonstrating strong correspondence between 
these variables; indeed, high school GPA has been shown to predict university GPA more 
strongly than even college entry exam performance (i.e., ACT or SAT; Richardson et al., 
2012).  Thus, in the interest of including first-semester students and therefore preserving 
statistical power, high school cumulative GPA was used as a substitute for students for 
whom no university cumulative GPA data yet existed.  Nonetheless, future studies may 
benefit from comparison of current results to those obtained in of an older sample (i.e., 
second year and above) for whom university GPA data are available.  Notably, older 
participants may also be in more challenging academic courses and therefore may be at 
greater risk of engagement in NMUPS (Desantis & Hane, 2010; McCabe, Knight, Teter, 
& Wechsler, 2005).   
Relatedly, there may be limits to the generalizability of current results.  Although 
the sample was representative of the university where data were collected, it is unclear 
how current results (based on a majority-Caucasian sample) will generalize to university 
students of other cultural backgrounds and geographic areas.  Ethnic background has 
been shown to be relevant for risk of engagement in neuroenhancement (Weyandt et al., 
2008); therefore, it will be important to continue to understand the interplay of self-
control and academic functioning as relates to neuroenhancement risk in other groups.  
Finally, the current sample was somewhat more balanced with regards to gender than is 
typical for participant pool samples (Dickinson et al., 2012).  Although this may improve 
the generalizability of the current findings with the university student population in 
general, it may problematize comparisons with studies based on more typical 
undergraduate samples.   
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Finally, a limitation inherent to the method of quantifying non-medical prescription drug 
use via the TLFB assessment must be acknowledged.  Drug use quantities provided in the 
TLFB reflected number of pills used, rather than specific dose (see Appendix B).  This 
method boasted several benefits; first, in other studies in this work, a subset of 
participants indicated that they were unsure which ADHD medication they had taken 
(e.g. see Chapter II), suggesting that (at least for some participants) assessment of 
specific substance/dose used may be unreliable.  Additionally, assessing number of pills 
used enabled creation of a composite variable across ADHD medications.  However, as a 
result, it must be acknowledged that the derived variable quantifies instances/frequency 
of NMUPS behavior and does not provide data regarding dosage.  Thus, future studies 
utilizing TLFB methodology may benefit from assessment of drug- and dose-specific 
factors in order to further understand patterns of use and drug-specific effects.  Such 
efforts may be aided by use of aids to enhance participants’ accuracy in identifying 
substances used (e.g., visual pill identification charts).    
Despite these limitations, the current study makes important contributions to the 
academic understanding of students’ non-medical use of stimulant drugs.  Specifically, 
the current results highlight poor academic performance as a possible risk factor for 
lifetime initiation of NMUPS.  However, deficient self-control appears to be a critical 
factor for not only lifetime but also active use of NMUPS.  Given the significant risk 
associated with NMUPS (Urban & Gao, 2017) and indication that it may not actually 
reduce academic strain (Wolff et al., 2014), the issue of NMUPS remains an important 
area that needs to be addressed on university campuses.  Current results suggest that 
resources directed at bolstering students’ academic performance (e.g., class review 
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sessions, availability of peer tutoring) may reduce students’ perceived need to engage in 
NMUPS in order to meet the academic demands of the university setting.  Moreover, 
current results highlight individuals with low self-control as a population at particular risk 
of lifetime and active engagement in NMUPS.  As such, systemic efforts to identify these 
individuals and provide accessible, effective interventions are highlighted as a possible 
route to decreasing participation in NMUPS. 
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Table 1 
Study 3 Participant Demographic Characteristics and Descriptive Statistics for Model 
Variables 
 
  % endorsed 
  total 
sample  
(N = 
210) 
psychology 
pool  
(n = 200) 
university-
wide 
recruitment  
(n = 10) 
Gender Female 58.6 57.5 80.0 
 Male 40.5 41.5 20.0 
 No response 0.9 1.0 0.0 
Ethnic 
back-
ground1 
Aboriginal/First Nations 1.0 1.0 0.0 
Black/African  11.9 12.0 10.0 
East Asian  3.3 3.0 10.0 
South Asian/Indian 8.6 7.5 30.0 
 Hispanic/Latino 2.4 2.5 0.0 
 Caucasian or non-Hispanic  
     White/European  
52.9 55.0 10.0 
 Arab/Middle Eastern  12.9 12.0 30.0 
 Biracial/multiethnic 5.7 5.5 10.0 
 Other 0.5 0.5 0.0 
 Prefer not to answer 1.0 1.0 0.0 
Academic 
faculty 
(program 
of study) 
Arts, humanities, and social sciences 67.6 68.0 60.0 
Education 1.0 1.0 0.0 
Engineering 2.9 2.5 10.0 
Kinesiology 4.8 5.0 0.0 
Law 0.5 0.0 10.0 
Nursing 4.3 4.0 10.0 
Business 8.1 8.6 0.0 
Science 9.0 9.0 10.0 
 Undecided 0.5 0.5 0.0 
 No response 1.4 1.5 0.0 
Honors 
status 
Enrolled in honors program 6.7 7.0 0.0 
Not enrolled in honors program 91.9 91.5 100.0 
No response 1.4 1.5 0.0 
Year of 
study  
First 20.5 20.0 30.0 
Second 17.6 17.5 20.0 
 Third 30.5 32.0 0.0 
 Fourth 22.9 21.5 50.0 
 Fifth 6.7 7.0 0.0 
 Sixth and beyond 0.5 0.5 0.0 
 No response 1.4 1.5 0.0 
(continued on next page)
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT   
171 
(continued) 
   M (SD)  
  
Total 
sample 
(N = 210) 
Psychology 
pool (N = 
200) 
Recruited 
through 
university 
advertisement 
(N = 10) 
Age 21.61 
(4.32) 
21.59 
(4.37) 
22.00  
(3.46) 
GPA (%) –university cumulative average* 73.73 
(8.24) 
78.29 
(8.16) 
78.29  
(8.16) 
GPA (%) – last semester average** 75.00 
(8.80) 
79.43 
(8.48) 
79.43  
(8.48) 
Self-Control Scale total score 113.07 
(15.17) 
113.19 
(15.29) 
110.29  
(12.45) 
ADT % time on task 75.75 
(23.59) 
75.86 
(21.39) 
73.25  
(26.44) 
Procrastination Scale total score 38.29 
(9.30) 
38.16 
(9.32) 
40.80  
(8.87) 
Note.  1Categories are not mutually-exclusive.  Abbreviations: GPA = grade point 
average; ADT = Academic Diligence Task. *university cumulative average only 
available for students in their second semester and beyond.  **students in their first 
semester (n = 35) were asked to report last semester of cumulative high school GPA. 
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Table 2 
Non-Medical Use of Prescription Stimulant Endorsement Characteristics 
Gallucci (2001) – NMUPS survey 
%  
Endorsed 
History of ADHD diagnosis 6.2 
Current prescription for a stimulant medication 4.8 
History of NMUPS1 --- 
     Lifetime 21.9 
     Past thirty days 6.7 
History of using a prescribed stimulant medication in excess/for 
unintended purposes: 
--- 
     Lifetime 4.3 
     Past thirty days 0.5 
History of taking prescription stimulant without a prescription: --- 
     Lifetime 21.9 
     Past 30 days 6.2 
30-day timeline follow-back for NMUPS 
% 
Endorsed 
M (SD) 
     Any history of NMUPS in past 30 days  7.7 --- 
     Number of occasions of NMUPS2 --- 0.55 
(3.07) 
Note.  1Includes both use of prescribed mediation in excess/for unintended purposes and 
taking prescription stimulant without a prescription.  2One occasion = one stimulant pill.  
Abbreviation: NMUPS = non-medical use of prescription stimulants. 
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Table 6 
Study 3 - Variable Intercorrelations for Variables Included in Model 3 (N = 195) 
 r pr pr2 sr sr2 
GPA1 -.06 -.10 .01 -.10 .01 
Self-Control Scale total score .10 .11 .01 .11 .01 
ADT time on task -.05 -.08 .01 -.08 .01 
Procrastination Scale total score -.08 -.01 .00 -.01 .00 
Note. *p < .05; **p < .01; ***p < .001. 1 Point-biserial correlation.  2Cumulative GPA at 
last semester; students in their first semester were asked to report last semester of 
cumulative high school GPA. Abbreviations:  r =  zero-order correlation, pr = partial 
correlation, sr = semi-partial correlation; GPA = grade point average; ADT = Academic 
Diligence Task; NMUPS = non-medical use of prescription stimulants; TLFB = timeline 
follow-back assessment.   
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V. GENERAL DISCUSSION 
Primary Aims 
 Students’ use of substances for the purposes of cognitive or academic 
performance enhancement (often referred to as “neuroenhancement”) has attracted 
increasing research attention in recent years.  While the non-medical use of prescription 
stimulants has been a particularly frequent focus of the neuroenhancement literature, it 
has been suggested that the use of any substance to enhance or facilitate 
cognitive/academic performance reflects instrumental behaviour (Müller & Schumann, 
2011) and therefore merits research attention under the neuroenhancement construct 
(Englert & Wolff, 2015).   
Until recently, however, the preponderance of work in this area has been limited 
to epidemiological studies of the prevalence and demographic patterns of use.  Although 
it represents a burgeoning area of interest in the field, less is known regarding the 
psychological and behavioural correlates of engagement in different classes of 
neuroenhancement behaviour.  Beyond adding to the sparse data regarding 
neuroenhancement in the Canadian university student population, the studies reported in 
this work aimed to add to the literature by examining whether low levels of one such 
psychological factor, self-control, may act as a risk factor for university students’ 
engagement in neuroenhancement behaviour.  In doing so, the current investigation 
harnesses evidence-based assessment of students’ self-regulatory skills (which 
necessitates a multi-method approach; Duckworth & Kern, 2011) and lends insight into 
the neuroenhancement construct itself. 
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 Under this overarching aim, three studies were executed to investigate specific 
facets of the self-control/neuroenhancement relation.  The first study (Chapter II) sought 
to examine whether associations of neuroenhancement with a multivariate array of self-
control variables differed across three classes of neuroenhancement (i.e., legal 
neuroenhancement, illicit drug neuroenhancement, prescription drug neuroenhancement).  
It was anticipated that results would illuminate not only the association of deficient self-
control with students’ engagement in neuroenhancement, but also attest to the optimal 
approach to defining the neuroenhancement construct.  Indeed, it has been suggested that 
neuroenhancement can be conceptualized as a unitary construct (united by a single 
means-end relationship) rather than discrete, substance-specific classes of behaviour 
(Englert & Wolff, 2015).   
In the study reported in Chapter III, the relevance of state variation in self-control 
was investigated through application of the controversial strength model of self-control 
(also known as the ego strength or resource model of self-control; Baumeister, 2013) to 
the neuroenhancement construct.  In addition to addressing the limitations of a previous 
effort in this area (Wolff et al., 2013), it was anticipated that this study could extend the 
existing literature by moving from description of trait-level correlates of 
neuroenhancement into discussion of impact of phasic influences on neuroenhancement 
risk.  In the context of ongoing debate regarding the reliability and validity of the so-
called “ego depletion effect” (Friese et al., 2018), an ancillary function of this study 
included an effort to utilize cornerstone methods from the ego strength literature to 
independently replicate a depletion effect on students’ state self-control.  
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Finally, the third study (Chapter IV) sought to explore contributions of self-
control to the previously-demonstrated finding of poorer academic achievement among 
students who engage in non-medical use of prescription stimulants (NMUPS) for 
neuroenhancement purposes (Arria et al., 2013; Clegg-Kraynok et al., 2011; Rabiner, 
Anastopoulos, Costello, Hoyle, & Swartzwelder, 2009; Rabiner et al., 2010).  It was 
anticipated that the association between grade point average (GPA) and NMUPS (defined 
both dichotomously [over lifetime and past-30-day intervals] and dimensionally [as past 
30-day TLFB frequency]) could be accounted for by self-control.  Beyond the primary 
aims of elucidating the role of self-control in the academic underachievement of students 
who engage in NMUPS, this study addressed critical limitations of extant works in this 
area (e.g., limited studies differentiating one-time vs. more active/frequent use; lack of 
studies directly addressing the role of self-control in NMUPS). 
Thematic Results 
Who Engages in Neuroenhancement? 
 Associations of neuroenhancement with self-control.  This dissertation 
provided clarity to the psychological and academic correlates of engagement in 
neuroenhancement behaviour in university students.  Across studies, trait self-control 
emerged as an important factor associated with lifetime engagement in 
neuroenhancement; however, there were notable nuances to this relation.  In Chapter II, 
results suggested associations of self-control with neuroenhancement, but highlighted a 
need to refine the notion that neuroenhancement may be conceptualized as a unitary 
construct (e.g., Englert & Wolff, 2015).  ADHD symptoms—which, under one 
conceptual model of ADHD are reflective of deficient self-control (Nigg, 2016)—
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appeared to unify the three classes of neuroenhancement behaviour (consistent with the 
hypothesis that neuroenhancement constitutes self-medication of sub-clinical or 
undertreated ADHD symptoms, e.g., Wilens et al., 2008).  Additionally, an array of other 
self-reported variables related to self-control (i.e., trait self-control, non-planning 
impulsiveness, motor impulsivity) loaded onto variates explaining both legal and illicit 
drug neuroenhancement, echoing prior work supporting an association of self-control-
related variables with neuroenhancement (e.g., Ilieva & Farah, 2015; Lookatch et al., 
2012; Peterkin et al., 2011).   
 In addition to these results, the results reported in Chapter II highlighted an 
otherwise distinct pattern of associations of self-control across the three modes of 
neuroenhancement.  Interestingly, associations of self-control with illicit drug 
neuroenhancement (which consisted primarily of cannabis use) were paradoxical, 
characterized by poor self-ratings of self-control contrasting less impulsive performance 
patterns on one task-based measure of self-control (delay discounting task).  This may 
reflect the planful effort of students to use cannabis to reduce negative affectivity 
(Middendorff et al., 2012) in support of improved academic outcomes.  However, given 
that statistical prediction of cannabis-related neuroenhancement was limited by small cell 
sizes, future research is needed to replicate and further explore this interesting finding. 
 In the study reported in Chapter IV, trait self-control was again identified as a 
correlate of neuroenhancement behaviour – this time, within the specific class of 
NMUPS.  Both self-reported trait self-control and performance on an academically-
oriented self-control task were significantly associated with lifetime history of NMUPS 
(although the latter did not predict unique variance in predicting the dichotomous 
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outcome variable reflecting lifetime NMUPS history above and beyond the variance 
accounted for by participants’ academic performance and self-control ratings).  Similarly, 
trait self-control ratings marginally predicted the dichotomous outcome variable 
reflecting 30-day (i.e., “active”) history of NMUPS.  Interestingly, self-control was not 
associated with past 30-day frequency of engagement in NMUPS (as measured by 
TLFB), suggesting that although self-control may drive entry into lifetime and active use 
of NMUPS, other factors may drive high-frequency engagement in this behaviour. 
 In contrast to the broad demonstration of an association of trait-level differences 
in self-control with students’ engagement in neuroenhancement generally (and the 
specific case of NMUPS), there was not clear support for an association of state self-
control variation with neuroenhancement in the current work.  In Chapter III, an 
experimental protocol was implemented that has been purported to “deplete” participants’ 
self-control.  According to the strength model of self-control and a prior study which 
demonstrated an impact of self-control depletion on students’ neuroenhancement 
behaviour (Wolff et al., 2013), this would make participants more likely to revert to their 
established behavioural response (e.g., students who had a history of engaging in 
neuroenhancement would be more likely to engage in neuroenhancement when state self-
control was depleted).  However, results did not support this notion; the experimental 
group (which received the supposedly “depleting” manipulation) did not meaningfully 
differ from the control group across aggregate measures of both neuroenhancement 
attitudes and intent, although trait self-control was again a statistically-significant 
predictor of both more pro-neuroenhancement attitudes and intent to engage in 
neuroenhancement in the future.  There was likewise no significant effect for the 
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interaction of lifetime neuroenhancement history with experimental group, challenging 
the notion that depleted students “revert” to previously-established neuroenhancement-
related behavioural repertoires.  Thus, although trait self-control appears to be one 
indicator of risk of engagement in neuroenhancement, research investigating a possible 
role of state variation in neuroenhancement risk (i.e. Wolff et al., 2013 and Chapter III, 
this work) has produced conflicting results. 
Associations of neuroenhancement with other personality variables.  Beyond 
self-control, there is a rich literature suggesting that a range of personality features confer 
risk of engagement in neuroenhancement.  In the study reported in Chapter II, the 
contributions of neuroticism and conscientiousness (two personality dimensions 
associated with self-control) to risk of engaging in various modes of neuroenhancement 
was examined.  For the paradoxical effect of self-control on illicit drug 
neuroenhancement (described above), one candidate explanation may be that highly 
neurotic students engage in higher-risk classes of neuroenhancement (primarily cannabis 
use) in order to reduce negative affectivity as they seek to facilitate academic 
performance.  Although this prospect would be supported by literature demonstrating that 
mood repair constitutes a primary motive for students’ use of cannabis (Middendorf et 
al., 2012), the small loadings of neuroticism onto variates explaining illicit drug 
neuroenhancement appear to stand in contrast to this finding.  Loadings of neuroticism 
onto the legal neuroenhancement variate were likewise minimal, as were loadings of 
conscientiousness onto both the legal and illicit neuroenhancement variates.  Neither 
conscientiousness nor neuroticism was robustly associated with prescription drug 
neuroenhancement.  Thus, neuroticism and conscientiousness did not uniquely contribute 
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to understanding the individual differences that relate to neuroenhancement behaviour 
beyond the contributions of other self-control-related variables.  Although the current 
study aided significantly in the exploration of self-control as a correlate of 
neuroenhancement, future research will benefit from examination of the personality 
facets which drive entry into neuroenhancement and sustainment of various forms of this 
behaviour beyond those self-control variables specified in the current research effort. 
 Associations of neuroenhancement with academic functioning.  The current 
project likewise provided additional clarity to academic factors conferring risk for 
engagement in neuroenhancement behaviour.  Specifically, an association of poorer 
academic performance (operationalized as cumulative GPA) with lifetime and active 
(past 30-day) history of NMUPS was demonstrated in Chapter IV, consistent with prior 
literature demonstrating poorer academic outcomes among students who engage in this 
behaviour (e.g., Arria et al., 2013, 2017; Clegg-Kraynok et al., 2011; Rabiner, 
Anastopoulos, Costello, Hoyle, & Swartzwelder, 2009; Rabiner et al., 2010).  Likewise, 
students with a lifetime history of NMUPS spent, on average, less time on academic 
problem-solving in a self-directed, performance-based measure of academic self-control.   
Importantly, however, in the model statistically predicting active (past 30-day) 
NMUPS, the marginal association of GPA with the outcome variable was fully accounted 
for by ratings of trait self-control.  Chapter IV therefore offers further insight into 
previously-identified associations of academic performance with NMUPS, suggesting 
that dispositional features (such as self-control) may predispose students to both poor 
academic outcomes and active engagement in NMUPS (perhaps as a means—albeit an 
ineffective means—of ameliorating the effects of poor self-control).   
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 Neuroenhancement attitudes and intention as correlates of behaviour.  In 
Chapter III, neuroenhancement attitudes and future neuroenhancement intent were used 
as outcome variables in the models examining effect of self-control depletion on 
neuroenhancement.  It has been suggested that attitudes and intentions have high 
correspondence with actual engagement in a behaviour (Ajzen & Fishbein, 1977), 
although only one study to date has examined congruence of neuroenhancement 
attitudes/reported intent with behaviour (Wolff & Brand, 2013).  Interestingly, this 
association was only partially replicated in the current work (Chapter III).  Although self-
control was a robust predictor of both neuroenhancement attitudes and intent, lifetime 
history of neuroenhancement (using any substance) predicted future neuroenhancement 
intent above and beyond the effect of trait self-control ratings.  However, 
neuroenhancement history was not associated with neuroenhancement attitudes.  
Therefore, neuroenhancement attitudes may not maintain strong correspondence with 
behaviour and thus may not serve as an appropriate substitute for measurement of actual 
behaviour in the specific case of neuroenhancement.   
It must be noted, however, that as these findings were produced using a measure 
of global neuroenhancement history (i.e., any substance), they may not generalize to 
substance-specific classes of neuroenhancement behaviour.  Given the current evidence 
supporting a view of neuroenhancement as separate, substance-specific classes of 
behaviour (Chapter II), it follows that associations of attitude/intent with actual behaviour 
may vary across substance-specific classes.  For example, attitudes toward the specific 
case of NMUPS may more robustly predict engagement in NMUPS (versus 
neuroenhancement using other substances).  Future examination of the associations of 
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attitudes/intent with actual behaviour is clearly warranted across modes of 
neuroenhancement. 
Assessment of Neuroenhancement 
 Definition of neuroenhancement.  The current research effort lends additional 
insight into the definitional basis of the neuroenhancement construct itself, adding to the 
current conversation regarding whether neuroenhancement is best conceptualized as 
distinct, substance-specific constructs (e.g., Maier et al., 2015) or as a single class of 
behaviour reflecting the same means-end relationship (e.g., Englert & Wolff, 2015).  
Specifically, although associations of self-control were observed across multiple modes 
of neuroenhancement, demonstration of distinct patterns of association for various modes 
of neuroenhancement (Chapter II; summarized above) suggests that there exist 
meaningful differences between legal, illicit, and prescription drug neuroenhancement.  
Thus, results of the current work suggest that the approach of “collapsing” various modes 
of neuroenhancement into a single macroconstruct may wash out the unique motives and 
personality characteristics which differentiate various classes of neuroenhancement 
behaviour.  Further, although illicit drug neuroenhancement and prescription drug 
neuroenhancement are often unified within a single category of neuroenhancement 
behaviour (“pharmacological cognitive enhancement”; e.g., Franke et al., 2013), the 
differences between these two classes of neuroenhancement in the current investigation 
(and indeed, many students’ identified use of cannabis specifically for neuroenhancement 
purposes) suggest a need to examine neuroenhancement minimally at the level of the 
drug class (if not at the level of the specific drug compound) used for this purpose. 
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 Differentiation of lifetime vs. active use.  Within the literature on 
neuroenhancement (particularly NMUPS), few studies have directly compared correlates 
of this behaviour across different assessment time-frames.  However, the study described 
in Chapter IV also highlights a need for differentiation of active neuroenhancement 
(operationalized as use in the past 30 days; Wickersham et al., 2016) versus lifetime 
neuroenhancement history.  The different pattern of associations elicited by differences in 
NMUPS assessment time-frame suggest that individuals who actively engage in NMUPS 
are distinct from those who have engaged in NMUPS in their lifetime, but not necessarily 
in the past 30 days.  The more active users may constitute a more severe group who are 
differentiated from non-using peers on the basis of poor self-control alone (vs. also poor 
academic performance, as was found for lifetime users) and are therefore in more urgent 
need of intervention. 
 Need for examination of neuroenhancement frequency.  There is a general 
paucity of work investigating frequency of engagement in neuroenhancement (and factors 
associated with more/less frequent engagement in this behaviour; McCabe, West, Teter, 
& Boyd, 2014).  Chapter IV reinforces need for increased examination of 
neuroenhancement frequency and use of dimensional approaches to quantifying 
neuroenhancement.  Indeed, the dimensional measure of neuroenhancement frequency 
derived from the TLFB assessment of NMUPS was not associated with any of the 
academic- or self-control-related variables that were significant factors in the prediction 
of categorical measures of neuroenhancement history (i.e., lifetime and 30-day use 
histories).  As this research effort aimed to explore the specific association of self-control 
with students’ engagement in neuroenhancement behaviour, examination of a broad 
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range of psychological factors that may differentially predispose engagement in various 
modes and frequencies of neuroenhancement was beyond the scope of the current study.  
However, given the apparently meaningful distinctions between various 
modes/frequencies of engagement in neuroenhancement, continued attempts to 
understand psychological factors predisposing different engagement in various 
neuroenhancement “subtypes” are needed.  Deeper investigation of how measurement 
method (i.e., single-item vs. TLFB) impacts neuroenhancement endorsement is also 
warranted. 
Overall Limitations 
 The above-described results must be understood within the context of some 
limitations.  First, the ability to draw causal inferences regarding the nature of the relation 
between trait self-control and neuroenhancement is limited by the correlational, cross-
sectional design utilized in Chapters II and IV.  It is plausible that poor self-control both 
exerts a direct impact on students’ engagement in neuroenhancement (e.g., poor 
estimation of risks associated with neuroenhancement behaviour) and indirectly 
predisposes students to engagement in neuroenhancement by failure over time to 
appropriately work toward long-term goals (e.g., favoring recreational activities over 
studying; putting off projects until just before they are due).  However, alternative 
relations cannot be ruled out, such as the impact of a third variable on both self-control 
and neuroenhancement behaviour.  Although less plausible, it is also possible that 
neuroenhancement engagement exerts an impact on self-control (or, rather, participants’ 
perceptions of their own self-control, given that the preponderance of effects identified in 
the current project involved self-report measures).  The exact nature of these relations 
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cannot be fully delineated based on current data.  Future research may benefit from 
adoption of longitudinal approaches to study the evolution of these interrelated constructs 
throughout the course of students’ academic careers. 
 Although an attempt was made to employ a multi-method approach to the 
measurement of key variables (particularly those related to self-control in Studies 1 and 
3), it also must be emphasized that the majority of effects that emerged nonetheless 
involved self-report variables.  Therefore, the current results may be subject to common 
limitations associated with use of self-report measures, including bias associated with 
common-method variance and social desirability in reporting (Podsakoff et al., 2003; Van 
de Mortel, 2008).  It is therefore recommended that ongoing efforts in this area continue 
to attempt to supplement self-report measures with other approaches that may attenuate 
bias from these sources (e.g., use of performance-based measurement, informant report). 
 The current research effort also utilized a relatively homogeneous sample, 
collected from a single, mid-sized public university in Ontario.  On the whole, 
participants did not endorse participation in competitive academic programs (e.g., the 
majority of students were not in an honours program) and the majority reported academic 
majors within the humanities/social sciences.  Given that neuroenhancement is more 
prevalent in academic settings with competitive admissions criteria (e.g., Ivy league 
universities; McCabe, Knight, Teter, & Wechsler, 2005), it is not clear how current 
findings would generalize to samples collected from more competitive academic 
environments or similarly, from other academic disciplines that tend to have competitive 
retention standards (e.g., pre-med).  However, despite these considerations, high rates of 
endorsement of various modes of neuroenhancement in the current sample reaffirm that 
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neuroenhancement is a widespread phenomenon within the Canadian academic 
landscape.   
 The current project (and the literature surrounding neuroenhancement as a whole) 
was also limited by the lack of standardized, well-validated measures that assess the full 
spectrum of neuroenhancement behaviour.  Indeed, while several brief measures of 
NMUPS are described in the literature (including the measure by Gallucci [2011] utilized 
in Chapter IV), there remains a general paucity of research regarding the utility, 
reliability, and validity of measures designed to assess other modes/frequencies of 
neuroenhancement.  The neuroenhancement survey (used across studies) and the TLFB 
assessment (used in Chapter IV) created for the current project are put forth as possible 
tools for enhancing future measurement of the full spectrum of neuroenhancement-
focused substance use.  However, further study of these measures is needed, including 
comparison to more robust measures developed for assessment of other forms of 
substance use.  Methods less subject to retrospective recall bias, such as ecological 
momentary assessment, have been used successfully in the study of conventional 
substance use (Shiffman, 2009) and therefore also hold promise as a tool for 
measurement of neuroenhancement substance use. 
Conclusions and Implications 
To date, the majority of research investigating neuroenhancement behaviour has 
been epidemiological in nature.  As such, research investigating psychological risk 
factors for neuroenhancement, as was done in the current dissertation, is in its relative 
infancy.  Adding to the literature demonstrating the importance of appropriate self-
regulation for success across functional domains, the three studies contained in this work 
SELF-CONTROL CONTRIBUTIONS TO NEUROENHANCEMENT  
189 
highlight poor trait self-control as a potential risk factor for lifetime entry into 
neuroenhancement and active engagement in this behaviour.  Indeed, individuals with 
poorer self-rated self-control tended to report more favorable views of neuroenhancement 
and indicated greater intent to engage in this behaviour in the future.  Moreover, in the 
case of active neuroenhancement, previous associations of poor academic functioning 
with neuroenhancement could be accounted for on the basis of students’ self-control 
skills.  Thus, an understanding of the essential cognitive capacity of self-control is vitally 
important to understanding the likely multifactorial contributions to students’ 
engagement in neuroenhancement behaviour and associated poor academic outcomes.   
The current findings have broad policy and clinical implications.  First, the 
current project highlights the widespread nature of neuroenhancement, including as 
relates to use of illicit substances and non-medical use of prescription drugs.  The 
frequency with which these behaviours occur suggest that university personnel should be 
prepared to address the issues of fairness, equity, and health/safety that accompany 
increasing engagement in risky substance use for the purposes of neuroenhancement.   
There are also important implications for the demonstrated association of self-
control with the spectrum of neuroenhancement behaviour.  Specifically, these results 
suggest that interventions aimed at improving self-control may assist in curbing the so-
called “neuroenhancement epidemic”, while also equipping students to succeed in other 
domains (e.g., Tangney, Baumeister, & Boone, 2004).  To this end, mindfulness-based 
interventions hold particular promise as a tool for improving self-control (e.g., Elkins-
Brown, Teper, & Inzlicht, 2017); such programming may also reduce risk of 
neuroenhancement by reducing stress and other risk factors for engagement in 
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neuroenhancement substance use.  Thus, in conjunction with other methods targeting the 
multifactorial contributions to students’ neuroenhancement behaviour (e.g., students’ 
perceptions regarding high pressure academic environments; misperceptions regarding 
enhancing effects of common neuroenhancement substances), mindfulness-based 
interventions and other programming targeting improved self-control may assist in 
reducing health-related risk on university campuses. 
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APPENDICES 
Appendix A   
Demographic Questionnaire 
Personal information: 
1. Your current age:    ______ years old 
 
2. Gender:  ______________   
 
3. How do you describe your ethnicity (circle all that apply)? 
a. Aboriginal/First Nations 
b. Black/African descent 
c. East Asian descent 
d. South Asian/Indian descent 
e. Hispanic/Latino 
f. Caucasian or non-Hispanic White/European descent 
g. Arab/Middle Eastern descent 
h. Biracial/Multiethnic 
i. Other (please describe): _____________________________________ 
j. Prefer not to answer 
 
4. Your native (first) language:  
5. Other languages spoken (if applicable):   
 
6. Relationship status (circle one): 
a. Single 
b. In a relationship 
c. Married / in a civil union 
d. Cohabitating 
e. Divorced 
f. Widowed 
g. Prefer not to answer 
 
7. Are you a member of a fraternity, sorority, or other similar group? 
a. Yes (please describe):   
b. No 
 
8. Are you a member of any organized sports teams? (if NO, skip to item #10) 
a. Yes, varsity-level sports at the university (describe):  _____________ 
b. Yes, club sports (describe):   
c. Yes, intramural sports (describe):   
d. Yes, community recreational team (describe):   
e. Other:   
f. No, I am not involved in any sports teams 
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9. On average, how many hours per week do you estimate that you spend on 
activities related to your sports team (e.g., training, practicing, in 
games/matches)? 
 ______ hours per week 
 
10. Current living situation (please circle one): 
a. Living in residence 
b. Living in a fraternity / sorority house 
c. Living off-campus with family 
d. Living off-campus with friends 
e. Living off-campus with acquaintances 
f. Living off-campus with spouse/partner/significant other 
g. Other:   
 
11. Are you employed outside of the home? 
a. yes (please describe position):   
b. no 
c. prefer not to answer  
 
Academic information: 
1. Current year of study (please circle one):     1       2       3       4      5      6+ 
 
2. Current major: _____________________________________________________ 
 
3. Grades:  (note: you can find this information on 
http://my.uwindsor.ca/web/uw/transcripts  click on the current and previous 
semester to expand) 
a. Current cumulative grade average (overall): ___________________________ 
b. Current cumulative grade average (major): ____________________________ 
c. Sessional average for last full semester: ______________________________ 
 
4. Have you ever been diagnosed with a learning disability (circle one): 
a. yes (describe) ___________________________________________________ 
b. no 
 
5. Have you ever been diagnosed with a mental health condition (e.g., depression, 
anxiety, attention-deficit/hyperactivity disorder [ADHD])? 
a. yes (describe) ___________________________________________________ 
b. no 
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6. Please indicate whether a doctor has ever prescribed you each of the following 
medications.  If you have had a prescription for any of the medications, please 
indicate the name/type and approximate dates taken (MM/YYYY – MM/YYYY).  
If you are unsure, it’s okay to estimate. 
 No, I have 
NOT had a 
prescription 
for this 
medication 
Yes, I 
HAVE had 
a 
prescription 
for this 
medication 
Medication 
name/ 
description 
Dates 
Taken 
Methylphenidate (e.g. 
Ritalin) 
    
Amphetamine (e.g. 
Adderall) 
    
Modafinil (e.g. 
Provigil) 
    
Omecetin (e.g. 
Cognient) 
    
Other ADHD 
medication 
    
Beta blockers     
Other antidepressant 
medication 
    
Other anxiety 
medication 
    
Other mental health 
medication 
    
 
7. Have you ever received educational accommodations (e.g. Individual Education 
Plan [IEP], extra time to take tests, etc.)? Please include time before you entered 
the University of Windsor. 
a. yes (describe) ___________________________________________________ 
b. no 
 
8. Are you currently receiving educational accommodations or services through the 
Student Disabilities Office (e.g. Individual Education Plan [IEP], extra time to 
take tests, etc.)? 
a. yes (describe)___________________________________________________ 
b. no  
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For the following questions, please circle the response that best applies to you: 
1 
very false 
for me 
2 
somewhat false 
for me 
3 
somewhat true 
for me 
4 
very true 
for me 
 
 very 
false 
for me 
somewhat 
false for 
me 
somewhat 
true for 
me 
very 
true for 
me 
1. I enjoy school. 1 2 3 4 
2. I am excited by my program of 
study.  
1 2 3 4 
3. School is difficult.  1 2 3 4 
4. I feel pressure to succeed.  1 2 3 4 
5. The academic atmosphere at this 
university is competitive. 
1 2 3 4 
6. I have what it takes to succeed 
academically. 
1 2 3 4 
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Appendix B 
Quantity Guidelines for Timeline Follow-Back Reporting of NMUPS 
Substance Amount represented by “1” 
Coffee One average-sized cup 
Energy Drinks One standard energy drink or packaged 
“energy shot” (e.g. Five Hour Energy) 
Caffeine pills One 100mg tablet 
Herbal supplement One dose as indicated on packaging (if 
multiple types of supplements, count each; 
e.g. if one vitamin and one omega-3, this 
counts as 2) 
Probiotics One dose as indicated on packaging (if 
multiple types of probiotics, count each; e.g. 
if one supplement and one serving of yogurt 
for cognitive enhancement, this counts as 2) 
Alcohol 12 oz. beer  
10 oz. wine cooler  
4 oz. wine  
1 oz./1 shot 100 proof liquor 
1 ¼ oz. (one shot) 80 proof liquor 
1 cocktail with one shot as described above 
Nicotine 1 average-sized cigarette 
Approx. 15 puffs on an e-cigarette 
One piece of nicotine chewing gum 
One pouch of chewing tobacco 
Cannabis Number of “times” used cannabis on given 
day – one occasion where smoked one 
joint/bowl/pipe/bong/vaporizer etc. within 
one time period.  For example, if split one 
bowl with a friend, that would be one 
“time”; if repacked it and smoked it again, 
that would be two “times” so would record 
2 for that day 
Other illicit substances Used an illicit substance on that day  
Methylphenidate Number of pills per day 
Amphetamine Number of pills per day 
Modafinil Number of pills per day 
Other ADHD Number of pills per day 
Beta blockers Number of pills per day 
Other prescription medication Number of pills per day 
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